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1. Summary 
 
The life cycle of mRNA, from transcription to decay, is a tightly regulated biological process. mRNA is an 
essential molecule that the cell utilizes to alter gene expression. Degradation is one process through which 
the cell can regulate mRNA levels. P-bodies constitute the main mRNA decay pathway in yeast cells and are 
induced in response to various stresses. The presented work aimed to create a better understanding of P-
body localization and regulation and to uncover the mRNAs contained within them. 
A former graduate student in the lab examined P-body formation in secretory mutants and how 
this stress differed from other stresses such as starvation. Surprisingly, she found numerous P-bodies were 
induced in secretory mutants. Similarly, the addition of Ca2+ was able to phenocopy  the increased P-body 
induction as seen in secretory mutants. The calcium-binding protein calmodulin, as well as the core P-body 
proteins Scd6 and Pat1, were required for the formation of these P-bodies. In addition, different pathways 
appeared to control P-body number. Lastly, we observed that in yeast, P-bodies occur in close proximity to 
the ER, implying that the ER may play a role in post-transcriptional regulation. 
This finding that P-bodies were associated with the ER led us to examine proteins that may regulate 
the formation of P-bodies. Through a crosslinking tandem affinity purification approach we were able to 
identify several P-body components as well as two polysome-associated ER localized proteins: Scp160 and 
Bfr1. We went on to show that Scp160 is able to associate with P-body components in an mRNA dependent 
manner at polysomes. Loss of either BFR1 or SCP160 caused the formation of many Dcp2 positive foci under 
normal growth conditions, suggesting that Bfr1 and Scp160 may be inhibiting the formation of P-bodies. 
Furthermore, in ∆scp160 cells P-bodies failed to properly assemble, indicating the Scp160 is required for P-
body assembly. Despite the increase in P-body number under normal growth conditions, general translation 
was unaffected, thus, uncoupling P-body formation and translation attenuation. Taken together, our results 
suggest that Bfr1 and Scp160 inhibit P-body formation under normal growth conditions, possibly by limiting 
the mRNA that is passed from polysomes to P-bodies. 
Lastly, we modified a published protocol to uncover the mRNAs that are contained within P-bodies 
under various stresses. Several rounds of trials and changes were performed and although these 
modifications were not sufficient to produce a library for deep sequencing, our group has further developed 
the method and now has a reliably working protocol.  
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Protein Sorting in Eukaryotic Cells 
 
The trafficking of proteins is crucial for cell survival. While many proteins remain cytosolic, the secretory 
pathway acts as a packaging and shipping route for membrane-bound proteins. In the yeast cell, 
approximately half of all the proteins produced will take this route and be sorted into various organelles 
(Lodish et al., 2003). The secretory pathway directs proteins from the endoplasmic reticulum (ER) through 
the Golgi complex and ultimately to the plasma membrane or another organelle within the cell. In order for 
cargo proteins to travel between these compartments, they must be packaged into small membrane-
enclosed carriers, known as vesicles. Various coat proteins in the cell recognize cargo proteins and deform 
the membrane, which eventually leads to vesicle budding (Schekman and Orci, 1996). Three coat complexes 
are well characterized: COPII, COPI, and clathrin. COPII transports cargoes in an anterograde manner from 
the ER to the Golgi complex, COPI mediates transport within Golgi cisternae and retrograde transport from 
the Golgi to the ER, and clathrin is involved in the transport of vesicles between the trans-Golgi network 
(TGN) and the plasma membrane (Bonifacino and Glick, 2004; Fig. 2.1). In addition to coat proteins, GTP-
binding proteins regulate the spatial and temporal aspects of vesicular traffic. One such protein, the small 
GTPase Arf1 is responsible for COPI and clathrin coat assembly and is a critical component in vesicular 
formation at the Golgi (D’Souza-Schorey and Chavier, 2006).  
 
 
Figure 2.1: The secretory pathway mediates the transport of cargo proteins throughout the cell. 
Coat proteins aid in the recognition and transport of cargoes at various compartments within the cell. COPII 
coated vesicles (blue) travel from the ER to the Golgi, COPI coated vesicles (red) transport cargoes within the 
Golgi stacks as well as from the Golgi to the ER and clathrin coated vesicles (yellow) mediate transport between 
the Golgi and plasma membrane. Arf1 regulates several transport steps at the Golgi. (From Bonifacino and Glick, 
2004). 
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The small GTPase Arf1 
 
Small GTPases are involved in a wide array of cellular processes including, but not limited to, cell 
differentiation, cell growth, and vesicular transport. GTPases act as switches, turning on when bound to 
GTP and off when bound to GDP (ten Klooster, 2007; Gillingham, 2007). The exchange of GDP to GTP is 
catalyzed by Guanine nucleotide Exchange Factors (GEFs) and GTP to GDP hydrolysis is facilitated by GTPase 
Activating Proteins (GAPs; Fig. 2.2). 
  One family of small GTPases is the ARF family, which is conserved from yeast to mammals. In yeast 
three different Arf proteins are expressed: Arf1, Arf2, and Arf3. Arf1 and Arf2 arose through gene 
duplication and share 96% identity, but Arf1 is up to 10 times more abundant than Arf2 (Sterns et al., 1990, 
Kahn et al., 2005). Although single deletions of ARF1 or ARF2 are viable, the double deletion is lethal. Arf3 
is important for the organization of the actin cytoskeleton as well as cell polarity, but it is not essential for 
survival of the cell (Huang et al., 2003; Lambert et al., 2007; Tsai et al., 2008).  
Arf1 is involved in many different processes within the cell. Aside from its well-defined role in 
vesicular trafficking at the Golgi, Arf1 is an activator of phospholipase D in phospholipid metabolism and is 
involved in the regulation of the actin cytoskeleton (Brown et al, 1993; Jones et al., 2000; Fucini et al., 2000; 
Myers and Casanova, 2008). In addition, recent studies have implicated Arf1 as having a role in mRNA 
transport and turnover (Trautwein, 2004; Kilchert, et al, 2010; Kilchert and Spang, 2011). There are likely 
more roles of Arf1 in the cell that are yet to be uncovered.  
 
Figure 2.2: The GTPase cycle of Arf1 
The guanine nucleotide exchange factor (GEF) activates cytosolic GDP-Arf1. It then is able to associate with the 
membrane. Inactivation of Arf1 takes place through GTPase activating proteins (GAPs). (From Trautwein, 2004) 
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Previously our lab performed a differential affinity chromatography screen for novel Arf1 
interacting proteins. One of the hits that bound specifically to the active form of Arf1 was the poly(A) 
binding protein Pab1 (Trautwein et al., 2004). Pab1 is an essential protein, which binds the mRNA poly(A) 
tail, thus stabilizing the mRNA, and is a major translational activator in the cell (Tarun and Sachs, 1995). The 
interaction between active Arf1 and Pab1 was mRNA dependent and Arf1-Pab1 ribonucleoprotein 
complexes (mRNPs) could be immunoprecipitated from a yeast lysate (Trautwein et al., 2004). In addition, 
vesicular coat components were also constituents of the Arf1-Pab1 mRNP. Moreover, COPI vesicles 
generated in vitro from Golgi membranes contained the Arf1-Pab1 complex (Trautwein et al., 2004). More 
recent studies revealed that mRNA is also associated with COPI vesicles in neurons (Bi et al., 2007; Peter et 
al., 2011). These findings collectively link mRNA transport and vesicular traffic. Furthermore, the 
involvement of Arf1 in mRNA transport opens the possibility that it may play a role in gene expression. 
 
The Life Cycle of mRNA 
 
In eukaryotic cells, gene expression is a 
tightly controlled process. Changes in 
mRNA levels are one way through which 
gene expression is regulated. From the 
moment that a gene is transcribed into 
mRNA in the nucleus until its decay, 
various RNA binding proteins (RBPs) cover 
the mRNA (Fig. 2.3). With roughly 10% of 
the yeast genome encoding RBPs, there is 
little doubt that RNA regulation is a 
complex process  (Hogan, et al., 2008). To 
date certain binding motifs in mRNA have 
been identified, which allows for the 
mRNA to be recognized and bound by 
RBPs. These sequences can direct the 
movement of mRNA to a specific location 
in the cell, promote or repress translation, 
and even facilitate mRNA storage or 
decay. In the end, the RBPs which once 
protected the RNA will eventually be 
replaced with those that will lead to its decay. 
 
Figure 2.3: Life cycle of an mRNA 
From the transcription of RNA (blue line) in the nucleus 
until its decay in the cytoplasm, RNA is covered in a variety 
of RNA binding proteins (different colored ovals). (Modified 
from McKee and Silver, 2007) 
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RNA binding proteins 
 
RNA binding proteins (RBPs) form a complex regulatory network that controls all stages of the RNA lifecycle. 
RBPs, together with mRNA and associated proteins form mRNP complexes. mRNP association begins in the 
nucleus when newly transcribed mRNA is bound by RBPs. As it moves out of the nucleus and into the 
cytoplasm, the mRNPs must remodel appropriately. One example of RBP remodeling occurs when an mRNA 
is shuttled into the translational pool. Once the mRNA is exported from the nucleus and into the cytoplasm, 
export factors are exchanged with translation initiation factors and eventually the mRNA is bound by 
ribosomes and translated into protein.  
The exchange of proteins on mRNA is mediated by a wide variety RNA binding domains (RBD), which 
have different mRNA  binding affinities. The identification of amino acid (aa) motifs and domains that bind 
RNA was facilitated through the discovery of heterogeneous nuclear ribonucleoproteins (hnRNP) and other 
pre-mRNA/mRNA-binding proteins (Burd et al., 1994). To date there are several different classes on RBPs 
based on their RNA binding domains, including, but not limited to: RNA recognition motifs (RRM), hnRNP 
K-homology (KH) domains, Sm domains, and DEAD box domains (Glisovic et al., 2008; Fig. 2.4). Additionally, 
many RBPs contain several different RBDs, creating functional diversity amongst the proteins. Having 
multiple copies of the same RBD may allow for the protein to recognize a larger target, whereas having a 
variety of RBDs may lead to higher target specificity.  
  
 
 
mRNA Localization  
 
The localization of mRNA has proven to be a critical step in gene regulation. Thirty years ago the first 
asymmetrically localized mRNA was discovered in Ascidian eggs (Jeffery et al, 1983). In the following years, 
Figure 2.4: The diversity of 
RNA binding domains in 
eukaryotic cells RBPs 
demonstrate a huge diversity of 
binding domains. Listed are 
examples of different eukaryotic 
RNA binding proteins. The box at 
the right contains examples of 
different, known RBDs (different 
colors indicate different 
domains). The RBPs may contain 
the same domains, as seen in 
PABP or vigilin, or may contain a 
variety of different RBDs such as  
in the RNAi pathway protein 
Dicer. (From Glisovic et al., 
2008) 
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the specific localization of several RNAs was noted throughout eukaryotes from yeast to chicken cells (Holt 
and Bullock, 2009). A recent high throughput study in Drosophila shed light on how common it is for cells 
to localize mRNA. Of the over 3000 mRNAs examined in Drosophila oocytes and embryos, more than 70% 
showed a specific subcellular localization (Lécuyer et al., 2007).  
 In order for mRNA to properly localize in the cell, many mRNAs contain signal sequences known as 
zip codes (Singer, 1993), which allow for specific RBPs to bind and facilitate intracellular mRNA transport. 
Defining a zip code is not particularly simple as they may not be linear sequences, but are often 
characterized by structural features and can be found in the 5’ UTR, coding sequence, or 3’UTR of the mRNA 
(Jansen, 2001).  
 Until recently, it was thought that mRNA localization was the exception to the rule. Though not 
every mRNA is localized to specific areas in the cell, mRNA localization is a common way to regulate gene 
expression. Once an mRNA that must be localized is bound by the appropriate RBPs, the RNP complex is 
transported, via motor proteins or through diffusion, to the site where it will be translated. In many cases 
translation is halted during mRNA transport. Motor proteins and the cytoskeleton play a major role in the 
transport of these RNP complexes (Jansen, 2001; Holt and Bullock, 2009). Upon reaching its destination, 
the mRNA is anchored and translational repression is relieved. A key example of an actively localized mRNA 
is the yeast mRNA ASH1, which is involved in the inhibition of mating type switching and is localized to the 
bud tip in growing yeast cells (Long et al, 1997; Takizawa et al., 1997). It is transported via actin cables from 
the mother cell to the daughter cell in stalled state via RBPs known as the SHE machinery. Once ASH1 
reaches the bud tip, the repressor protein Khd1 is phosphorylated by the kinase Yck1, which in turn allows 
for the translation of ASH1 mRNA locally (Paquin et al., 2007). Another form of active, directed transport is 
by co-translational transport as is the case with signal recognition particle (SRP)-dependent mRNAs and 
ABP140 mRNA (Walter and Blobel, 1981; Kilchert and Spang, 2011). In both cases, the exposed nascent 
peptide directs the complex to the location where it will be translated. SRP recognizes the nascent peptide 
of SRP-dependent mRNAs present in the cytoplasm, halts translation, and targets these mRNA-ribosome-
nascent protein complexes to the ER where translational repression can be alleviated (Walter and Blobel, 
1981). In the case of Abp140, the N-terminal portion of the protein encodes for an actin-binding domain. 
Once this peptide is exposed during translation, it binds to actin cables and the complex of mRNA, nascent 
protein, and polysomes are transported through retrograde flow to the distal pole of the yeast (Kilchert and 
Spang, 2011).  There is also evidence that mRNA can be transported in RNPs via vesicles and ER (Trautwein 
et al, 2004; Bi et al., 2007; Gerst, 2008; Peter et al., 2011). As mentioned previously, Pab1-Arf1 mRNPs were 
found to associate with COPI vesicles, suggesting that mRNA may also be transported on vesicles (Trautwein 
et al., 2004). Lastly, several mRNAs, such as SRO7, SEC4, WSC2, EAR1 and CDC42 have been shown to anchor 
to the ER and “hitch a ride” to a new location, such as the bud tip in yeast (Aronov et al., 2007; Fundakowski 
et al., 2012).       
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But why would a cell want to localize its mRNA? By localizing mRNA, a cell can perform localized 
protein synthesis, which in turn creates an asymmetry in the cell and generates polarity. One example is 
bicoid and oscar mRNAs in Drosophila, where mRNA localization sets up a protein gradient which induces 
cell polarization (Berleth et al., 1988; Kim-Ha et al., 1991). The transport of a single mRNA is far more energy 
efficient for the cell than it would be to transport many proteins (Jansen, 2001). By transporting this mRNA, 
proteins can be synthesized locally, thus preventing any harmful effects that may occur due to ectopic 
expression. Additionally, mRNA localization is important for mRNA metabolism and depending on the state 
of the cell, mRNAs may need to be shuttled out of translation and into sites of decay. 
 
Processing bodies 
 
Processing bodies (P-bodies) are highly conserved non-membrane bound mRNPs implicated in silencing, 
storage, and decay of mRNA. The core constituents of P-bodies are involved in translational repression and 
mRNA decay. One feature of P-bodies is their inducibility in response to different stresses such as oxidative 
stress, starvation, or hyper-/hypo-osmotic stress (Teixeira and Parker, 2007). Ribosomal proteins are not 
found in P-bodies and it appears that the P-body mRNP must be free of ribosomal proteins before further 
aggregation can occur (Cougot et al 2004; Eulalio, et al 2007; Teixeira, et al 2005). P-bodies are highly 
dynamic structures, and fluorescence recovery after photobleaching (FRAP) experiments revealed that 
many components cycle in and out of P-bodies (Andrei et al., 2005; Kedersha et al., 2005; Guil et al., 2006; 
Aizier et al., 2008).  A major component of P-bodies is mRNA in various states of decay. Accordingly, P-
bodies are observed to dissociate during RNase treatment in yeast cell extracts or permeabilized Drosophila 
S2 cells (Teixeira et al., 2005; Eulalio et al., 2007), or in situations where mRNAs are locked on ribosomes 
using translation elongation inhibitors (Cougot et al., 2004; Eulalio et al., 2007b; Teixeira et al., 2005). It was 
established that P-bodies were not exclusively sites of mRNA decay (Brengues et al., 2005; Bhattacharyya 
et al. 2006).  During starvation conditions, reporter mRNAs move into P-bodies and are released back into 
the pool of translation after the stress is alleviated. This process required translation initiation for mRNAs 
to exit P-bodies (Brengues et al., 2005), however the exact factor involved in moving mRNA out of P-bodies 
and back into translation remains elusive. Therefore, not every mRNA that enters into a P-body is destined 
for decay, but may be returned to translational once the stress is terminated.  
 
Composition of P-bodies 
 
P-bodies constitute one of the two major pathways of mRNA decay in eukaryotic cells, the other pathway 
being via the exosome. Both P-bodies and the exosome first require that the poly(A) tail of the mRNA be 
shortened through deadenylation by the predominant deadenylase in the cell, the Ccr4-Not complex 
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(Tucker et al., 2001; Wiederhold and Passmore 2010; Fig. 2.5). In P-bodies, mRNA is decayed from 5’ to 3’, 
whereas the exosome degrades in the 3’ to 5’ direction. 5’ to 3’ decay is how the bulk of mRNAs are decayed 
in S. cerevisiae (Parker and Song, 2004; Parker and Sheth, 2007).  
 
 
 
After the poly(A) tail is shortened, the mRNA is subjected to decapping by the complex consisting 
of Dcp1 and Dcp2 (Fig. 2.6). Dcp2 is the catalytic subunit of the decapping complex that removes the m7-
GDP cap. In vitro studies have shown that Dcp2 is able to decap mRNA alone, but addition of Dcp1 greatly 
enhances the process (Schwartz and Parker, 2000; She et al, 2004; She et al, 2008; Deshmukh et al., 2008). 
After removal of the cap, the mRNA becomes a substrate for degradation by the 5’ to 3’ exonuclease Xrn1 
(Larimer et a., 1992; Decker and Parker, 1993; Muhlrad et al., 1994; Beelman et al., 1996; Dunckley and 
Parker, 1999). 
At the 3’ end of the mRNA, a heptometric ring complex, consisting of the proteins Lsm1-7, 
surrounds the RNA. Lsm1-7 interacts with Pat1, which acts as a scaffold for the decapping complex and 
promotes the assembly of the P-body. Moreover, the Lsm1-7/Pat1 complex is required for the efficient 
decapping of mRNA (Bouveret et al., 2000; Tharun et al., 2000; Tharun et al., 2005; Chowdhury et al., 2007; 
Fig. 2.6). 
 
Figure 2.5: The 
conserved mRNA 
decay pathways 
mRNA is 
deadenylated by 
the Ccr4-Not 
complex followed 
by degradation via 
the exosome (left) 
in the 3’ to 5’ 
direction or 
decayed in the 5’ to 
3’ via P-body 
components. 
(Modified from 
Parker and Sheth, 
2007) 
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Table 2.1: 
Protein components of P-bodies  (S: S. cerevisiae; C: C. elegans, D: D. melanogaster, M: Mammals) 
 
 
Dhh1, Edc3, and Scd6 complete the set of core proteins in a P-body (Table 2.1; Fig. 2.6). Dhh1 is a 
DEAD box RNA helicase that unwinds RNA. It also plays a role in inhibiting translation initiation and is 
required for efficient decapping (Coller et al., 2001). Edc3 and Scd6 are both RNA binding proteins. Edc3 
plays a major role in aggregation of P-bodies and, like Pat1, serves as a scaffold for decapping factors 
(Decker et al., 2007). Scd6 was originally found as a suppressor of clathrin deficiency indicating that aside 
from a role in P-bodies it may be involved in vesicular trafficking (Nelson and Lemmon, 1993). New studies 
indicate the Scd6 is able to repress translation by binding to eIF4G (Rajyaguru et al., 2012). Scd6 also 
functions in stimulating the decapping of specific mRNAs (Jain and Parker, 2013). Furthermore, both Edc3 
and Scd6 compete for the same interaction site on Dcp2 and stimulate decapping, likely by preventing the 
decapping complex from adopting an inactive conformation (Fromm et al., 2011). In addition to the 
components mentioned above, the list of P-body associated proteins is ever growing and future studies will 
be needed to determine their exact role in P-body formation (Sweet et al, 2007; Swisher and Parker 2010; 
Jain and Parker, 2013).  
 
Core Components Function Organism 
Dcp1 Decapping enzyme subunit S, C, D, M 
Dcp2 Catalytic subunit of the decapping 
enzyme 
S,C,D,M 
 
Dhh1 DEAD box helicase; activator of 
decapping; required for translational 
repression 
S,C,D,M 
Edc3 Decapping activator S,D,M 
Lsm1-7 Decapping activator S,C,M 
Pat1 Decapping activator and translational 
repressor 
S,C,D,M 
Scd6 Translational repressor S,C,D,M 
Xrn1 5’ to 3’ exonuclease S,M 
   
Figure 2.6: The core components in yeast 
P-bodies 
Two complexes are recruited to mRNA 
targeted for 5’ to 3’ degradation. The 
decapping complex, made up of Dcp1 and 
Dcp2, is recruited to the 5’ end of the RNA, 
whereas the Lsm1-7/Pat1 complex 
associates with the deadenylated 3’ end.  
Additionally, the RNA helicase Dhh1, the 
enhancer of decapping Edc3, the exonuclease 
Xrn1, and translational repressor Scd6 make 
up the core proteins in a P-body  (From 
Nissan et al, 2010) 
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P-body Aggregation 
 
The formation of P-bodies is caused through the aggregation of individual, submicroscopic P-body mRNPs 
under stress conditions. This larger structure, the P-body, can be visualized under the microscope. Many of 
the core proteins found within P-bodies contain aggregation domains, including glutamine-asparagine 
(Q/N) rich-domains (Fig. 2.7; Reijns, 2008). The best studied of these Q/N rich regions in P-bodies is the 
Lsm4 C-terminus and deletion of this domain impairs P-body assembly (Decker et al., 2007; Reijns et al., 
2008). Additionally, Edc3 harbors a self-aggregation domain (Yjef), which is also important for the formation 
of P-bodies in yeast. The simultaneous deletion of EDC3 and the C-terminus of Lsm4 results in the loss of 
macroscopic P-bodies (Decker et al., 2007; Reijns et al., 2008). The occurrence of aggregation domains in P-
body components may be required to quickly form large P-body aggregates under stress conditions. It is 
concevible that phosphorylation or other post-translational modifications may occur on Q/N containing P-
body components in response to specific stresses. Indeed two P-body proteins, Dcp2 and Pat1, contain 
phosphorylation sites that alter their recruitment to P-bodies (Yoon et al., 2010; Ramachandran et al., 
2011). Post-translational modifications that may change other P-body proteins have not yet been 
described. These modifications may allow for masking/unmasking of Q/N rich domains, allowing it to 
become available for binding and, thus, target proteins to P-bodies.  
 
 
Dynamic Equilibrium 
 
There are two main models that have been proposed regarding the formation of P-bodies upon stress 
induction: dynamic equilibrium and signaling pathways. It has been proposed that under normal growth 
conditions, mRNA is bound by translation initiation factors and ribosomes and shuttled into the pool of 
translation. If a cell encounters stress, mRNAs would be released from ribosomes and bound by 
translational repression factors. This balance between translation and decay is referred to at dynamic 
equilibrium (Coller and Parker, 2005). Thus, blocks in translation would tip the scales away from translation 
and shuttle mRNAs into P-bodies (Fig. 2.8).  
Figure 2.7: P-body 
components contain Q/N rich 
regions 
Schematic representation of the 
Q/N rich areas (white boxes) 
found in various P-body 
proteins. The length of the 
protein is indicated in numbers 
of aa. 
** indicate components of the 
Ccr4/Not deadenylase complex. 
(Modified from Reijns et al., 
2008) 
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There seems to be at least two different categories of P-bodies: P-bodies formed during non-
adaptive stress and P-bodies formed during adaptive stress. In a non-adaptive stress, e.g. starvation, the 
cell may try to adapt to its environment, but it is unable to and in order for the stress to be alleviated, a 
food source must be re-introduced. During starvation very few P-bodies are present in the cell 
(approximately 1-3 P-bodies) and they persist as long as the cell remains starved (Brengues et al, 2005; 
Teixeira et al., 2005). When general translation is observed under starvation, the dynamic equilibrium 
model holds true; translation is strongly attenuated and P-bodies form (Coller and Parker, 2005). 
On the other hand, adaptive stress such as hyperosmotic stress results in the formation of many, 
highly dynamic P-bodies, disappearing after roughly 30 minutes (Romero-Santacreu et al., 2009; Kilchert et 
al, 2010). When the cell is exposed to hyperosmotic stress, translation is not as strongly attenuated as in 
starvation; rather it displays an intermediate monosome to polysome level. These findings indicate that P-
body number is likely not linked to the level of translation attenuation. 
 If stresses are then combined, i.e., starvation and hyperosmotic stress, one might predict based on 
the dynamic equilibrium model, strong translational attenuation and few P-bodies as is seen in starvation. 
Surprisingly, translation is strongly attenuated, even to a greater extent than starvation alone, but multiple 
P-bodies, as are seen in the hyperosmotic stress, persist (Kilchert et al., 2010). These findings indicate that 
P-body number does not necessarily correlate with the strength of the translational block, but rather on 
the stress that the cell encounters. This also highlights that the dynamic equilibrium model is not enough 
to explain P-body formation under every stress the cell encounters and that there are signals other than 
translational repression that cause P-body formation. 
 
  
 
Figure 2.8: The dynamic equilibrium model of translation and repression  
Coller and Parker proposed that there is a constant competition between mRNA translation and repression. 
mRNAs can either be in a translationally active state or bound by translational repressors and shuttled into P-
bodies. If the cell becomes stressed, the mRNA is shuttled out of translation and the equilibrium shifts towards 
repression. (Coller and Parker, 2005) 
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Signaling pathways in P-body formation 
 
Recent work has implicated cellular signaling pathways in assembly of P-bodies in yeast. In secretory 
mutants, numerous P-bodies were formed upon shift to the non-permissive temperature (Kilchert et al., 
2010). Addition of Ca2+ to wild type cells mimicked the P-body formation observed in secretory mutants. 
These Ca2+ induced P-bodies required the calcium binding protein calmodulin and the P-body proteins Scd6, 
Pat1, though it is unclear if these proteins act in parallel or if calmodulin is upstream of the P-body 
components. It was proposed that calmodulin would sense the change in intracellular calcium levels and 
then promote P-body formation through Scd6 and Pat1 (Kilchert el al., 2010). Future work to determine the 
interaction partner for calmodulin as well as how it interacts with P-body components would provide 
further insight into P-bodies induced through calcium signaling.  
 Moreover, inactivation of the protein kinase A (PKA) signaling pathway appears to be both 
necessary and sufficient for P-body formation under glucose starvation (Ramachandran et al., 2011). PKA 
directly phosphorylates the scaffolding protein Pat1, which in turn disrupted interactions with other P-body 
components, such as Dhh1, thereby preventing P-body formation. Perhaps the phosphorylation of Pat1 
causes masking of its Q/N domain, which would reduce the association of other P-body proteins. 
Furthermore, nutrient sensing pathways involving kinases such as TORC1 and Snf1 were tested, but they 
did not significantly effect P-body formation (Ramachandran et al., 2011). The decapping protein Dcp2 is 
also phosphorylated, not through PKA, but through direct phosphorylation by the MAP kinase Ste20 (Yoon 
et al; 2010). Dcp2 was specifically phosphorylated under stresses such starvation, hydrogen peroxide 
treatment, or high cell density, but not during exponential growth. Further investigation revealed that the 
phosphorylation of Dcp2 affects its accumulation in P-bodies, its interactions with other P-body proteins, 
and may modulates the levels and/or decay of certain yeast mRNAs (Yoon et al., 2010). These studies 
provide evidence for the role of different signaling pathways in the formation of P-bodies. 
   
P-body localization 
 
How P-bodies move within the cell has been the subject of several recent studies (Yang et al., 2004; Kedesha 
et al., 2005; Sweet et al., 2007; Aizer et al., 2008, Loschi et al., 2009). Work in mammalian cells observed 
that P-bodies were motile structures and able to associate with actin bundles and microtubules (Kedersha 
et al., 2005; Aizer et al., 2008). Dynein was also observed to localize to mammalian P-bodies under specific 
stress conditions (Loschi et al., 2009).  There is conflicting evidence over the localization of P-bodies to the 
yeast cytoskeleton. Under conditions of microtubule disruption, P-bodies could still aggregate and 
colocalized with the microtubule protein Tub1 (Sweet et al., 2007). Another study identified Myo2 (a class 
V myosin motor) as a member of a large mRNP complex containing P-body components. Loss of actin cables 
through treatment with latrunculin A caused P-bodies to dissociate from the cell cortex and aggregate in 
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the cytoplasm (Chang et al., 2008). Further studies may uncover whether P-bodies are truly able to localize 
to both components of the cytoskeleton.  
In addition to their localization with the cytoskeleton and motor proteins, P-bodies associate with 
a variety of membrane bound organelles in different organisms. In Drosophila, P-body-like granules 
associate with ER exit sites and are required for their proper function (Wilhelm et al, 2005). Similarly, P-
bodies in yeast were shown to localize to the ER through biochemical and immuno-electon microscopy 
studies (Kilchert, et al., 2010). Moreover, the P-body component Scd6 and its orthologues appear to be 
important for membrane function. In yeast, overexpression of Scd6 suppresses a mutation of clathrin and 
in Drosophila and C. elegans, mutations in the Scd6 orthologues alter the dynamics of the ER (Nelson and 
Lemmon, 1993; Wilhelm et al., 2005, Squirrell et al., 2006). Interactions between P-bodies and 
multivesicular bodies (MVBs), transport vesicles destined for lysosomal degradation, have been reported 
in Drosophila and mammalian cells (Gibbings et al., 2009; Lee et al., 2009).  The P-body associated proteins 
GW182 and Argonaute, which are important in miRNA mediate silencing, localize to MVBs. Blocking 
formation of MVBs leads to defective P-body assembly and loading of RISC, ultimately impairing silencing 
(Lee et al., 2009). Further evidence suggests that MVBs may serve as an organizing center for recruiting and 
loading RISC. P-bodies have also been observed to associate with the mitochondria in a microtubule 
dependent manner in various human cell lines (Huang, et al., 2011).  It was noted that although P-bodies 
were found within 25 nm of the mitochondria by electron microscopy, no such localization to ER or MVBs 
was observed (Huang, et al., 2011). To date, no association of P-body components with mitochondria has 
been reported in yeast. In contrast, early studies of P-bodies in mammalian cells observed that by 
immunoelectron microscopy GW-182, a mammalian P-body protein, localized adjacent to the cytoplasmic 
face of the nuclear envelope, which is continuous with the ER (Yang et al., 2004). The ER and mitochondria 
form contact sites to exchange lipids and Ca2+ (Rizzuto et al., 1998; Kornmann et al., 2009), and it may be 
that certain conditions require mammalian P-bodies to more closely associated with either the ER or the 
mitochondria. The significance of the P-body-mitochondria interaction remains to be explored, but the 
contacts may allow for the exchange of specific mRNAs (Weil and Hollien, 2013). The association of P-bodies 
with different organelles and the cytoskeleton allows for a variety of possibilities. These organelles may 
exchange proteins or mRNAs with the P-bodies,  they may act as a means of transport for P-bodies through 
the cell, or act as a recruitment platform for RNA silencing machinery. Despite these studies it is not yet 
clear how and why P-bodies associate with the cytoskeleton and different membrane bound organelles 
within the cell.  
 
Additional roles for P-bodies in higher eukaryotes 
 
As mentioned previously, P-bodies are highly conserved from yeast to mammals. In mammalian cells, P-
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bodies appear morphologically different than in yeast (Yang et al., 2004; Kilchert et al., 2010; Erickson et 
al., 2011; Huang et al., 2011). By electron microscopy, yeast P-bodies often appear as a ring-like structure 
approximately 40-100 nm in diameter and in close proximity to the ER (Kilchert et al., 2010). In mammalian 
cells, P-bodies appear as electron dense clusters and range in size from 100-300 nm (Yang et al., 2004; 
Huang et al., 2011). Besides their role in mRNA decay, P-bodies are also sites that contain RNA interference 
(RNAi) machinery. In higher eukaryotic cells, microRNAs (miRNA) and small interfering RNAs (siRNAs) are 
important for post-transcriptional gene regulation. Members of the RNA induced silencing complex (RISC) 
have been shown to overlap with P-bodies and many P-body components are required for efficient miRNA 
silencing (Jakymiw et al., 2005; Liu et al., 2005; Pillai et al, 2005; Behm-Ansmant et al, 2006; Chu and Rana, 
2006; Eulalio et al., 2007b). P-bodies have been observed in neurons and at post-synaptic sites in dendrites, 
suggesting that the may control local mRNA translation and turnover and contribute to synaptic plasticity 
(Zeitelhofer et al., 2008). For local protein synthesis to occur in a spatial and temporally restricted manner 
in neurons, mRNAs must be kept translationally quiescent during transport. Furthermore, many P-body 
components are essential for this long-range transport of silenced mRNAs in neuronal mRNPs  (Kiebler and 
Bassell, 2006; Barbee et al, 2006). Lastly, viruses even hijack P-body components, which often are required 
for the completion of the viral life cycle (Beckham and Parker, 2008).  
Stress Granules 
 
Stress granules have been thoroughly studied in metazoan systems and were recently discovered in 
budding yeast (Hoyle et al., 2007; Buchan et al., 2008; Gaillard et al., 2008; Grousl et al., 2009). They are 
non-membrane bound mRNPs that harbor the translation pre-initiation complex including translation 
initiation factors, translational activators, ribosomal subunits, and polyadenylated mRNA (Table 2.2; Buchan 
and Parker, 2009). Like P-bodies, stress granules are induced in response to stress, although the types of 
stresses that induce P-bodies and stress granules differ. Furthermore, the composition of stress granules 
appears to be stress-type dependent and their composition has been observed to change over time 
(Kedersha et al., 1999; Stoecklin et al., 2004; Kedersha et al., 2005; Serman et al., 2007, Mollet et al., 2008).  
There is evidence that stress granules may stem from P-bodies or vice versa, though this is still a 
matter of debate. During starvation in yeast, for example, P-body formation occurs prior to stress granules 
formation, but stress granules initially overlap with the pre-existing P-body (Hoyle et al., 2007; Buchan et 
al., 2008). Not all stress granules form in association with P-bodies though and there is evidence in 
mammalian and yeast cells that the two mRNPs can also form independently (Mollet et al., 2008; Buchan 
et al., 2008; Fig. 2.9). The interaction between P-bodies and stress granules suggests an mRNP cycle where 
components from each complexes as well and mRNA and proteins can be readily exchanged (Parker and 
Sheth, 2007; Buchan and Parker, 2009). Further studies into P-body and stress granule dynamics have 
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observed cases of docking between the two mRNPs in mammals, strengthening the possibility that protein 
components and/or mRNA may be passed between them (Wilczynska et al., 2005; Kedersha et al., 2005).   
 
 
Table 2.2:   Protein components of Stress Granules in S. cerevisiae 
Core Components Function 
Eap1 eIF4E binding protein 
Cdc33 Translation initiation factor 
Tif4631/4632 Translation initiation factor 
Gbp2 mRNA export 
Hrp1 3’ end processing; export 
Ngr1 Translation regulator 
Nrp1 Putative mRNA binding protein 
Pab1 Poly(A) binding protein; promotes translation initiation and 
mRNA stability 
Pbp1 mRNA processing 
Pub1 Poly(U) binding protein; stabilizes mRNA 
Ygr250c Putative RNA binding protein 
 
 
 
 
Figure 2.9: Model of P-body and stress granules during stress conditions 
Upon stress conditions mRNA becomes part of a speculative mRNP cycle. This model allows for nascent 
transcripts to enter several mRNP complexes, including P-bodies and stress granules, which may lead to 
translation, storage, or degradation. There is much controversy surrounding the formation of P-bodies and stress 
granules including the factors involved. (From Buchan et al., 2008) 
 
 
 
2. Introduction 
   28 
The potential role of RBPs in the regulation of P-bodies 
 
In order gain an understanding of P-body localization we performed a tandem affinity purification approach 
to identify P-body interacting proteins that may regulate their formation. It is concevible that P-bodies 
localize adjacent to the ER in order to be in close proximity to sites of active translation. Under cellular 
stress, mRNA would be released from ribosomes and immediately taken into P-bodies. We reasoned that 
there may be a protein at the ER, which would regulate this transfer of mRNAs into P-bodies. In our screen 
we found several proteins, including RBPs, which associated with P-body components at the ER in S. 
cerevisiae. For the purposes of this work, we have chosen to focus on two, ER localized proteins: the RNA 
binding protein Scp160 and the Scp160-mRNP member Bfr1. Furthermore, Bfr1 and Scp160 are 
compontents of an mRNP complex that localizes to translating polysomes at the ER, making them ideal 
candidates for regulating the hand over of mRNAs into P-bodies.    
 
The many roles of the RNA binding protein Scp160 
 
Scp160 was first described as being necessary for correctly segregating chromosomes during cell division 
(Wintersberger et al., 1995). Deletions of SCP160 resulted in abnormal cell morphology, improper 
segregation of genetic markers, and an increase in DNA content; hence its name: S. cerevisiae protein 
involved in the Control of Ploidy (Wintersberger et al., 1995). Scp160 is a 160 kD protein that contains 14-
KH domains, pointing towards a role in RNA binding (Weber et al., 1997; Fig. 2.10). In addition, Scp160 
contains both a nuclear localization signal (NLS) and a nuclear export signal (NES), but there is currently no 
experimental data to suggest that Scp160 shuttles between the nucleus and the cytoplasm (Brykailo et al., 
2007). Numerous studies using live cell imaging and immunofluorescence localized Scp160 to the ER in 
yeast (Winterberger et al., 1995; Frey et al., 2001; Lang et al., 2001). Since Scp160 lacks a transmembrane 
domain, it is assumed that it associates with a resident protein at the surface of the ER.  
 
 
Scp160 shares homology with the eukaryotic family of RNA binding proteins known as vigilins. 
Vigilins are a large family of multi-KH domain containing proteins found throughout eukaryotes and are 
Figure 2.10: Scp160 is a 
14 KH-domain RNA 
binding protein  
Scp160 contains 7 
conserved KH domains 
and 7 divergent KH 
domains as well as 
nuclear localization (NLS) 
and nuclear export (NES) 
signals. (From Brykailo et 
al., 2007) 
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implicated in various cellular processes including mRNA metabolism. The large number of KH-domains 
found in Scp160 suggested that it acts as an RNA binding protein in yeast. Despite the large number of 
identified KH domains, only 7 of the 14 found in Scp160 are thought to be “true” KH domains, with the 
others containing deteriorating sequences (Weber et al., 1997). Nonetheless, Northwestern blotting 
showed that Scp160 was able to bind to ribohomopolymers with different affinities as well as binding to 
rRNA (Weber et al., 1997). More recent studies focused on identifying which mRNAs were bound by Scp160 
and microarray and high-throughput studies have now generated a list of numerous Scp160-bound mRNAs 
(Li et al., 2003; Hogan, et al., 2008).  
 Several studies suggested that Scp160 is in involved in translational regulation (Lang and Fridovich-
Keil, 2000; Frey et al., 2001; Mendelsohn et al., 2003; Baum et al., 2004; Sezen et al., 2009). Deletion of 
SCP160 causes cells to become sensitive against translational inhibitors such as cycloheximide and 
hygromycin B (Baum et al., 2004). Scp160 associates with polysomes and upon EDTA treatment, is released 
as a large mRNP complex (Lang et al., 2000; Frey et al., 2001). The poly(A) binding protein, Pab1, as well as 
the protein Bfr1 were identified as members of these Scp160 containing complexes (Lang et al, 2000). 
Further studies indicated that Bfr1 is required for the polysome association of Scp160 and this interaction 
was independent of mRNA (Lang, et al., 2001). Scp160 bound a specific set of mRNAs, suggesting that it 
controls the translation of these mRNAs at polysomes (Li et al., 2003). The C-terminus of Scp160, specifically 
the last two KH domains, was shown to be important for binding to the ribosomal 40S ribosomal subunit 
close to the mRNA exit tunnel. This ribosome association is partially dependent on the interaction with 
Asc1, the yeast orthologue of mammalian receptor of activated C-kinase (RACK1; Baum et al., 2004). RACK1 
integrates inputs from different signaling pathways on the ribosome and regulates translation through 
recruitment of activity-modulating kinases (Nilsson et al., 2004). There is also evidence that Scp160 may be 
involved in the elongation step of translation since it can be crosslinked with the elongation factor 1A 
(eEF1A) at the ribosome (Baum et al., 2004). This association has also been observed with the Scp160 
homologue vigilin in mammalian cells (Kruse et al., 1998). Furthermore, Scp160 regulates the translation of 
POM34 mRNA via the SESA (Smy2-Eap1-Scp160-Asc1) complex, which acts at the yeast nuclear 
envelope/ER. POM34 mRNA encodes an integral membrane protein of the nuclear pore complex and the 
SESA complex inhibits POM34 mRNA translation when spindle pole body defects occur (Sezen et al, 2009). 
This finding supports the idea that Scp160 participates in the regulation of a subset of cellular mRNAs.  
In addition to being a translational regulator, Scp160 performs other functions in the cell. Scp160 
was implicated in the yeast mating response pathway as a potential effector of the G protein alpha subunit, 
Gpa1 (Uetz et al., 2000). Subsequent studies indicated that the association of Scp160 and the activated 
form of Gpa1 was essential for transmittance of the pheromone signal (Guo et al., 2003). Recently the role 
of Scp160 in the mating response pathway was re-examined, which lead to the identification of a subset of 
mRNAs involved in polarity, secretion, and the mating pathway, to be dependent on Scp160 for proper 
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localization (Gelin-Licht et al., 2012).  Furthermore, the RNA binding function of Scp160 was critical for the 
penetrance of the pheromone mediated mating response. Scp160 was also found to play a role in telomeric 
silencing. Deletion of SCP160 relieved silencing at telomeres and at the mating type locus and a decrease 
in the deposition of the silencing protein Sir3 was observed. It was initially proposed that Scp160 may bind 
a subset of mRNAs involved in the deposition of Sir3 or to SIR3 mRNA itself, but experiments revealed that 
Sir3 expression remained unaffected in ∆scp160 cells. Chromatin immunoprecipitation (ChIP) experiments 
failed to find Scp160 associating with telomeric DNA (Marsellach, 2006). The authors suggested that Scp160 
may play a yet undefined role in the maintenance of the Sir-dependent pathway of telomeric clustering and 
silencing (Marsellach, 2006).  There are also links between Scp160 and Arf1-mediated vesicle transport. 
Scp160 interacts physically with the ARF-GEF Gea1 and acts as a multi-copy suppressor of at least one 
known GEA mutation, gea1-4 ∆gea2 (Peyroche and Jackson, 2001), but the biological significance of this 
Scp160-Gea1 interaction remains to be determined.  
 
Bfr1 is found in an Scp160-containing mRNP 
 
Bfr1 was originally identified as a multi-copy suppressor the fugal toxin of brefeldin A (BFA), which disrupts 
organelles in the secretory pathway (Jackson and Képès, 1994). Bfr1 was later identified as a component of 
Scp160-containg mRNP complexes through affinity-chromatography studies (Lang and Fridovich-Keil, 
2000). Interestingly, Bfr1 and Scp160 displayed a similar phenotype when either gene was deleted, having 
aberrant cell morphology and impaired nuclear segregation (Lang et al., 2001). These similarities between 
deletions in SCP160 and BFR1 indicated that Bfr1 might play a role in mRNA metabolism in S. cerevisiae. 
Bfr1 has been described to bind to numerous mRNA and it is known that its interaction with Scp160 relies 
on the presence of mRNA, though the exact role of Bfr1 in mRNA metabolism remains unknown (Hogan et 
al., 2008; Lang et al., 2001).  Furthermore, Bfr1 has links to Arf1. Scp160-Bfr1 mRNPs co-immunoprecipitate 
with Arf1 and a double deletion of ARF1 and BFR1 is lethal (Trautwein et al, 2004). Additionally, BFA is an 
inhibitor of Arf1 activation and overexpression of Bfr1 suppresses the effects of BFA. These studies raise 
the question as to the role of Bfr1 in these Scp160 containing complexes. As Bfr1 does not appear to contain 
any known RBDs, perhaps it acts as an adaptor protein for RBPs. In the case of the Scp160-Bfr1-Pab1 
complex, Bfr1 might be an adaptor for these mRNA binding proteins at specific translating ribosomes. In 
addition, the interactions between Bfr1 and Arf1 further strengthen the role between vesicular trafficking 
and mRNA metabolism.  
2. Introduction 
   31 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
    32 
 
 
 
 
 
Aim of this Study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3. Aim of this Study 
   33 
 
 
 
 
 
 
 
 
3. Aim of this Study 
 
 
A eukaryotic cell must be able to quickly alter its proteome in order to adapt to the environment.  One way 
in which a cell can change gene expression is through mRNA levels. P-bodies are non-membrane bound 
protein aggregates found throughout eukaryotes that play a key role in mRNA metabolism as sites of decay. 
P-bodies can be induced through a variety of different stresses and to various levels. Recently, it was also 
found that in S. cerevisiae P-bodies localize in close proximity to the endoplasmic reticulum (ER), raising the 
possibility that the ER acts as a platform to link mRNA translation and decay. We asked whether there were 
proteins at the ER that regulate P-body formation. Furthermore, we wanted to known how P-bodies are 
localized to the ER and whether there is a protein that tethers P-bodies, keeping them at the ER. 
Although much knowledge has been gained regarding the protein components of P-bodies and how 
they are induced, little is known about their association with specific mRNAs. mRNA is a key component of 
P-bodies and in the absence of mRNA, P-bodies disassemble. Within P-bodies mRNAs are in various states 
of decay and, thus, isolation and identification of transcripts is not trivial. One major question is which 
mRNAs are present in P-bodies and does this composition change in response to different types of stress. 
We set out to establish a protocol based on recently published crosslinking immunoprecipitation (CLIP) 
methods to identify P-body associated mRNAs. 
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4. Defects in the secretory pathway and high Ca2+ induce multiple 
 P-bodies 
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Supplementary Figures 
 
 
 
Suppl. Figure 1: Wild-type or arf1-11 cells expressing Dhh1-GFP were shifted to 37°C for 1 h. While multiple 
foci were observed in arf1-11, only 0-2 PBs/cell were induced in wild-type cells. 
 
 
 
 
 
 
 
Suppl. Figure 2: (A) arf1-11 cells expressing Dcp2-GFP and deleted for PUB1 were shifted to 37°C for 1 h. 
Multiple foci are still observed in this strain. (B) Wild-type cells expressing the SG marker eIF3B-GFP were 
shifted to 37°C for 1 h or to 46°C for 10 min. There was a marked induction of eIF3B-GFP containing granules 
after high heat shock. When cells were stressed by incubation in H2O, rich medium containing 0.5 M NaCl, or 
medium lacking a carbon source (-D) for 15 min, no SG formation was observed with this marker. 
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Suppl. Figure 3: Calmodulin is lost from the small bud tip in arf1-11 and after Ca2+ treatment. Wild-type or 
arf1-11 cells expressing Cmd1-GFP were shifted to 37°C for 1 h or treated with 200 mM CaCl2 for 15 min at 
23°C. White arrowheads point towards small bud tips. The white bar represents 5 µm. 
 
 
 
 
 
Suppl. Figure 4: The immuno-gold labeling is specific. Wild-type cells 
were prepared for thin section electron microscopy. Thin sections 
were labeled with myc-antibody and secondary antibodies coupled 
to gold. A few gold particles were observed scattered throughout the 
cell. The arrowheads point to individual gold particles. No gold 
clusters as in Error! Reference source not found. C were observed. 
he bar in the images represent 0.5 
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5. The polysome-associated proteins Scp160 and Bfr1 inhibit P-body 
formation under normal growth conditions 
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Abstract  
 
Most mRNAs in S. cerevisiae are degraded in processing bodies (P-bodies). In logarithmically growing 
cells only 1-2 P-bodies per cell are detectable. However, the number and appearance of P-bodies 
change once the cell encounters stress. The polysome-associated mRNA binding protein Scp160 
interacts with P-body components such as the decapping protein Dcp2 and the scaffold protein Pat1. 
Loss of either Scp160 or its interaction partner Bfr1 caused the formation of Dcp2-positive structures. 
These Dcp2-positive foci contained mRNA, since their formation was inhibited by the presence of 
cycloheximide. In addition, Scp160 was required for proper P-body formation because only a subset 
of bona fide P-body components could assemble into the Dcp2-positive foci in ∆scp160 cells. In either 
∆bfr1 or ∆scp160, P-body formation was uncoupled from translational attenuation as the polysome 
profile remained unchanged. Collectively, our data suggest that Bfr1 and Scp160 prevent P-body 
formation under normal growth conditions probably by limiting the passage of mRNAs from 
polysomes into P-bodies.  
 
 
 
 
Introduction 
 
The protein content in a cell at any given time is regulated by transcription, translation and protein 
degradation. While transcription largely determines the number of mRNA molecules, the balance of 
mRNA translation and protein degradation is key for protein homeostasis. Upon encountering stress 
a cell needs to quickly alter its proteome. Thus very often, as sort of a primary response to stress, 
translation becomes attenuated. As a consequence, mRNAs that are then no longer engaged in 
translation often become stored in processing bodies (P-bodies) (Parker and Sheth, 2007). P-bodies 
consists of decapping enzymes Dcp1 and Dcp2, the helicase Dhh1, activators of decapping such as 
Pat1, Scd6, Edc3 and the Lsm1-7 complex, and the 5’-3’ exonuclease Xrn1 (Parker and Sheth, 2007). 
On top of this basic assortment of P-body components, an ever-growing list of proteins associated 
with P-bodies is reported (Mitchell et al., 2013; Parker and Sheth, 2007).  
To date P-bodies have been reported to be involved in mRNA decapping, nonsense-mediated 
decay, translational repression, mRNA storage and other RNA related functions (Parker and Sheth, 
2007). Transcripts stored in P-bodies are in a dynamic exchange with the translating pool of mRNAs 
and may therefore either be degraded or be bound by ribosomes for translation.   
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P-bodies are not the only ribonucleoprotein (RNP) structures forming upon stress. Numerous 
stress conditions will also promote the formation of stress granules. Stress granules are mainly 
composed of stalled translation initiation components and are sites of mRNA storage. The analysis of 
the different RNPs is complicated by the fact that numerous factors are found in both types of 
granules, such as the exonuclease Xrn1 (Buchan and Parker, 2009). In addition mRNA may traverse 
from P-bodies into stress granules and vice versa (Buchan et al., 2008). Moreover, P-bodies and stress 
granules are found in close contact to each other, which may facilitate the transfer of components 
and mRNA.  
In yeast, P-bodies degrade most of the mRNA, even in unstressed cells. Under these 
conditions, only very few P-bodies are observed and they often may be below the resolution of light 
microscopy. However, once the cell encounters stress, P-bodies become visible, which is thought to 
occur through the aggregation of P-body components. These aggregates are nevertheless highly 
dynamic and can dissolve either upon adaptation of the cell to the stressor or when the stress ceases 
to exist (Brengues et al., 2005; Teixeira and Parker, 2007). Depending on the stress encountered the 
size and number of P-bodies varies. For example glucose starvation induces a few relatively large foci, 
whereas high salt and high Ca2+ cause the formation of smaller, but more numerous P-bodies 
(Brengues et al., 2005; Kilchert et al., 2010). The reason for the different responses is not clear. 
However, it has to be noted that while glucose starvation can only be remedied by addition of glucose, 
cells can adapt to stresses such as high salt. As a consequence, P-bodies formed under such stressors 
disassemble after adaptation (Kilchert et al., 2010). 
P-bodies are found in close proximity to the ER, and they might be even physically linked to 
the ER (Kilchert et al., 2010). To better understand why P-bodies were found in close proximity to the 
ER, we aimed to identify ER proteins with which P-body components could interact. We identified the 
peripheral ER proteins Scp160 and Bfr1 as interactors of P-bodies at the ER. The association of Scp160 
and Bfr1 with polysomes prompted us to test whether Scp160 and Bfr1 might play a role in P-body 
formation. Our results suggest that Bfr1 and Scp160 act independently as negative regulators of P-
body formation at the ER. Moreover our data imply that at least Scp160 is required for proper P-body 
assembly. In addition Scp160-P body component interaction was not sensitive to stress, indicating that 
Scp160 is a novel P-body component regulating P-body formation.  
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Results 
Screen for novel P-body interacting proteins at the endoplasmic reticulum 
 
We have shown previously that P-bodies are localized in close proximity to endoplasmic reticulum 
(ER) membranes (Kilchert et al., 2010). In order to identify potential ER-localized interaction partners 
of P-body components, we employed tandem-affinity purification after cross-linking with the P-body 
components Dcp2 and Scd6, which would be part of the 5’ and the 3’UTR-associated complex of P-
bodies, respectively. We chose a cross-linking approach because P-bodies are highly dynamic and their 
interaction with the ER could be transient (Teixeira and Parker, 2007). We opted also for a stringent 
method and therefore selected the HBH-tag for the purification scheme. The HBH tag consists of a 
biotinylation sequence, which is flanked by two His6-peptides, allowing tandem purification under 
denaturing conditions (Tagwerker et al., 2006).  
The temperature-sensitive arf1-11 mutation in the small GTPase Arf1p causes the formation 
of numerous P-bodies at the restrictive temperature (Kilchert et al., 2010). arf1-11 mutant cultures 
expressing chromosomally-tagged Dcp2-HBH or Scd6-HBH and wild-type cells were shifted to 37°C for 
one hour to induce P-bodies. Protein complexes were cross-linked in vivo, extracted from membrane 
pellets enriched in ER membranes, and purified over NiNTA and streptavidin beads under denaturing 
conditions (Fig. 5.1A). The proteins were digested, and peptides analyzed by mass spectrometry. This 
approach was successful because we could identify P-body components in our purification scheme 
(Table 5.1). In addition, proteins were identified that were neither present in the untagged wild-type 
control or in other HBH purifications for unrelated baits performed in our group (Ritz et al., in prep). 
Those proteins present only in the Dcp2-HBH or Scd6-HBH sample, or in both samples were considered 
for further analysis (Table 5.1).  
Bfr1 and Scp160 are novel P-body interacting proteins at the ER 
 
Three of the hits of the tandem-affinity purifications were ER-associated proteins: Bfr1, Scp160 and 
Cdc48. Cdc48 is a AAA-ATPase involved in homotypic membrane fusion during karyogamy and in the 
extraction and retrotranslocation of polypeptides from the ER destined for degradation by the 
proteasome (Hitchcock et al., 2001; Latterich et al., 1995; Schuberth and Buchberger, 2005). Due to 
Cdc48’s function in ER associated degradation, it might also transmit a signal to induce P-body 
formation under ER stress conditions. We decided however to focus on the two other hits, Scp160 and 
Bfr1. Scp160 is an mRNA-binding protein that together with Bfr1 associates with translating polysomes 
at the ER (Lang et al., 2001). Loss of Scp160 caused mislocalization of the asymmetrically localized 
ASH1 mRNA  
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Table 5.1: Proteins identified by HBH-purification 
 
Found only in  
Dcp2-HBH 
Found only in 
Scd6-HBH 
Found in both 
Purifications 
Nog1 Sbp1 Dcp2 
Hta1 Eap1 Xrn1 
Atp1 Not1 Edc3 
Cdc48** Rps12 Scd6 
 Hef3 Bfr1** 
 Hsp12 Dhh1 
 Tif5 Tef4 
 Scp160** Sti1 
 Yra1 Pab1 
 Tif3 Cpr1 
 Psp2 Nam7 
 Lsm5 Pat1 
 Lsm2 Def1 
 Dcp1 Vma13 
  Hsp26 
  Mpg1 
 
Bold indicates P-body components, Italic indicates RNA related function, ** indicates ER association 
 
(Irie et al., 2002; Trautwein et al., 2004) and SRO7 mRNA after pheromone treatment (Gelin-Licht et 
al., 2012). Bfr1 was identified as multicopy suppressor of brefeldinA induced lethality (Jackson and 
Kepes, 1994). However the molecular function of Bfr1 remains still elusive.  
First, we wanted to establish that Scp160 and Bfr1 are still ER-associated at 37°C, the temperature at 
which we performed the cross-link. To this end, we appended both Scp160 and Bfr1 chromosomally 
with a GFP tag in strains that expressed the ER marker Sec63-RFP. Both proteins remained ER 
associated, irrespective of the temperature (23°C vs 37°C) or the strain background (wild-type vs arf1-
11) (Fig. 5.1B).  
Since, we used a cross-linking approach to detect interactors of P-body components, we 
wanted to ensure that Scp160 and Bfr1 were not only localized in the vicinity of P-bodies and therefore 
caught in the complex, but that they were also able to interact with P-body components in the absence 
of cross-linking agents. Flag-tagged Scp160 co-immunoprecipitated Dcp2-9myc, irrespective of 
whether the cells were stressed by glucose starvation, high intracellular Ca2+ or unstressed (Fig. 5.2A 
and B). Bfr1-Dcp2 association was detected to a lower extent and the levels were more variable, 
indicating that Dcp2 might interact primarily with Scp160 rather than with Bfr1. Similar results were 
obtained when we probed the interaction of Scp160 and Bfr1 with Pat1-6HA and Edc3-6HA without 
stress and under glucose starvation (Fig. 5.2C). In all cases the stress seemed to slightly but 
consistently increase the  
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Figure 5.1: Bfr1p and Scp160 are identified as potential Processing Body interactors at the ER  
(A) General scheme of HBH-purification. Dcp2- or Scd6-HBH tagged cells were subjected to heat stress 
through a shift to 37˚C for 1 hr to induce P-body formation. Cells were fixed through the addition of 
formaldehyde in order to capture interactions among P-body proteins as well as proteins interacting with 
P-bodies at the ER. These cells were then lysed under denaturing conditions and fractionated to create a 
pellet containing ER membranes before incubating with Ni-NTA. Complexes were eluted with imidazole, 
bound to streptavidin-agarose and on-bead digested for LC/MS analysis. (B) Bfr1 and Scp160 localize to 
the ER. Strains were created in which Bfr1 and Scp160 were chromosomally tagged with GFP. These strains 
were then transformed with a plasmid containing Sec63-RFP to illuminate the ER. Cells were observed at 
23˚C and after a 1 hr shift to 37˚C to mimic the conditions used for the HBH purification. At both 
temperatures Bfr1-GFP and Scp160-GFP localized to ER membranes. Scale bar represents 5 µm. 
 
 
 
interaction of Scp160 with these P-body components. In contrast, Scd6-6HA was not co-
immunoprecipitated with Scp160-FLAG (Fig. 5.2C). Moreover, the ability of Scp160 to interact with P-
body components appeared to be independent of stress, indicating that that stress-induction is not a 
pre-requisite for the interaction between P-body components and Scp160.  Because Dcp2 and Pat1  
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play a more prominent role in P body assembly (Teixeira and Parker, 2007), our data indicate that at 
least partially assembled P-bodies are present on translating ribosomes.   
Given that Scp160 is an RNA-binding protein and interacts with the machinery that stores and 
decays mRNAs, we next tested whether the interaction between Scp160 and Dcp2 was dependent on 
Figure 5.2: Scp160 associates with P-
body components independent of 
stress 
(A) Scp160 associates with Dcp2 
independent of glucose starvation. Co-
immunoprecipitation experiments were 
performed using anti-FLAG antibody and 
lysates from strains chromosomally 
tagged with Scp160-3FLAG or Bfr1-
3FLAG. All strains also contain Dcp2-
9myc. Where indicated, cells were 
subjected to starvation for 10 min prior 
to the immunoprecipitation. Dcp2-9myc 
co-precipitated with Scp160-3FLAG in 
both conditions. A weak precipitation of 
Dcp2-9myc with Bfr1-FLAG was 
sometimes observed. (B) Ca2+ stress does 
not affect Scp160-Dcp2 association. Cells 
were treated with 200 mM CaCl2 for 10 
min then a 5-min washout in rich media 
without CaCl2 was performed before 
lysate preparation. Under stressed and 
unstressed conditions, Dcp2-9myc co-
immunoprecipitated with Scp160-
3FLAG. (C) Scp160 associates with P-
body components. Pat1, Edc3, or Scd6 
were chromosomally appended with 
6HA. The strains were treated as in (A). 
Scp160-3FLAG was able to precipitate 
Pat1-6HA and Edc3-6HA under both 
conditions, but not Scd6-6HA. (D) 
Association of Scp160 and Dcp2 is lost in 
the absence of RNA. To determine if RNA 
was needed for the interaction between 
Scp160 and Dcp2, strains were treated as 
in (A) and then subjected to a 1 hr 
RNaseA treatment prior to 
immunoprecipitation. Upon RNaseA 
treatment, the association of Dcp2-9myc 
with Scp160-3FLAG was no longer 
observed under either condition. 
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mRNA. Indeed, treatment of yeast lysates with RNase strongly reduced the amount of co-
immunoprecipitated Dcp2 (Fig. 5.2D). We conclude that Scp160 is novel mRNA-dependent interactor 
of P-body components at the ER.  
 
Scp160 and Bfr1 are not required for the ER-localization of P-bodies  
 
P-bodies are localized in close proximity to the ER (Kilchert et al., 2010). Therefore, we asked, whether 
Scp160 and Bfr1 would be required for P-body localization at the ER. Dcp2-9myc –positive structures 
were detected in close proximity to the ER in both ∆bfr1 and ∆scp160 cells using immunoelectron 
microscopy (Fig. 5.3). The distribution of the Dcp2-9myc signal, suggestive of some sort of ring-like, 
globular structure, was similar in both strains. To confirm the results from the ultrastructural analysis, 
we chose a biochemical assay. We have shown previously that Dcp2-9myc co-migrates with ER 
membranes in a sucrose gradient (Kilchert et al., 2010). None of the deletions drastically altered the 
Dcp2 ER-association (Fig. 5.S1); in either case similar amounts of Dcp2-9myc floated to the 0/40% 
sucrose interphase. Our data demonstrate that neither Scp160 nor Bfr1 are essential for Dcp2 
recruitment to ER membranes.  
 
Loss of Bfr1 or Scp160 induces the formation of multiple Dcp2-positive structures 
 
When we performed the immuno electron microscopy experiment, we noticed, that unlike in wild-
type, in ∆scp160 and ∆bfr1 cells, Dcp2-9myc-positive structures were already readily observed under 
normal, no-stress growth conditions (Fig. 5.3, 23°C). This observation prompted us to check, whether 
P-bodies would form in the mutant strains without any stress being applied at the normal growth 
temperature. Indeed, when we visualized Dcp2-GFP in ∆bfr1, ∆scp160 and in the ∆bfr1 ∆scp160 
double mutant, we found a strong increase in P-body number compared to wild-type, which typically 
contained 1-2 P-bodies/cell (Fig. 5.4A and B). Importantly, this increase in Dcp2-positive structures 
was restricted to normal growth conditions. Shifting the mutant cells to 37°C degrees, which causes a 
mild temperature stress as indicated by the slight increase in P-body number in wild-type cells, 
reduced the number of the  
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Dcp2-positive structures in the mutant strains to even below wild-type levels (Fig. 5.4A and B). We 
aimed to phenocopy the effect of the ∆scp160 deletion by expressing an Scp160 C-terminal truncation 
that has been shown previously to compromise Scp160 function (Baum et al., 2004). The removal of 
the 4 most C-terminal located KH domains induced the formation of multiple Dcp2-positive foci (Fig. 
5.S2), consistent with this truncation being hyper-sensitive towards cycloheximide and its proposed 
role in translation (Baum et al., 2004). These data suggest that Scp160 and Bfr1 negatively regulate P-
body formation under normal growth and no-stress conditions.  
 
Loss of Scp160 or Bfr1 does not induce stress granule formation 
 
Given the increase of P-bodies in ∆bfr1 and ∆scp160 cells, and that under certain conditions, P-body 
formation is coupled to stress granule formation (Yoon et al., 2010), we next asked whether stress 
granule number would also be increased under standard growth conditions in the mutant strains. 
Stress granule formation has been demonstrated to occur under glucose starvation and under heat 
stress (Buchan et al., 2008; Grousl et al., 2009). As a marker for stress granule formation, we used the 
polyU-binding protein Pub1p (Buchan et al., 2008). Indeed, we observed stress granule formation in 
wild-type  
Figure 5.3: Loss of BFR1 or 
SCP160 does not impair P-
body association with the ER 
P-bodies are still in close 
proximity to ER membranes in 
∆bfr1 and ∆scp160 cells. Cells 
expressing Dcp2-9myc in 
which BFR1 or SCP160 were 
deleted were grown at 23˚C 
and then shifted for 1 h to 
37˚C. Cells were fixed, and 
prepared for immunoelectron 
microscopy. Dcp2-9-myc was 
visualized with gold particles. 
Scale bars represent 500 nm. 
The inserts are a 2x 
magnification of the area 
where the gold particles were 
found. White arrowheads 
indicate ER membranes.   
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cells under both conditions, while in ∆scp160 and ∆bfr1 stress granules were only visible after heat 
stress (Fig. 5.4C and D). Thus, Scp160 and Bfr1 might be required for stress granule formation only 
under certain stresses. Consistently, ∆bfr1 and ∆scp160 did not induce stress granule formation under 
standard growth conditions (Fig. 5.4C and D). Therefore, the P-body induction phenotype in ∆bfr1 and 
∆scp160 is not strictly coupled to stress granule formation. 
Figure 5.4: Loss of BFR1 or SCP160 increases P-body number under normal growth conditions (A) 
Increased P-body number was observed in ∆bfr1, ∆scp160 and ∆bfr1∆scp160 cells. Dcp2 was chromosomally 
tagged and used as a marker for P-bodies. Under normal growth conditions at 23˚C in the wild type strain 1-2 
P-bodies were observed. Upon deletion of BFR1, SCP160 or both from the cell the number of P-bodies increased. 
Scale bar represents 5 µm (B) Quantification of the P-body phenotype observed in the wild type and deletion 
strains upon temperature shift. A minimum of 200 cells from at least 3 independent experiments were counted 
per condition shown. The size of the box is determined by the 25th and 75th percentiles; the whiskers represent 
the 5th and 95th percentiles; the horizontal line and the triangle represent the median and mean, respectively. 
***p<0.001, **p<0.01 (C) Stress granules failed to form in ∆bfr1 or ∆scp160 cells under starvation conditions.  
Wild type, ∆bfr1, and ∆scp160 cells were transformed with a high copy plasmid expressing the stress granule 
marker Pub1-mCherry. Cells were grown to mid log phase at 23˚C then shifted to 46˚C or incubated in rich 
media lacking a carbon source (-D) for 10 min. Scale bar represents 5 µm (D) Quantification of Pub1 positive 
foci observed under various stresses. ***p<0.001.  
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Overexpression of SCP160 or BFR1 
rescues the enhanced P-body 
formation phenotype of ∆bfr1 or 
∆scp160, respectively 
 
Bfr1 and Scp160 form a complex at 
translating polysomes, and their 
localization at the ER is interdependent, 
nevertheless, they do have distinct 
functions (Lang et al., 2001). For 
example only Scp160 binds mRNA, and 
only Bfr1 causes resistance to brefeldinA 
when overexpressed (Jackson and Kepes, 1994; Lang and Fridovich-Keil, 2000; Weber et al., 1997). 
Moreover, Scp160 rather than Bfr1 would bind to the mRNA associated P-body components. 
 
Figure 5.5: Overexpression of 
SCP160 or BFR1 rescues the Dcp2-
foci phenotype in the reciprocal 
deletion 
(A) Overexpression of Bfr1-GFP or 
Scp160-GFP led to saturation of ER 
sites, whereas Bfr1-GFP or Scp160-
GFP remained at the ER in TEF1-
SCP160 or TEF1-BFR1 cells, 
respectively. The endogenous 
promoters of BFR1 or SCP160 were 
chromosomally exchanged for the 
constitutive TEF1 promoter and 
localization of Bfr1-GFP or Scp160-
GFP was observed. Scale bar 
represents 5 µm (B) Dcp2 positive 
foci were reduced in TEF1-SCP160 
∆bfr1 or TEF1-BFR1 ∆scp160 strains 
compared to the deletions alone. 
BFR1 or SCP160 were overexpressed 
in strains expressing Dcp2-GFP in 
which either SCP160 or BFR1 were 
deleted. Scale bar represents 5 µm 
(C) Quantitation of the Dcp2 positive 
foci in cells in (B). See Figure 4B for 
details on the representation. 
***p<0.001, *p<0.05 
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Therefore, we wondered whether the interaction of Scp160 with Bfr1 would be required to prevent 
P-body formation at normal growth conditions or whether Bfr1 and Scp160 could act independently. 
To distinguish between these possibilities, we overexpressed BFR1 or SCP160 in the reciprocal 
deletion. To this end, we replaced theendogenous promoters of SCP160 and BFR1 by the strong TEF1 
promoter in ∆bfr1 and ∆scp160, respectively, and in wild-type. In wild-type cells, the increase in 
expression caused both proteins to also localize to the cytoplasm, indicating that the binding sites at 
the ER were saturable (Fig. 5.5A). When we overexpressed BFR1 in ∆scp160 or SCP160 in ∆bfr1, the 
Dcp2-positive foci were reduced to wild-type levels (Fig. 5.5B and C). These data indicate that both 
Scp160 and Bfr1 are able to independently prevent P-body formation under normal growth 
conditions.  
 
 
Loss of Scp160 generates pseudo P-bodies 
 
So far we have shown that loss of Scp160 and Bfr1 induces Dcp2-positive foci. P-bodies are highly 
dynamic structures in which P-body components assemble in sort of an aggregation status, similar to 
prions. In fact, a number of P-body proteins contain prion-like domains (Alberti et al., 2009; Reijns et 
al., 2008). Thus it would be conceivable that in the absence of Scp160 or Bfr1 no proper P-bodies are 
formed. The formation of P-bodies requires the presence of RNA in these structures (Coller and Parker, 
2005; Teixeira et al., 2005). The amount of mRNA that could be sequestered into P-bodies can easily 
be reduced by the addition of cycloheximide. Cycloheximide will lock the ribosomes on mRNA and, 
therefore, little if any mRNA should be available as a substrate for P-body formation. As expected, 
treatment of cells with cycloheximide abolished the Dcp2-positive foci in the mutants (Fig. 5.6A), 
implying that ∆scp160 and ∆bfr1 cause the appearance of bona fide P-bodies. To extend our results, 
we determined the localization of 3 more P-body constituents (Scd6, Edc3, and Dhh1) (Fig. 5.6B and 
C). While in ∆bfr1 cells all markers formed multiple foci, only a few Scd6- or Edc3-positive structures 
were observed in ∆scp160, and Dhh1 did not form foci that would correspond to P-bodies. These data 
indicate that in ∆bfr1 bona fide P-bodies were formed in the absence of stress. In contrast, loss of 
Scp160 led to partially assembled P-bodies, to which we will refer to as pseudo P-bodies. Our results 
suggest that Scp160 may play a role in the assembly of P-body proteins. Taken together, our data are 
consistent with Bfr1 and Scp160 being both negative regulators of P-body formation in the absence 
of stress. 
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Scp160 and Bfr1 do not repress P-
body formation under stress  
 
We hypothesized that since Bfr1 and 
Scp160 are associated with translating 
polyribosomes, they may prevent access 
of P-body components to mRNA during 
translation. During stress conditions, 
under which translation would be 
attenuated, polysomes would 
disassemble and Scp160 and Bfr1 may lose their protective role on the mRNA and not be involved in 
the control of P-body formation. Therefore the loss of Scp160 or Bfr1 should not affect P-body 
Figure 5.6: Pseudo P-bodies are formed 
in ∆scp160 cells. (A) Cycloheximide 
inhibits the formation of Dcp2-positive foci. 
Dcp2-GFP expressing cells were grown at 
23˚C to mid log phase and then 
cycloheximide was added to a final 
concentration of 100 µg/ml for 10 min 
before imaging. In all cases, few if any Dcp2-
positive foci were observed upon addition 
of cycloheximide, indicating that the Dcp2 
containing foci contain RNA. Scale bar 
represents 5 µm (B) Pseudo P-bodies are 
formed in ∆scp160 cells. To test if the Dcp2 
containing foci are bona fide P-bodies, 
strains expressing Edc3-GFP, Scd6-GFP, or 
Dhh1-GFP were deleted for either BFR1 or 
SCP160. Although multiple foci were 
observed in ∆bfr1 cells for all markers, very 
few foci were observed in ∆scp160 cells. 
Scale bar represents 5 µm (C) 
Quantification of the Edc3-GFP, Scd6-GFP, 
and Dhh1-GFP foci observed in (B) 
***p<0.001. For a description of the 
quantification, see Figure 4B. (D) 
Starvation induces Dcp2 positive foci. Cells 
containing Dcp2-GFP were grown to mid 
log phase and then incubated in rich media 
without a carbon source (-D) for 10 min 
before imaging. Bright Dcp2 positive foci 
were observed in wild type, ∆bfr1 and 
∆scp160 cells. In ∆scp160 cells, foci of 
different sizes were observed. Scale bar 
represents 5 µm  (E) Quantification of the 
Dcp2-GFP foci observed in the starvation 
condition in (D). ***p<0.001 
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formation under those stress conditions. When we withdrew glucose from wild-type, ∆scp160 or ∆bfr1 
cultures, we observed P-body induction to a similar extent in wild-type and ∆bfr1 (Fig. 5.6D and E). A 
slight increase in number of Dcp2-positive structures was observed in ∆scp160, consistent with a role 
of Scp160 in proper P-body assembly. A similar result was obtained for heat stress (Fig. 5.S3). Our 
results are consistent with a negative role of Scp160/Bfr1 on P-body formation only in the absence of 
stress. 
 
Loss of Scp160 or Bfr1 does not decrease general translation 
 
Another prediction from our hypothesis above is that deletion of ∆scp160 or ∆bfr1 should not affect 
translation per se, as their role would rather be to restrict access of P-body components to mRNA 
during translation. We recorded polysome profiles of wild-type, ∆scp160, ∆bfr1 and ∆bfr1∆scp160 
cells under conditions under which P-body number would be increased (23°C) in the mutants or be 
similar to wild-type (37°C) (Fig. 5.7). Under neither of these conditions did we find a significant change 
in the polysome profile, or an increase in the 80S monosome fraction, which would be indicative of 
translation attenuation (Fig. 5.7A and B). These data are in agreement with previously published data 
(Baum et al., 2004; Li et al., 2003). Thus, loss of Scp160/Bfr1 does not interfere with translation 
efficiency.  
 
Discussion 
 
P body formation is an essential process by which eukaryotic cells respond to a plethora of stresses 
such as environmental, metabolic and cellular stress. Here we aimed to understand why P bodies are 
localized in close proximity to the ER membrane. We find that P-body components interact with the 
polysome-associated mRNA binding protein Scp160. This interaction predisposes the P body 
components to mRNA molecules as soon as they would be released from the polysomes. The function 
of Scp160, and its interacting protein Bfr1, would be to keep the P body components in a ‘waiting’ 
position but nevertheless inhibit the formation of P bodies under normal growth, non stress conditions 
(Fig. 5.8). As soon as the cell would encounter stress, the guarding function of Scp160 and Bfr1 would 
be lost and P body components would have unrestricted access to mRNAs.  
 We find that loss of either Bfr1 or Scp160 causes the formation of multiple Dcp2-positive 
structures. Although both structures contain mRNA, only the Dcp2-positive foci in ∆bfr1 appear to be 
fully assembled P bodies (Fig. 5.8). In ∆scp160 cells, the Dcp2-positive structures do not contain all P-
body 
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components and hence are probably not functional in terms of mRNA decay. Thus, Scp160 appears to 
play a perhaps regulatory role in proper P-body assembly. We assume that this role is more in the 
regulation of the process, because P-bodies formed in ∆scp160 strains under glucose starvation, and 
also stress granules appeared under heat stress.  
The association of P body components with polysomes is perhaps not surprising. Different 
labs put forward a model of dynamic equilibrium in which P body formation would be directly coupled 
to translation attenuation (Coller and Parker, 2005; Franks and Lykke-Andersen, 2008). Probably the 
most plausible way to achieve this coupling would be through direct interaction. Moreover the P body 
components Dhh1 and Pat1 were shown to be translational repressors, indicating that there might be 
some feedback mechanism between P-bodies and ribosomes (Franks and Lykke-Anderson, 2008; 
Pilkington and Parker, 2008). 
Scp160 and Bfr1 are most likely not the only proteins that can restrict the access of P-body 
components to polysome-associated mRNA. Moreover they are not essential for P-body localization 
close to the ER. Still, it is noteworthy that Scp160 is predominantly associated with membrane-bound 
polysomes (Weber et al., 1997). Thus, it cannot be excluded that Scp160 has some role in P-  
Figure 5.7: Translation is not attenuated in ∆bfr1 and ∆scp160 cells. (A) Loss of BFR1 or SCP160 did not 
cause translation attenuation. Cells were grown to mid-log phase at 23˚C and shifted for 1 hr to 37˚C and subjected 
to polysome profile analysis. Despite the large increase in P-body number in ∆bfr1, ∆scp160, and ∆bfr1∆scp160 
cells at 23˚C, there was no attenuation in translation. (B) No noticeable change in ratio of polysomes to total was 
observed. Polysome profiles were analyzed and the area under the curves was measured to determine the ratio 
of polysomes to total area under the curve. (C) In ∆bfr1 and ∆scp160, a decrease in the ratio of monosomes to 
total was observed as compared to wild type cells. Similar to (B), the ratio of monosomes to total was measured. 
Data represents at least 3 profiles ± SD. **p<0.01, *p<0.05 
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 body localization to the ER. It has been established that Scp160 only binds to a subset of mRNAs 
(Gelin-Licht et al., 2012; Hogan et al., 2008; Li et al., 2003). A biological role for the mRNA-Scp160 
interaction has been demonstrated for ASH1 mRNA localization and pheromone sensing (Gelin-Licht 
et al., 2012; Irie et al., 2002; Trautwein et al., 2004). Importantly Scp160 bound DHH1 mRNA and was 
required for efficient translation of this message (Li et al., 2003). Thus, Scp160 could be part of a 
regulatory loop that controls translation of specific messages. This role could be regulated by 
phosphorylation as Scp160 is phosphorylated upon inhibition of the TOR complex by rapamycin, 
mimicking amino acid starvation (Soulard et al., 2010). In addition, Scp160 is part of a complex that 
contains Eap1, a negative regulator of translation (Cosentino et al., 2000; Mendelsohn et al., 2003). In 
fact, the SESA (Smy2, Eap1, Scp160, Asc1) complex has been shown to act as translational repressor 
of the POM34 mRNA in response to spindle pole body  (SPB) duplication defects (Sezen et al., 2009). 
Pom34 is a component of the nuclear pore complex that plays a role in the insertion of the SPB into 
the nuclear envelope.  
Figure 5.8: Scp160 and Bfr1 
inhibit P-body formation under 
normal growth conditions  
In wild-type cells under normal 
growth conditions, Scp160 and Bfr1 
guard RNA at polysomes. Scp160 
interacts with RNA and P-body 
components and leaves P-bodies in a 
“waiting” position while still 
inhibiting P-body formation. In ∆bfr1 
cells, Scp160 is not efficiently 
recruited to the polysomes and 
cannot properly guard the RNA, thus 
allowing P-body components to 
access RNAs. In ∆scp160, Bfr1 can 
somewhat be recruited to 
polysomes, but without Scp160, 
proper P-body assembly cannot 
occur leading to the formation of 
pseudo P-bodies. 
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The cellular function of Scp160 seems to be multifold: Scp160 controls ploidy (hence the name 
Saccharomyces protein controlling ploidy) (Wintersberger et al., 1995), Scp160 is required for the 
asymmetric localization of mRNAs (Gelin-Licht et al., 2012; Irie et al., 2002; Trautwein et al., 2004), 
Scp160 is part of translational repressor complex (Sezen et al., 2009), Scp160 may act as a signaling 
platform on ribosomes to control translation of specific mRNAs (Baum et al., 2004), Scp160 acts as an 
effector of a G protein in the mating response pathway (Guo et al., 2003), Scp160 contributes to the 
regulation of telomere silencing (Marsellach et al., 2006) and Scp160 negatively regulates P-body 
formation in the absence of stress and might be a novel P-body component. How can all these 
functions be performed in by one protein? Scp160 could be part of different complexes that may 
regulate Scp160 functions and recruit it to the proper site of function. Such an adaptor function could 
be performed by Bfr1. Scp160 requires Bfr1 for efficient polysome association and Bfr1 may recruit 
the SESA complex to the SPB (Sezen et al., 2009). However, Bfr1 must perform at least an additional 
function besides being an Scp160 interactor. Overexpression of BFR1 in a ∆scp160 strain was sufficient 
to alleviate the pseudo P body phenotype. Bfr1 might itself interact with P body components; yet with 
a lower affinity than Scp160. Overexpression of BFR1 could potentially increase its interaction with P 
body components and keep the P body components in the ‘waiting’ position.  
In addition, at least the ASH1 mRNA localization at the bud tip is not only dependent on 
Scp160 but also on Bfr1 and ribosomes (Irie et al., 2002; Trautwein et al., 2004). Thus it is conceivable 
that Bfr1 would be the adaptor for complexes involved in translation activation and repression. 
Clearly, Scp160 would have other adaptors to fulfill the Bfr1-independent functions, such as the G 
protein effector or the silencing of telomeres. 
 Scp160 is conserved up to humans; the closest homologues being vigilin and the fragile X 
syndrome protein FMRP (Currie and Brown, 1999; Weber et al., 1997). Vigilin has been proposed to 
have a role in cytoplasmic mRNA metabolism (Goolsby and Shapiro, 2003), and to protect vitellogenin 
mRNA from degradation by the mRNA endonuclease PMR-1 (Cunningham et al., 2000). In addition, 
vigilin binds to the mRNA of the proto oncogene c-fms and inhibits its translation, thereby suppressing 
breast cancer suppression (Cao et al., 2004; Woo et al., 2011). These function might be similarly 
regulated through binding to polysomes, because akin to Scp160, vigilin binds with its C-terminal tail 
to ribosomes (Vollbrandt et al., 2004). Also the second mammalian homologue of Scp160, FMRP binds 
to a subset of mRNA, and the I304N mutation first described in an FXP patient reduces the association 
with mRNAs and polysomes (Ascano et al., 2012; Feng et al., 1997; Siomi et al., 1994). Therefore, it is 
also conceivable that the function of Scp160 to control the translation of a subset of mRNAs is also 
conserved in vigilin and FMRP.  
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Materials and Methods 
 
Yeast Methods 
Standard genetic techniques were used throughout (Sherman, 1991). All modifications were carried 
out chromosomally, with the exceptions listed below. Chromosomal tagging and deletions were 
performed as described in Knop et al (1999) (Knop et al., 1999) and Gueldener et al (2002) (Gueldener 
et al., 2002) . For ER co-staining, cells were transformed with plasmid pSM1959 (LEU2) carrying 
Sec63p-RFP (kindly provided by S. Michaelis, Johns Hopkins University, Balitmore, MD). pRP1661 
(URA3) expressing Pub1-mCherry, was provided by R. Parker (University of Colorado, Boulder, CO). 
The plasmid pMS499 carrying the ∆C4 truncation of Scp160 was obtained from M. Seedorf (ZMBH 
Heidelberg, Germany). Strains used in this study are listed in Supplementary Table 5.S1. 
 
HBH-Purification 
The HBH-purification was carried out according to Tagwerker, et al. (2006) (Tagwerker et al., 2006) 
with modifications. Cells expressing Dcp2–HBH or Scd6-HBH were grown to mid to late log phase at 
23˚C then shifted for 1 h to 37˚C. Cells were fixed by adding 37% formaldehyde to a final concentration 
of 1% and incubated at room temperature for 2 min with gentle agitation. The formaldehyde was 
quenched for 5 min by the addition of glycine to a final concentration of 1.25 mM. Cells were 
harvested (4,700 x g for 3 min at 4˚C), washed in 50 ml ice-cold ddH2O, pooled, sedimented by 
centrifugation (5 min at 3,000 x g), flash frozen in liquid nitrogen and stored at -80˚C. Cells were 
thawed and resuspended in 2 ml buffer 1 (50 mM NaPi pH 8.0, 8M urea, 300 mM NaCl 20mM 
imidazole, 0.5% Tween-20) per gram of yeast cell pellet. One ml of the cell suspension was added per 
2 ml screw capped tube containing 500 µl glass beads. Lysis was performed in a FastPrep for 4 x 45 
sec at 4˚C. Glass beads and cell debris was cleared with a slow spin  (1,300 x g for 10 min at 4˚C) and 
the supernatant was removed and pooled. The supernatants were spun at 20,000 x g for 15 min at 
4˚C and the resulting pellets were resuspended in 500 µl buffer 1 with 1% additional Tween-20 added. 
2.5 ml of Ni-NTA slurry washed in buffer 1 was added to the pooled lysates and rotated overnight at 
room temperature. The tubes were spun at RT for 3 min at 2,500 x g and washed with 10 ml buffer 1. 
Tubes were spun as before and a series of 10 ml washes and spins were sequentially performed (buffer 
2: 50 mM NaPi pH 6.4, 8 M urea, 300 mM NaCl, 0.5% Tween-20; buffer 3: 50 mM NaPi pH 8.0, 8 M 
urea, 300 mM NaCl, 0.5% Tween-20, 20 mM imidazole; buffer 4: 50 mM NaPi pH 8.0, 8 M urea, 300 
mM NaCl, 0.5% Tween-20, 40 mM imidazole). After the final wash and spin, 4 ml of elution buffer (50 
mM NaPi pH 6.4, 8 M urea, 300 mM NaCl, 0.5% Tween-20, 300 mM imidazole) was added and rotated 
with the beads for 45 min. The beads were spun down as before, the elution was collected, and the 
elution step was repeated. 300 µl streptavidin agarose washed in buffer 1 was added to the 8 ml of 
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elute and rotated for 2 h at room temperature. The slurry was then spun as before and washed with 
10 ml buffer 6 (50 mM Tris/HCl pH 8.0, 8 M urea, 300 mM NaCl, 2% SDS). This step was then repeated 
with 10 ml buffer 7 (50 mM Tris/HCl pH 8.0, 8 M urea, 300 mM NaCl, 0.2% SDS).  The final wash was 
performed in buffer 8 (50 mM Tris/HCl pH 8.0, 8 M urea, 300 mM NaCl) and the streptavidin agarose 
was resuspended in 1 ml buffer 8. The slurry was then washed with 3x 1 ml 50 mM Tris/HCl pH 8.0, 
0.1% SDS, and 50 µl solution was left in the tube after the final wash.  To each tube 0.25 µl of 1 mg/ml 
ELC  (Endoproteinase LysC) was added and the tubes were placed at 37˚C with shaking. After 2 h, 0.25 
µl of 1 mg/ml ELC was added and the tubes were placed at 37˚C overnight with shaking. The tubes 
were briefly spun down and the supernatant was collected. The beads were extracted 2x with 50 mM 
Tris/HCl pH 8.0, 0.1% SDS (1x 200 µl, 1x 100 µl). The 3 samples were pooled and dried in the Speed-
Vac. The peptides were resuspended in 400 µl BS (85% acetonitrile; 10 mM ammonium acetate/formic 
acid pH 3.5) and loaded twice on a HILIC TopTip PolyLC spin column (PolyLC Inc.) that had been 
equilibrated with 3x 50 µl ES (5% acetonitrile; 10 mM ammonium acetate/formic acid pH 3.5) and 3x 
50 µl BS. The column was washed (3x 50 µl BS) and the peptides were eluted 4x with 25 µl ES. All 
elutions were pooled and dried in a Speed-Vac. The peptides were then resuspended in 50 µl 50 mM 
NH4HCO3 and subjected to trypsin digest with 0.5 µl 1 mg/ml trypsin (Promega) for 6 hrs at 37˚C. Mass 
spectrometric analysis was performed using LC-MS/MS (Orbitrap). 
 
Fluorescence Microscopy 
Cells were grown in YPD to early log-phase and then either shifted to 37°C for 1 h or subjected to 
various stresses as indicated. Cells were spun at 3,000 x g for 3 min and resuspended in HC-complete 
medium and immobilized on concanavalin A-coated slides. Fluorescence was monitored with an 
Axiocam mounted on an Axioplan 2 fluorescence microscope (Carl Zeiss, Oberkochen, Germany) using 
Axiovision software. Image processing was performed using Image J and Adobe Photoshop CS5 (San 
Jose, CA). For counting a minimum of 200 cells from at least 3 independent experiments were counted 
per condition. In the quantification graphs, the size of the box is determined by the 25th and 75th 
percentiles, the whiskers represent the 5th and 95th percentiles, the lines and the triangles mark the 
median and the mean, respectively. 
 
Immunoelectron Microscopy 
Cells expressing Dcp2-9myc were grown to early log-phase at 23°C and then shifted to 37°C for 1 h. 
Cells were fixed and treated for immunoelectron microscopy as described (Prescianotto-Baschong and 
Riezman, 2002). Ten-nanometer gold particles coupled to goat anti-rabbit IgG (BBInternational, 
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Cardiff, United Kingdom) were used to detect the binding of polyclonal rabbit anti-myc antibodies 
(Abcam, Cambridge, MA).  
 
Immunoprecipitations  
Immunoprecipitations were performed similarly as described (Sezen et al., 2009). Twenty OD600 units 
of logarithmically growing cells grown in YPD and subjected to the various stresses as indicated were 
disrupted with glass beads in 300 µl IP buffer (50 mM triethanolamine pH 6.0, 150 mM KCl, 5 mM 
EDTA, 5 mM EGTA, Roche protease inhibitor tablet, 1 mM PMSF and 1 mM benzamidine). Lysates 
were incubated with 1% Triton X-100 for 10 min at 4°C. Extracts were cleared by centrifugation (3,000 
x g for 10 min at 4°C). An aliquot was removed that served as the input control and the remainder of 
the extract was incubated with monoclonal anti-FLAG M2 antibody (Invitrogen) and magnetic bead 
slurry (Dynal) for 2.5 hrs at 4˚C. Beads were washed 3x with IP buffer containing 0.1% Triton X-100. 
The beads were resuspended in sample buffer and analyzed by immunoblot. 
For the RNase A treated samples, after the extracts were cleared by centrifugation, they were 
treated with 40 U of RNase inhibitor (Promega) or 1 µg/µl RNase A and incubated for 1 h at 4˚C.  The 
extracts were then spun 3 min at 3,000 x g and the supernatant was used for the immunoprecipitation 
as described above. 
 
Antibodies 
Proteins and epitope tags were detected using the following anti-bodies: anti-myc (9E10, 1:1,000, 
Sigma-Aldrich), anti-hemagglutinin (HA11, 1:1,000, Covance, Princeton, NJ), anti-Scp160 (1:1,000), 
anti-Bfr1 (1:1,000), and anti-Sec61 (1:10,000, a gift from M. Spiess, Biozentrum, Basel, Switzerland). 
 
Flotation of P-bodies 
Flotation of ER membranes was performed as described previously (Schmid et al., 2006). The 
equivalent of 50 OD600 units was converted into sphereoplasts at 37˚C and lysed by Dounce 
homogenization in 3 ml lysis buffer (20 mM HEPES/KOH, pH 7.6, 100 mM sorbitol, 100 mM KAc, 5 mM 
Mg(Ac)2, 1 mM EDTA, 1 mM DTT, 100 µg/ml cycloheximide, protease inhibitors). After removal of 
cellular debris (5 min, 300 x g), membranes were pelleted by centrifugation (10 min, 13,000 x g), 
resuspended in 2 ml lysis buffer containing 50% sucrose, and layered on top of 2 ml 65% sucrose in 
lysis buffer. Two additional 5 ml and 2 ml cushions (40% and 0% sucrose) were layered on top. The 
step gradient was spun in a TST41.14 rotor for 16 h at 28,000 rpm. After centrifugation, 1 ml fractions 
were collected from each of the cushions and the interphases and were TCA-precipitated. The samples 
were analyzed by SDS-PAGE and immunoblotting. 
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Polysome Profile Analysis 
Preparations of polysomes were performed as described previously (de la Cruz et al., 1997) on 4-47% 
sucrose gradients prepared with a Gradient Master (Nycomed Pharma, Westbury, NY). Gradient 
analysis was performed using a gradient fractionator (Labconco, Kansas City, MO) and the Äcta FPLC 
system (GE Healthcare) and continuously monitored at A254.  
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Figure 5.S1. Dcp2 associates with 
ER membranes in the absence of 
BFR1 or SCP160.  
Wild-type, ∆bfr1, and ∆scp160 yeast 
cells expressing Dcp2-9myc were 
shifted to 37˚C for 1 hr. Lysates were 
prepared and a pellet was formed 
from a 13,000 x g spin (P13) and 
corresponding supernatant fraction 
(S13). The pellet was subjected to 
buoyant density centrifugation. In all 
conditions, a portion of Dcp2-9myc 
floated with the ER marker Sec61p at 
the 0/40% interphase. 
 
Figure 5.S2. Deletion of the last 4 KH domains 
in Scp160 results in multiple P-bodies. 
The endogenous copy of SCP160 was replaced 
through homologous recombination with the 
linearized plasmid pMS449, in which the 4 most 
C-terminally located KH domains of Scp160 had 
been deleted. This strain also contains Dcp2-GFP 
tagged. The cells were grown at 23˚C and P-body 
formation was observed. Similarly to the ∆scp160 
strain, Scp160∆C4 led to an increase in P-bodies 
under normal growth conditions. Scale bar 
represents 5 µm  
 
Figure 5.S3. Heat stress induces P-
bodies in ∆bfr1 and ∆scp160 
similarly than in wild-type. Wild-
type, ∆bfr1, and ∆scp160 cells 
expressing Dcp2-GFP were shifted 
to 46˚C for 10 min before imaging. 
In all strains, P-body formation was 
observed. Scale bar represents 5 µm. 
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Table 5.S1: Yeast strains used in this study 
 
Strain Designation Genotype Reference 
YPH499 WT MAT a ade2-101 his3-200 leu2-1 lys2-801 trp-63 ura3-52 Sikorski and 
Hieter, 1989 
NYY0-1 ARF1 MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 Yahara et al., 
2001 
NYY11-1 arf1-11 MAT a ade2::arf1-11::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 Yahara et al., 
2001 
YAS2501 Dcp2-HBH MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 DCP2::DCP2-HBH-
kanMX4 
This study 
YAS2502 arf1-11 Dcp2-HBH MAT a ade2::arf1-11::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 DCP2::DCP2-HBH-
kanMX4 
This study 
YAS3240 Scd6-HBH MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 SCD6::SCD6-HBH-
TRP1   
This study 
YAS3257 arf1-11 Scd6-HBH MAT a ade2::arf1-11::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 SCD6::SCD6-HBH-
TRP1   
This study 
YAS1031A Dcp2-GFP MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 DCP2::DCP2-yEGFP-
kanMX4 
This study 
YAS1271 Bfr1-GFP MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 BFR1::BFR1-yEGFP-
kanMX4 
This study 
YAS1184 Scp160-GFP MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 SCP160::SCP160- 
yEGFP-kanMX4 
This study 
YAS1272 arf1-11 Bfr1-GFP MAT a ade2::arf1-11::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 BFR1::BFR1-yEGFP-
kanMX4 
This study 
YAS1185 arf1-11 Scp160-GFP MAT a ade2::arf1-11::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 SCP160::SCP160-
yEGFP-kanMX4 
This study 
YAS3135 Dcp2-GFP ∆bfr1 MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 DCP2::DCP2-yEGFP-
kanMX4 bfr1::LEU2   
This study 
YAS3136 Dcp2-GFP ∆scp160 MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 DCP2::DCP2-yEGFP-
kanMX4 
scp160::URA3   
This study 
YAS3137 Dcp2-GFP 
∆bfr1∆scp160 
MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 DCP2::DCP2-yEGFP-
kanMX4 bfr1::LEU2  scp160::URA3   
This study 
YAS2238 Edc3-GFP  MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 his3 leu2 EDC3::EDC3-yEGFP-TRP1  This study 
YAS2867 Edc3-GFP ∆bfr1 MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 his3 leu2 EDC3::EDC3-yEGFP-TRP1 
bfr1::URA3   
This study 
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YAS2778 Edc3-GFP ∆scp160 MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 his3 leu2 EDC3::EDC3-yEGFP-TRP1 
scp160::URA3   
This study 
YAS1153 Dhh1-GFP  MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 DHH1::DHH1-yEGFP-
kanMX4 
This study 
YAS2878 Dhh1-GFP ∆bfr1 MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 DHH1::DHH1-yEGFP-
kanMX4 bfr1::URA3   
This study 
YAS2782 Dhh1-GFP ∆scp160 MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 DHH1::DHH1-yEGFP-
kanMX4 scp160::URA3   
This study 
YAS2315 Scd6-GFP  MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 SCD6::SCD6-yEGFP-
kanMX4 
This study 
YAS2819 Scd6-GFP ∆bfr1 MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 SCD6::SCD6-yEGFP-
kanMX4 bfr1::URA3   
This study 
YAS2783 Scd6-GFP ∆scp160 MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 SCD6::SCD6-yEGFP-
kanMX4 scp160::URA3   
This study 
YAS1294 Dcp2-9myc MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 DCP2::DCP2-9myc-
TRP1 
This study 
YAS2880 Dcp2-9myc bfr1 MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 DCP2::DCP2-9myc-
TRP1  
bfr1::URA3   
This study 
 
YAS2881 Dcp2-9myc scp160 MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 DCP2::DCP2-9myc-
TRP1  
scp160::URA3   
This study 
 
YAS3113 Dcp2-9myc  
Scp160-3FLAG 
MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 DCP2::DCP2-9myc--
kanMX4 
SCP160::SCP160-3FLAG-TRP1  
This study 
YAS3112 Dcp2-9myc 
 Bfr1-3FLAG 
MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 DCP2::DCP2-9myc--
kanMX4 
BFR1::BFR1-3FLAG-TRP1  
This study 
YAS3330 Dcp2-9myc Scp160-
3FLAG Pat1-6HA 
MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 DCP2::DCP2-9myc--
kanMX4 
SCP160::SCP160-3FLAG-TRP1 PAT1::PAT1-6HA-hphNT1 
This study 
YAS3814 Dcp2-9myc Scp160-
3FLAG Edc3-6HA 
MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 DCP2::DCP2-9myc--
kanMX4 
SCP160::SCP160-3FLAG-TRP1 EDC3::EDC3-6HA-hphNT1 
This study 
YAS3815  Dcp2-9myc Scp160-
3FLAG Scd6-6HA 
MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 DCP2::DCP2-9myc--
kanMX4 
SCP160::SCP160-3FLAG-TRP1 SCD6::SCD6-6HA-hphNT1 
This study 
YAS3816 Dcp2-9myc Bfr1-
3FLAG Pat1-6HA 
MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 DCP2::DCP2-9myc--
kanMX4 
This study 
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BFR1::BFR1-3FLAG-TRP1 PAT1::PAT1-6HA-hphNT1 
YAS3817 Dcp2-9myc Bfr1-
3FLAG Edc3-6HA 
MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 DCP2::DCP2-9myc--
kanMX4 
BFR1::BFR1-3FLAG-TRP1  EDC3::EDC3-6HA-hphNT1 
This study 
YAS3818 Dcp2-9myc Bfr1-
3FLAG Scd6-6HA 
MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 DCP2::DCP2-9myc--
kanMX4 
BFR1::BFR1-3FLAG-TRP1 SCD6::SCD6-6HA-hphNT1 
This study 
YAS3236 Dcp2-GFP TEF1-Bfr1 MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 DCP2::DCP2-yEGFP-
kanMX4 
BFR1::natNT2-TEF1-BFR1 
This study 
YAS3242 TEF1-Bfr1-GFP MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 BFR1::natNT2-TEF1-
BFR1-yEGFP-kanMX4 
This study 
YAS3241A Scp160-GFP  
TEF1-BFR1 
MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 SCP160::SCP160-
yEGFP BFR1::natNT2-TEF1-BFR1 
This study 
YAS3237 Dcp2-GFP  
TEF1- SCP160 
MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 DCP2::DCP2-yEGFP-
kanMX4 SCP160::natNT2-TEF1-SCP160 
This study 
YAS3243 Bfr1-GFP TEF1-
SCP160 
MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 BFR1::BFR1-yEGFP 
SCP160::natNT2-TEF1-SCP160 
This study 
YAS3241 TEF1-Scp160-GFP MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 SCP160::natNT2-
TEF1-SCP160::SCP160-yEGFP-kanMX4 
This study 
YAS3239 Dcp2-GFP ∆bfr1  
TEF1-SCP160 
MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 DCP2::DCP2-yEGFP-
kanMX4 SCP160::natNT2-TEF1-SCP160 bfr1::loxp::ura3::loxp 
This study 
YAS3238 Dcp2-GFP ∆scp160 
TEF1-BFR1 
MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 DCP2::DCP2-yEGFP-
kanMX4 BFR1::natNT2-TEF1-BFR1 scp160::loxp::ura3::loxp 
This study 
YAS3789 Dcp2-GFP ∆bfr1 MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 DCP2::DCP2-yEGFP-
kanMX4 bfr1::loxp::ura3::loxp 
This study 
YAS3790 Dcp2-GFP ∆scp160 MAT a ade2::ARF1::ADE2 arf1::HIS3 arf2::HIS3 ura3 lys2 trp1 his3 leu2 DCP2::DCP2-yEGFP-
kanMX4 scp160::loxp::ura3::loxp 
This study 
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Further Discussion 
P-body associated proteins 
 
Due to our previous observation that P-bodies localize in close proximity to ER membranes we set out 
to identify proteins, which regulate the formation of P-bodies (Kilchert et al., 2010).  Through use of a 
crosslinking affinity purification approach using Dcp2 or Scd6 proteins as bait proteins and subsequent 
LC-MS/MS analysis, we identified a list of proteins that associate with P-bodies at ER membranes. This 
list of candidate proteins was compared to other tandem affinity purifications performed in our lab as 
well as an untagged control and common contaminating proteins were removed, leaving us with a list 
of potential P-body interacting proteins (Table 5.2).  From the remaining proteins, we noticed that 
many were RBPs such as Eap1, Not1, Tif3, Yra1, Pab1, Nam7, Psp2, Scp160. Since mRNA is the main 
component of P-bodies, and without mRNA they do not form, it is not surprising that other RBPs would 
be found in our purification. Perhaps some of these RBPs are involved in the formation of P-body 
intermediates or are members of mRNPs that interact with P-bodies.  
Interestingly, numerous proteins found through this purification method were also involved 
in translation (Tef4, Tif3, Tif5, Eap1 and Hef3). Although it is unexpected to find translation factors in 
a purification for decay aggregates, they may provide a link between translation and the decay 
machinery. First, it has been established that P-bodies localize in close proximity to the ER in yeast 
(Kilchert et al., 2010). Furthermore, roughly half of the 6000 genes in the yeast cell encode for proteins 
that need to be transported through the secretory pathway and, thus, a great deal of translation needs 
to occur at the ER membrane (Lodish et al., 2003). By placing translation close to decay, the cell could 
quickly modulate its gene expression. Perhaps these translation factors interact with another yet 
unknown protein to shuttle mRNA from translation and hand it off to the decay machinery. 
Alternatively, due to our enrichment of ER membranes we obtain many ribosomal proteins in our 
purification and we may have found initiation factors based on their association with ribosomes.  In 
any case, these finding merits further investigation as it may provide a new method for coupling 
translation and decay at the ER.  
In our purifications, we found three ER associated proteins: Bfr1, Scp160, and Cdc48. Due to 
Cdc48 having many, diverse roles in the cell, we chose to not pursue this finding further. Recent data 
has indicated that Cdc48 is involved in stress granule clearance through autophagy (Buchan et al., 
2013). In this case, Cdc48 was found through a screen to examine the mechanisms that control 
assembly, disassembly, and clearance of P-bodies and stress granules in the cell. P-bodies were found 
to be only very slightly affected by the autophagy caused by Cdc48 and that the main target was stress 
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granules (Buchan et al., 2013). We found Cdc48 through a P-bodies purification approach, but it is 
possible that Cdc48 somehow recognizes the difference between the two mRNPs and thus 
distinguishes which to send for autophagy. This option would have to involve some sort of 
posttranslational modification on the stress granule in order for it to be specifically targeted.  It was 
also suggested that autophagy takes longer than the amount of time for a P-body to mature/rearrange 
into a stress granule and, thus, P-bodies are not targeted for autophagy (Buchan et al., 2008; Buchan 
et al., 2013). Time course experiments often showed the P-body marker Dcp2 and the stress granule 
marker Pab1 co-localizing for over 30 minutes (Buchan et al., 2008). This time period would suggest 
that autophagy is a very slow process if it were to wait until a P-body was rearranged into a stress 
granule. Earlier studies in mammalian cells implicated p97, the mammalian Cdc48 homolog, in poly(Q) 
diseases and showed that they can interact with poly(Q) tracts in vivo (Hirabayashi et al., 2001). 
Furthermore, studies in Drosophila and C. elegans suggest that Cdc48 homologs act to dissociate 
poly(Q) aggregating proteins (Higashiyama et al., 2002; Yamanaka et al., 2004). As many P-body 
components contain Q/N rich regions (Reijns et al., 2008), it may be that Cdc48 somehow aids in their 
disassembly through disruption of their Q/N rich interaction domains. How Cdc48 acts in the clearance 
of stress granules is still unknown, but these findings open the possibility that Cdc48 may play 
additional roles in the remodeling or clearance of various mRNPs within the cell. 
Other candidate proteins found may provide insight into the regulation of P-bodies. The 
proteins Yra1 and Psp2 provide potential opportunities for new P-body interacting proteins. Psp2 in 
particular is an asparagine (N)-rich cytoplasmic protein with RGG repeats able to bind RNA (Formosa 
and Nittis, 1998). Perhaps Psp2 somehow acts to transport mRNAs to P-bodies and interact with P-
bodies components through their similar Q/N rich regions. In addition, Psp2 was identified through 
independent HBH-purifications as a potential P-body interacting protein (Cornelia Kilchert, 
unpublished data). The consistent co-purification of Psp2 may hint at that it has a genuine role in P-
body formation, though its interaction remains to be tested. Finally, the protein Yra1 is involved in the 
export of polyadenylated mRNA from the nucleus and perhaps during its time in the cytoplasm, it 
plays a role in P-body formation through the transport of mRNA to the P-body (Zenklusen et al., 2001).  
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 Table 5.2:  Proteins identified through HBH purification       
Gene 
Name Description (Source: Proteome) 
Found with 
both Dcp2- 
and Scd6-
HBH 
Found 
with  
Scd6-HBH 
Found 
with 
Dcp2-
HBH 
Dcp2 
mRNA decapping protein 2, a putative pyrophosphatase required with Dcp1p for mRNA decapping, 
suppresses the respiratory deficiency of a petite mutant X   
Xrn1 
KAR(-) enhancing mutation 1, a 5'-3' exonuclease for single-stranded RNA and DNA that degrades decapped 
mRNA, required for pseudohyphal and invasive growth, involved in the G1 to S phase transition X   
Pab1  
Poly(A) binding protein 1, a cytoplasmic and nuclear protein that is part of the 3'-end RNA-processing 
complex (cleavage factor I), involved in translation termination with Sup35p, has 4 RNA recognition (RRM) 
domains and functions in mRNA decay X   
Scd6 
Suppressor of clathrin deficiency, negatively regulates translation initiation, involved in mRNA decay, 
overproduction suppresses inviability exhibited by clathrin heavy chain (chc1) null mutant X   
Eap1 
Protein that inhibits <*cap*>-dependent translation, probable purine nucleotide-binding protein that 
associates with translation initiation factor eIF4E, also has an eIF4E-independent function in genetic stability  X  
Dhh1 
DEAD-box helicase homolog 1, a putative RNA helicase required for normal sporulation, involved in glucose-
starvation induced P body formation X   
Scp160 
S. cerevisiae protein involved in the control of ploidy 160, acts in control of mitotic chromosome transmission 
and telomeric silencing, an effector for Gpa1p in the mating response pathway, contains 14 KH domains 
which are found in RNA-binding proteins  X  
Edc3 
Enhancer of mRNA decapping 3, required for proper 5' to 3' degradation, and decapping, of cytoplasmic YRA1 
pre-mRNA, enhances dcp1 and dcp2 mRNA decapping mutants X   
Bfr1  
Protein that suppresses brefeldin A-induced lethality when overproduced, may be involved in mRNA 
metabolism X   
Pat1 
Protein associated with topoisomerase II, required for faithful chromosome transmission and normal 
translation initiation, involved in deadenylation-dependent mRNA decay, ethanol tolerance, and maintaining 
cell wall integrity X   
Cpr1 
Cyclophilin (peptidylprolyl cis-trans isomerase or PPIase) of the nucleus and cytoplasm that promotes 
meiotic gene expression, plays a role in the stress response, component of Set3p complex X   
Sbp1 
Single-stranded nucleic acid-binding protein 1, associated with small nucleolar RNAs (snoRNAs), involved in 
glucose starvation-induced translation repression and P body formation  X  
Tef4 Translation elongation factor EF-1gamma X   
Sti1 
Stress inducible 1, a stress-induced protein required for optimal growth at high and low temperature, TPR2A 
and DP2 domains mediate binding and signaling events associated with Hsp82p X   
Nam7 
Nuclear accommodation of mitochondria 7, a protein involved with Nmd2p and Upf3p in decay of mRNAs that 
contain premature nonsense codons X   
Yra1 
Yeast RNA annealing protein 1, a protein with RNA:RNA annealing activity, involved in mRNA packaging for 
export from the nucleus  X  
Mpg1 Mannose-1-phosphate guanyltransferase, GDP-mannose pyrophosphorylase X   
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Not1 
Cell division cycle 39, a nuclear protein and component of the CCR4-Not complex that negatively affects basal 
transcription from many promoters also plays a role in decapping some mRNAs  X  
Rps12 Ribosomal protein S12  X  
Nog1 
Nucleolar G protein 1, a putative essential nucleolar GTP-binding protein, required for large ribosomal 
subunit biogenesis and export from the nucleolus    X 
Cdc48 
Cell division cycle 48, member of the AAA family of ATPases required for cell division and homotypic 
membrane fusion, component of the ubiquitin/proteasomal-dependent ER-associated degradation (ERAD) 
system   X 
Vma13 
Vacuolar Membrane ATPase 13, subunit H of the V1 peripheral membrane domain of the vacuolar H(+)-
ATPase (V-ATPase), required for V-ATPase activity X   
Hsp26 
Heat shock protein of 26 kDa, a chaperone that binds unfolded citrate synthase and rhodanese and is 
expressed during entry to stationary phase and is induced by osmostress, may be required for resistance to 
ethanol and acetaldehyde X   
Hsp12 
Heat shock protein of 12 kDa, induced by heat, osmotic stress, oxidative stress and in stationary phase, may 
be required for ethanol and acetaldehyde resistance  X  
Psp2 High-copy suppressor of temperature-sensitive mutations in DNA polymerase alpha  X  
Tif5 
Translation initiation factor eIF5, catalyzes hydrolysis of GTP on the 40S ribosomal subunit-initiation complex 
followed by joining to the 60S ribosomal subunit  X  
Tif3 Translation initiation factor eIF4B, contains one RRM (RNA recognition motif) RNA-binding domain  X  
Hta1 Histone h two A 1, a chromatin binding protein that functions in chromatin related events   X 
Atp1 
ATP synthase 1, alpha subunit of the F1 subunit of ATP synthase-mitochondrial respiratory complex V, three 
molecules are present in each F1 complex   X 
Lsm5 U6 snRNA-associated protein of the Sm-like group  X  
Lsm2 U6 snRNA-associated protein of the Sm-like group  X  
Dcp1 
mRNA decapping 1, an mRNA decapping enzyme involved in mRNA turnover, plays a role in mediating proper 
translation termination via interaction with the Sup35p translation release factor  X  
 
Underline indicates ER localized proteins; proteins with RNA related abilities are shown in italics,  
and P-body proteins are shown in bold    
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One type of protein that was not identified in our screen were transmembrane proteins. We 
enriched for ER fractions in order to purify P-bodies and to hopefully capture potential interacting 
proteins. Due to P-bodies localizing in close proximity to the ER, we thought that there may be 
transmembrane proteins acting as tethering factors to keep P-bodies at the ER. The three ER 
associated factors that we found- Bfr1, Scp160, and Cdc48- are all soluble proteins that locaalize to 
the ER periphery. Bfr1 and Scp160 were determined by immuno-EM to not be the factors involved in 
tethering P-bodies to the ER since in their absence, P-bodies remained ER associated. We have not 
determined if Cdc48 is responsible for the localization of P-bodies to the ER, but one would image that 
Cdc48 may play a role more in the dissociation of P-bodies than the localization. There still may be a 
transmembrane protein tethering P-bodies to the ER, but modifications to our current purification 
protocol would likely be needed.   
 
The role of Bfr1 in P-body formation 
 
From our screening method we found two peripheral ER proteins that were reported to localize to 
translating polysomes: the RNA binding protein Scp160 and its reported interactor Bfr1. Through 
further studies we found that both proteins were involved in the inhibition of P-body formation. 
Scp160 was found to be an mRNA dependent P-body interacting protein localized to polysomes, but 
its Bfr1 has a more elusive role in inhibiting P-body formation. As described previously, loss of BFR1 
led to many Dcp2-positive foci similar to that seen in ∆scp160 cells, but unlike in ∆scp160 cells, ∆bfr1 
cells were able to form proper P-bodies consisting of mRNA and core P-body components. 
Overexpression of BFR1, however, was able to inhibit the formation of P-bodies in ∆scp160 cells 
indicating that the two proteins act independently to prevent P-body formation. In addition, Bfr1 does 
not appear to reliably associate with P-body components.  
So what exactly is Bfr1 doing in the regulation of P-bodies at the ER? Bfr1 was one of the 
subjects of a high-throughput study to identify which mRNAs specifically bound to various RBPs in S. 
cerevisiae (Hogan et al., 2008). One must note that Bfr1 is annotated as an RNA binding protein 
although it does not contain known RBDs. It was found to interact with Scp160 in an mRNA dependent 
manner at polysomes and, thus, RNA binding was inferred (Lang et al., 2001). It is possible that Bfr1 is 
able to directly bind RNA through an as yet identified structural motif or RBD. This idea is supported 
by the data from the high-throughput screen, as it was noted that Scp160 and Bfr1 had a significant 
overlap in the mRNAs that they bound, though each protein also had unique mRNA binding partners 
(Hogan et al., 2008). It may also be that Bfr1 binds to RNA in conjunction with another protein or set 
of proteins and that these interactions provide a surface for RNA binding. One such candidate for a 
scaffolding protein at ribosomes is Asc1, the homolog of mammalian RACK1. Asc1 acts as a platform 
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for signaling molecules and so in addition to acting as a scaffold for Bfr1-Scp160 binding at the 
ribosome, it may also receive and transmit stress signals. Studies have confirmed that Bfr1 interacts 
with both Scp160 and Asc1 in an mRNA dependent manner (Baum et al., 2004; Sezen et al., 2009). 
Also, even with Scp160 and, potentially Asc1, present at the ribosome this is not sufficient to inhibit 
the formation of P-bodies, reiterating that Bfr1 likely has a role in binding or perhaps signal 
transduction in P-body regulation that is not yet identified. 
There may also be a yet unknown protein that interacts with Scp160 and Bfr1 to regulate P-
body formation. This protein may be able to compensate for the loss of SCP160, but only situations 
where Bfr1 is overexpressed. There are at least two possible RBPs that have been shown to interact 
with Bfr1 and Scp160: Eap1, a 4E-binding protein, and the poly(A) binding protein Pab1 (Lang and 
Fridovich-Keil, 2000; Mendelsohn et al., 2003). Eap1 is a member of the SESA complex and interacts 
with Scp160 in an mRNA dependent manner (Mendelsohn et al., 2003; Sezen et al., 2009). 
Furthermore, loss of Scp160 caused disruption of Eap1 localization at membranes and on polysomes 
(Mendelsohn et al., 2003). Pab1 was also identified as an mRNA dependent interactor of Bfr1 and 
Scp160 at the translating ribosome (Lang and Fridovich-Keil, 2000). Furthermore, Eap1 and Pab1 were 
found in our screen for P-body interacting proteins they may be genuine interactors P-body 
components. In preliminary studies we observed that loss of EAP1 caused a multiple P-body 
phenotype similar to that seen with ∆bfr1 and ∆scp160 under normal growth conditions, indicating 
that Eap1 may indeed is involved in P-body formation. These proteins may play a role in the specificity 
and regulation of Scp160 bound mRNAs at the translating ribosomes and aid in linking translation with 
decay. Investigation into the relationship among these proteins in P-body formation may help to 
reveal if they act together with Scp160 and Bfr1 to inhibit P-body formation. 
Another possibility is that Bfr1 acts to regulate the binding and association of RNA binding 
proteins. Scp160 has many different roles in the cell ranging from asymmetric transport of mRNAs to 
maintenance of telomeres and now to association and assembly of P-bodies (Lang et al., 2000; Li et 
al., 2003; Baum et al., 2004; Trautwein et al., 2004; Marsellach et al., 2006; Hogan et al., 2008; Sezen 
et al., 2009). To ensure that Scp160 does not act in the wrong complex at the wrong time, there are 
certainly interactor proteins to regulate the spatial and temporal functioning of the protein. Perhaps 
Bfr1 is the interactor for Scp160, as it was previously observed that in the absence of Bfr1, Scp160 is 
unable to efficiently localize to polysomes (Lang et al., 2001). Post-translational modifications may 
also affect the relationship between the two proteins. Scp160 is phosphorylated in response to 
inhibition of TOR, which mimics nutrient stress (Soulard et al., 2010). Perhaps phosphorylation hinders 
the binding of Scp160 to Bfr1 and, therefore, loses its interaction at polysomes. This would then mimic 
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the loss of Bfr1, since Scp160 would be displaced due to its phosphorylation and mRNA would not be 
properly guarded.  
 
 
Scp160 as a translational regulator 
 
Previous studies indicate that Scp160 may be involved in translational control due to its 
association with ribosomes and various mRNA as well as the observation that ∆scp160 cells are 
sensitive to translational inhibitors (Lang et al., 2000; Baum et al., 2004; Li et al., 2003; Sezen et al., 
2009; Hogan et al., 2008). We have established that Scp160 requires RNA to interact with P-body 
components at polysomes, but we are unsure of which Scp160-bound mRNAs would be sent into P-
bodies. It is likely that Scp160 regulates the translation of numerous specific messages. It has been 
shown that Scp160 is required for the efficient translation of DHH1 mRNA and it regulates the 
translation of POM34 mRNA in response to spindle pole body defects (Li et al., 2003; Sezen et al., 
2009). It may be that the interaction between Scp160 and P-body components requires any Scp160-
bound mRNA that is in the process of being translated or the interaction could be transcript specific. 
Alternatively, the interaction amongst Scp160, P-body components, and mRNA may be due to a post-
translational modification on Scp160. As previously mentioned, Scp160 was shown to be 
phosphorylated and this modification may alter the mRNAs that it binds. Perhaps other stress 
conditions further modify Scp160 and in turn, different mRNAs are recognized as targets for decay. 
Although there are lists of numerous Scp160 associated mRNAs, very few transcripts have been 
studied in detail (Li et al., 2003; Sezen et al., 2009; Gelin-Licht et al., 2012). It would be interesting to 
investigate Scp160-bound mRNAs that may be destined for P-bodies and to determine their fate in 
the absence of Scp160. As ∆scp160 cells are not able to form bona fide P-bodies it is possible that 
these mRNAs would be stabilized and avoid degradation.  
 
The fate of mRNAs in the absence of SCP160 and BFR1 
 
One unanswered question regarding the relationship amongst Scp160, Bfr1, and P-bodies is the mRNA 
content. Although Bfr1 and Scp160 bind to a specific list of mRNAs in the cell, the list is quite large 
with more than 300 hits per protein and it is unclear if all of these candidate mRNAs are regulated at 
the translating ribosome (Hogan et al., 2008). Thus, one of the keys to understanding more about the 
role of Scp160 and Bfr1 would be through identification of the mRNA that they are guarding and 
whether these mRNA targets are the primary inhabitants of the Dcp2-positive foci in ∆scp160 and 
∆bfr1 cells. Of particular interest would be the mRNA content of the pseudo-P-bodies in ∆scp160 cells 
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and whether these messages are stabilized. It is unlikely that mRNAs are decayed in pseudo-P-bodies 
due to lack of presence of core P-body components. Perhaps the pseudo-P-bodies seen in ∆scp160 
cells represent an intermediate mRNP complex and understanding these pseudo-P-bodies may give 
insight into how Scp160 functions in P-body assembly. In any case, identifying the mRNAs present in 
pseudo-P-bodies would allow for not only decay experiments, but also experiments to examine 
protein binding and recruitment.   
Currently we do not have the necessary data to support or deny the decay state of pseudo-P-
bodies. qPCRs were performed on the total mRNA in the cell as well as through polysome profile 
fractionation, but the expression of the mRNAs examined fluctuated greatly from experiment to 
experiment. Perhaps some of the difficulties from the qPCR come from the fact that ∆scp160 and 
∆bfr1 have issues in nuclear segregation and often the cells become polyploid (Xue et al., 1996; 
Wintersberger et al., 1995; Lang et al., 2001). There is a degron construct of Scp160 that can be 
induced, and within 6 hours it phenocopies ∆scp160 without the having the additional issue of cells 
being a polyploidy (Ralf-Peter Jansen, unpublished data). This may be a viable option to examine for 
future experiments. Furthermore, one could create a similar degron for Bfr1 since it shares many of 
the same segregation problems as Scp160. Lastly, we chose candidate mRNAs reported to be bound 
by Scp160 (Li et al., 2003; Hogan et al., 2008), but we do not know when and where in the cell these 
mRNAs are bound. As previously mentioned, Scp160 has several roles in the cell and it likely binds 
different mRNAs depending on its role. It may be that the candidate mRNAs we have chosen are 
unaffected during the conditions where pseudo-P-bodies are formed. 
Further work may lead to a better understanding of the mRNAs contained within the Dcp2-
positive foci in ∆scp160 and ∆bfr1 cells. Due to the localization of Bfr1 and Scp160 at the ER we may 
have to examine the ER-associated polysomes to determine changes in translation. We, and others, 
have seen that ∆scp160 cells do not have a defect in general translation (Lang et al., 2001; Li et al., 
2003; Baum et al., 2004). Perhaps the changes that occur in the cell as a whole are not great, but 
examining the ER fraction may help to elucidate changes in specific Scp160 targets. Another way to 
identify mRNAs that may link Scp160 and P-bodies may be through IP experiments. One could perform 
an IP, extract RNA from the sample and perform a microarray experiment to identify potential P-body-
Scp160 mRNAs. As these mRNAs would just be leaving translation they should still contain their 
poly(A) tails and so oligo(dT) based arrays would be a viable option. The resulting candidates could 
then be examined by qPCR and Northern blot in order to determine if their stability 
is altered in the absence of SCP160.  
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6. A method toward the identification of mRNAs contained within P-bodies 
 
Extensive studies have been performed regarding the composition and stresses that cause P-body 
formation. One of the main questions in the P-body field is which mRNAs are contained within P-
bodies. Does the mRNA composition change depending on the stress that the cell must endure? 
Finally, are P-bodies mainly sites of mRNA decay or under certain conditions are they used primarily 
as storage modules? 
Recently, several groups performed crosslinking and immunoprecipitation protocols using a 
variety of RBPs, such as those involved in splicing or RNAi machinery, to identify RNA targets in various 
cell types, including yeast and mammalian cell lines (Hafner, et al 2010, Grannenman, et al 2009, 
Mitchell, et al., 2012). Using a variation of these methods, we set out to identify the mRNAs contained 
within P-bodies under various stress conditions. The initial challenge was how to proceed with 
identification of mRNAs contained within P-bodies. If an mRNA is a target for decay and contained 
within a P-body, it would be deadenylated and/or decapped, which would make identification of the 
RNA by oligo(dT)-based microarray difficult. Deep sequencing techniques allowed us to work 
independently of oligo(dTs), by ligating adaptors to the mRNA within P-bodies which allow for priming 
during reverse transcription and, thus, all of the isolated RNA is taken into account and the decay state 
is of little concern. Since P-body formation is quite a dynamic process, we needed a to establish a 
method to capture the interactions between P-body components and the RNA contained within. 
Lastly, we required a way to concentrate the decay machinery. In yeast it was recently discovered that 
P-bodies localize in close proximity to ER membranes (Kilchert et al., 2010). A purification approach 
through which P-bodies are purified from stressed cells may provide us with enough material to 
properly examine the associated RNA contained within.     
The identification of associated mRNA will enable us to understand which mRNAs localize to 
P-bodies in response to specific forms of stress. There may be mRNAs that localize to P-bodies during 
any stress or the entire mRNA composition may change based on the stress encountered. The dynamic 
equilibrium model proposes that blocks in translation lead to increased P-body formation (Coller and 
Parker, 2005). It was previously observed that different stresses induced varied responses in 
translation and P-body induction (Kilchert et al., 2010). Combining stresses, such as starvation and 
hyperosmotic shock, caused a strong block in translation, like in starvation, but numerous P-bodies, 
as seen in hyperosmotic shock, indicating that multiple pathways are likely responsible for P-body 
formation and that specific mRNAs are contained within each type of P-body. Additionally, with the 
list of P-body localized mRNAs that we would acquire, we can begin to elucidate the potential signals 
that drive mRNAs into P-bodies. These signals within the mRNA may be linear and sequenced based 
or, more likely, structure based. This knowledge about the mRNA composition of P-bodies would lead 
6. A Method Toward the Identification of mRNAs Contained witihin P-bodies 
 96 
to further insight into their role in their cellular role and whether they are merely sites of decay, 
storage compartments, or have an adaptive their role depending on the stress endured. 
 
Isolation of RNA from HBH purifications 
 
To identify mRNAs localized to P-bodies, we started from a tandem affinity purification protocol 
(Tagwerker et al., 2006; Chapter 5). In our initial purifications, we used strains containing the P-body 
components (baits) Dcp2, a key member of the decapping complex, or Scd6, a translational repressor 
and decapping activator, chromosomally appended with a His6-biotinylation sequence-His6 (HBH) tag. 
The purifications were performed using either wild-type yeast cells or cells harboring the temperature 
sensitive arf1-11 allele (Yahara et al., 2001; Kilchert et al., 2010). Our lab previously observed that 
upon shift to 37˚C, wild type cells induced few (~1-2) P-bodies, whereas numerous P-bodies (~ 6-10) 
were formed under non-permissive conditions in arf1-11 cells (Kilchert et al., 2010). Since P-bodies 
are dynamic structures, we relied on formaldehyde crosslinking to capture the interactions amongst 
the various P-body components and the mRNA contained within. The remainder of the protocol was 
performed as described in Chapter 5 (Fig. 6.1). Through this purification method we found several P-
body components bound to our bait protein, giving us confidence that we were isolating entire P-body 
mRNPs instead of individual components (Table 6.1).  
 Since we were able to successfully isolate entire P-bodies, we needed a reliable method to 
extract the P-body associated mRNA. We degraded proteins through proteinase K digestion to liberate 
the mRNA. The RNA was then isolated and subjected to reverse transcription using random hexamers, 
which were used for priming due to the various decay states of the mRNAs within P-bodies (Sheth and 
Parker, 2003). In order for an mRNA to be bound by P-body components, it must first be deadenylated 
and without a poly(A) tail, the oligo(dTs) would not prime. PCR was performed on the resulting cDNA 
and the products were TOPO cloned, transformed into E.coli and plated on Blue/White selection 
media. Plasmids were isolated from selected clones and sent for Sanger sequencing. Unfortunately, 
we found only very small fragments of DNA, which were less than 10 bp in length or many sequences 
corresponding to the TOPO plasmid. The small fragments did not correspond to any particular 
sequence and may have been the result of a contamination. 
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Table 6.1: P-body proteins identified by HBH-purifications 
 
P-body component Function 
Dcp1 Member of the decapping complex 
Dcp2 Catalytic subunit of the decapping complex 
Dhh1 Translation repressor; RNA helicase; 
decapping activator 
Edc3 Decapping activator 
Lsm2 Decapping activator 
Lsm5 Decapping activator 
Pat1 Decapping activator and translation 
repressor 
Scd6 Translation repressor 
Sbp1 Translation repressor 
Xrn1 5’ to 3’ exonuclease 
 
We concluded that our purification and isolation (Fig. 1) was not sufficient for isolating mRNA 
contained within P-bodies and we did not proceed to deep sequencing analysis.  
 
Adapting the CLIP protocol for P-body purifications 
 
 
Our initial purification scheme for isolating RNA from P-bodies yielded very little, low quality material. 
We then compared our protocol to the published CLIP (Cross-linking Immunoprecipitation) and CRAC 
(Cross-linking and Cloning of bound RNAs) methods in order to establish a  protocol to meet our needs 
(Hafner et al., 2010; Granneman et al., 2009). Several rounds of trials with different modifications, 
which are described below, to the published CLIP method were conducted in order to obtain a sample 
with better quality and quantity of P-body contained RNA. Based on the quality control step 
(mentioned in detail below) we would continue with our CLIP protocol and send samples for deep 
sequencing or we would re-evaluate our method and start again. 
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Addition of Adapters 
 
One of the first steps taken in this process was the introduction of 
adapters, as reported in the published protocols. The adapters were 
ligated onto the 5’ and 3’ ends of the RNA of interest. These adapters 
served several functions such as priming the sequences during the RT-PCR, 
allowing the sequence to bind to the flow cell, and identifying the RNA 
sequence. In the original studies, two types of adapters were used, one 
that ligated on the 5’ end and one that ligated on the 3’ end. Recent 
advances allow for “bar codes” to be added into the 5’ adapter sequence, 
introducing a unique identifier to be introduced to the target RNA (Meyer 
et al., 2010). For our protocol decided to use the barcoded adapters so that 
an entire experiment, which included up to four different stress conditions, 
could be run in one flow cell.  
 
Radioactive labeling 
 
The original CLIP method called for radioactive labeling in order to detect 
RNA throughout each step of the purification process (Hafner et al., 2010). 
We originally decided against using radioactive labeling in order to avoid 
several gel purification steps that could result in loss of material. We 
utilized a method in which we could perform a single purification step and, 
thus, limit the material loss. We observed that on a 15% urea-acrylamide 
gel used for purification of the RNA, the unligated 3’ adapter ran at the 
same height as the dye front. This single gel purification step would allow 
us to purify our RNA with and remove unligated 3’ adapter, which could 
interfere with the 5’ adapter ligation in the subsequent steps. Although we 
did purify RNA using this method, we were unable to determine the 
Figure 6.1: Initial scheme for isolating mRNAs from P-bodies 
Cells were temperature shifted to induce P-body formation, lysed, and a 
tandem affinity purification was performed. The isolated P-body 
components were then subjected to digestion with proteinase K to free the 
RNA. The RNA was then isolated, reverse transcribed into cDNA, and 
TOPO clones. Clones were then examined through sequencing. 
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amount of material that remained in our sample until the final cDNA library was created. We decided 
that the ability to monitor our RNA was more important for the success of the protocol and switched 
to radiolabeling of the RNA. 
 
rRNA removal 
 
In our initial small-scale CLIP trials, we discovered that the vast majority of the sequences identified 
though Sanger sequencing were ribosomal RNA (rRNA). Due to the localization of P-bodies in close 
proximity to the ER in yeast and from our MS results, we know that many ribosomal components were 
found in our purifications. Furthermore, rRNA is a common contaminant in the CLIP protocol (Lukasz 
Jaskewicz, personal communications). To improve the mRNA enrichment scheme, we used an rRNA 
depletion kit (Yeast Ribominus kit, Invitrogen), which contains probes that bind to the 18S and 25S/26S 
rRNA coupled to biotin, which are then removed by binding to magnetic streptavidin beads. The 
Ribominus kit improved the quality of our mRNA, as the cDNA libraries now contained distinct DNA 
bands rather than just a smear. The smear on the gel points to low efficiency in generating cDNA, 
possibly due to the high amount of rRNA in the sample. Through removal of rRNA, we were able to 
see RNA populations of more distinct sizes (Fig. 6.2). This step was added into the final protocol in 
order to help enrich for RNAs contained within P-bodies.  
 
 
 
 
Quality Control 
 
In order to check the quality of our library before performing deep sequencing, we assessed the 
quality of our sample. This check consisted of subcloning a portion of our cDNA library into the TOPO 
Figure 6.2: rRNA masks other RNA 
sequences present in CLIP sample 
 
Removal of rRNA led to more specific 
amplification. An RNA sample was split 
into two and treated with a Ribominus kit 
to remove yeast rRNAs or left untreated. 
cDNA was then made from the two 
samples and a portion of each was then 
run on an agarose gel. The white box in the 
right panel indicates additional bands that 
appear in the sample after depletion of 
rRNA 
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vector and performing Sanger sequencing. For this step 96 colonies from the TOPO cloning were 
screened by colony PCR and run out on an agarose gel (Fig. 6.3). This allowed us to determine what 
percentage of the inserts included adapter-adapter or rRNA in our sample. During this step we found 
that the rRNA fragments were usually quite large (approximately 40 bp) in comparison to other RNA 
sequences. We then sent out colonies that should contain inserts, which meant that they were larger 
that the approximately 65 bp of the adapters, for Sanger sequencing. We BLASTed the sequences to 
determine if they matched any mappable sequence in the genome. This quality control step became 
crucial to determine whether our library was suitable for deep sequencing as we could evaluate the 
approximate amount of rRNA and adapter it contained. Even with the Ribominus step, the majority of 
our clones contained rRNA or harbored plasmids containing nonsense sequences, which are described 
below in more detail. Based on the outcome of our quality control step, we could re-evaluate the 
protocol in order to decide what change may lead to a cDNA library suitable for deep sequencing.  
 
 
 
Figure 6.3: CLIP sequences are analyzed through TOPO cloning and colony PCR  
After reverse transcription, cDNA was PCR amplified using primers that annealed to the 5’ and 3’ adapter 
sequence. These PCR products were then subcloned into the TOPO vector and transformed into E. coli. 
Colonies were picked and subjected to single colony PCR using the same primers used in making the 
cDNA. Colonies with PCR products larger than 65 bp (corresponding to adapter-adapter) were grown up, 
mini-prepped and sent for sequencing.   
 
Nonsense reads 
 
During our trial runs we often found sequences by TOPO cloning that did not significantly match to 
any yeast sequences or often not to any known sequence. In addition these nonsense reads were 
usually very small (approximately 15 bp). Nucleotide BLAST alignment against the non-redundant 
sequence database, revealed in many cases, sequences from a variety of bacteria and other 
organisms. It is possible that some of the sequences were contaminations from bacterial enzymes 
used during the protocol. Certain recombinant enzymes, such as RNase T1, were used in the CLIP 
protocol and it may be that residual DNA remained from the host bacteria used to purify these 
enzymes. Alternatively, these nonsense reads could be due to crosslinks remaining on the RNA 
sequences, which may in turn lead to the reverse transcriptase to skip over these regions or stop 
transcribing. This would be an explanation for the short sequences or the nonsense reads as these 
shorter regions may be spliced together pieces of the original sequence.  
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 After our HBH purification, we attempted to reduce the number of nonsense reads in our 
library by performing a gel purification step on our radiolabeled RNA followed by a transfer onto a 
nitrocellulose membrane. This step is used in the CRAC protocol in order to allow any free/nonspecific 
RNA to pass through the membrane (Granemann et al, 2009). We then proceeded with the proteinase 
K and RNA isolation steps. Although this step in the protocol did reduce the number of random, 
nonsense sequences that we obtained, but it did not completely abolish them. In addition, it also led 
to loss of material due to the additional purification step. For further CLIP experiments this step was 
removed in order to retain material and other options for removing the nonsense reads were 
examined.   
During my time working on the CLIP, I was not able to solve these problems, but further 
modifications to the protocol by Congwei Wang decreased the number of nonsense reads and 
increased the length of the inserts. Lowering the concentration of RNase T1 was a key step in solving 
these problems. In the CLIP protocol, RNase T1 is used in two steps to degrade RNA found outside the 
crosslinked complexes; once before the lysate is bound to beads and again after the purification 
(Hafner et al., 2010; Kishore et al., 2011). Furthermore, Congwei added an additional high 
temperature incubation step to ensure that the formaldehyde crosslinking was reversed and she has 
been able to obtain mostly mappable sequences.  
 
The first deep sequencing run 
 
After several rounds of small-scale trials and protocol optimizations we had a method that allowed us 
to isolate RNA from P-bodies in large enough quantities for deep sequencing. Furthermore, our quality 
control step indicated that we were obtaining sequences other than adapter-adapter and rRNA. These 
sequences were not large (on average roughly 15 bp), but we thought that perhaps the TOPO vector 
had an affinity for taking up smaller pieces of cDNA and, thus, we were not able to detect larger pieces 
of inserts. The issue of small insert size and nonsense sequences was a problem that we continuously 
encountered throughout the modification of the CLIP protocol. We then prepared our first library of 
P-body associated RNAs and sent the sample for deep sequencing. We obtained several million reads, 
but unfortunately, there were no useable sequences. The sequences consisted of rRNA, “N”s within 
the sequence or made up entirely of “N”s, or adapter-adapter. Although this run provided us with no 
useable sequences, it highlighted the main problem; the presence of “N”s.  This prompted us to re-
examine our protocol and determine the origin of the “N” sequences. Further trials were then 
conducted in which we varied buffer conditions and crosslinking methods in an attempt to increase 
the quality of our RNA library for sequencing. 
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Crosslinking Methods 
 
One attempt to decrease the amount of “N”s which were found in our deep sequencing result was to 
change the crosslinking strategy. The published CLIP protocol utilized UV crosslinking, whereas our 
tandem affinity purification used formaldehyde crosslinking. First we had to determine whether the 
crosslinking method affected our ability to crosslink RNA to P-bodies for later identification. In order 
to examine the different crosslinking methods, small-scale purifications were performed. Cells were 
starved or heat shifted and either crosslinked by using 1% formaldehyde followed by quenching or UV 
crosslinking according to published protocols (Wolf et al., 2010; Granneman et al., 2009). We then 
performed HBH purifications with the samples, sent them for MS analysis, and compared the list of 
identified peptides. In our hands, the two crosslinking methods did not seem to differ, as we were 
able to identify a similar set of P-body components in either case. We ultimately chose to continue 
using formaldehyde crosslinking and quenching due to the quickness, precision, and controllability. 
UV crosslinking was much more time consuming than formaldehyde crosslinking and we worried that 
this added time would cause further stress to the cells. With UV crosslinking the cells had to first be 
filtered out of the media and due to the large volumes of our yeast cultures, filtering would often take 
upwards of 30 min, which is much longer than any of our stress conditions. Furthermore, during 
filtering there was the possibility that the cells would become stressed due to starvation or crowding 
and this would also cause P-body induction, thus complicating our experiment. In order to be 
confident that the P-bodies in the cell were caused by only the stress that we wanted imposed on 
them, we chose to perform formaldehyde crosslinking in our experiments.  
In addition, we wanted to know if the different crosslinking methods affected the quality of 
the RNA.  We continued with our CLIP protocol with no other changes and examined the RNA 
sequences during our quality control step. We found that both crosslinking methods still led to reads 
with “N”s. This suggested that the crosslinking itself was not responsible for the “N”s in the sequence 
and, therefore, we kept the formaldehyde crosslinking in our protocol. 
 
Urea versus Guanidine Hydrochloride 
 
One reason that we may have had so many “N” reads and unreadable sequences in our deep 
sequencing run may have been due to the use of urea. Perhaps the “N” reads were due modification 
of the RNA, which hindered the downstream reactions. The mammalian CLIP protocol relies on a non-
denaturing buffer system, whereas fully denaturing conditions are used in the yeast CRAC protocol.  
In the CRAC protocol, tandem affinity purification is performed in 6 M guanidine hydrochloride 
(GuHCl; Grannneman et al., 2009). In addition, previous HBH purifications performed in our lab had 
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used GuHCl so this denaturing buffer should work for our CLIP protocol. We performed small-scale 
HBH purifications using 6 M GuHCl instead of 8 M urea and left the rest of the CLIP protocol 
unchanged. We created a library as mentioned previously and performed Sanger sequencing to check 
for the presence of “N” reads. Indeed, the use of GuHCl appeared to solve the problem of unreadable 
sequences and the presence of “N”s. In subsequent trials, GuHCl was used for the HBH purification 
step and “N” reads were no longer found in our library sequences. 
 
Material Loss 
 
With the optimized protocol, we were able to isolate RNA and make a library with readable sequences 
by Sanger sequencing, but we had very little material. Loss of material was a concern throughout the 
entire protocol. Material can initially be lost during the tandem affinity purification steps through 
numerous washes and through sticking to beads. After each of the adapter ligation steps, gel 
purification must be performed, and the RNA must be extracted from the gel pieces leading to 
material loss. We were not able to change the gel purification steps as they allowed us to distinguish 
between ligated RNA and unligated adapter. Instead we decided to alter two early steps in our 
protocol to ensure that we would be able to isolate enough RNA using our modified CLIP protocol for 
future deep sequencing experiments. The two changes that we implemented included: 
1.) Perform a single step purification  
2.) Increase the amount of starting material 
The first change was to perform a single purification step instead of a tandem affinity purification. We 
first performed small-scale purifications to determine if we could retain specificity and still identify P-
body components in a single step purification. Indeed MS results identified several P-body 
components via the one step purification indicating that this method could be used. By changing to 
the single step purification scheme, we retained more material in our initial purification steps, which 
in turn led to a higher yield of RNA target sequences later on. 
 The second change was to increase the amount of cells used in our purification, which in turn 
should increase the amount if P-bodies that are isolated. In our first deep sequencing run we used 
approximately 10 g of yeast cells, grown to mid log phase, for the purification step. In subsequent 
purifications we increased the amount of yeast cells used to 20 g of yeast cells per condition. In the 
final working protocol, now performed by Congwei, greater than 40 g of yeast cells are used per 
condition. This increase in the amount of starting material has aided in the success of the final CLIP 
protocol. 
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The modified CLIP protocol for identifying RNAs contained within P-bodies 
 
To this point, much work was done to adapt the CLIP protocol in order to identify RNAs contained 
within P-bodies. Trials were conducted in order to determine which steps from the published CLIP 
protocols were necessary and which steps could be adapted to suit our needs. This particular protocol 
details the changes that I made while performing CLIP trials, but it never resulted in a library to be 
sent for deep sequencing. The final stages of my work on the CLIP protocol, were greatly helped by a 
graduate student in the lab Congwei Wang. She continued trials with the CLIP and further 
modifications resulted in a reliable working protocol. To date she has performed several deep 
sequencing runs and now has several lists of candidate RNAs localized to P-bodies under various stress 
conditions.  
 A brief schematic of the CLIP protocol that I was involved in modifying is found below. We 
performed trials to adjust the protocol at all levels to better suit our needs. The numbers on the 
scheme highlight some of the important changes were made to improve the protocol (Fig. 6.4). The 
first change to the CLIP protocol was to increase the amount of yeast cells used as starting material in 
order to purify more P-bodies and their associated mRNA (1). We then substituted GuHCl  for urea in 
our purification. (2). Purifications with GuHCl provided us with MS results similar to those seen with 
urea and abolished the “N” sequences found in out final cDNA libraries. A key change that greatly 
improved our final libraries was lowering the concentration of RNase T1 in our samples (3). This step 
was performed twice in the protocol to degrade non-specific RNA outside of P-bodies. We then 
changed from a tandem affinity purification to a single step purification on streptavidin agarose in 
order to retain more material without losing specificity (4). Finally, we introduced the Ribominus rRNA 
removal kit in order to remove contaminating rRNA and more efficiently generate a cDNA library (5).   
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Figure 6.4: Modified CLIP protocol for identification of mRNAs contained within P-bodies  
Briefly, yeast cells were subjected to temperature stress before formaldehyde crosslinking and lysis. P-
body components were purified using denaturing conditions and one-step purification. After isolation of 
P-body components the mRNA was radiolabeled, the protein was degraded, the RNA was isolated, and the 
3’ and 5’ adapters were ligated on, respectively. The adapter ligated RNA was reverse transcribed into cDNA 
and a DNA library was made for subsequent deep sequencing. In addition, the library was independently 
checked via TOPO cloning of the library and Sanger sequencing. Our end goal was to send the sample for 
deep sequencing. The circled green numbers indicate areas of change described in the text. ** indicates a 
step was performed twice.  
 
Future Work 
 
The goal of this chapter was to identify the RNA contained within P-bodies. Through modifications of 
established CLIP protocols, we were able to isolate P-body components and associated RNAs, but we 
did not obtain the quality of RNA that was needed for Illumina deep sequencing. Several steps to our 
initial protocol were performed in order to reduce background contaminants, increase yield, and 
improve quality of the P-body contained RNAs. In the end, this project was taken over by Congwei 
Wang, a graduate student in the lab, and she put much effort into further modifying the CLIP protocol. 
Presently, she has a final protocol that allows for isolation of P-body contained RNA suitable for 
Illumina sequencing. Several experiments have been successfully performed, sent for deep 
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sequencing, the data was analyzed, and a hit list was generated and these candidates are now being 
investigated (C. Wang, personal communication).  
 In addition, CLIP experiments extending to different P-body components are now being 
performed. CLIP experiments using Scd6 as bait will determine if the top candidates during a specific 
stress condition remain the same. Scd6 is a core component of P-bodies and we would expect that 
the CLIP lists of sequences generated from Scd6 would to be similar to that which was found with 
Dcp2. If the two lists of sequences identified between replicate experiments are similar, this would 
indicate that the CLIP method was reliable and reproducible way to identify P-body associated mRNAs. 
 Currently, the candidate mRNAs found in P-bodies under various stress conditions are being 
analyzed. The first experiments performed would verify the candidate mRNA’s localization to P-bodies 
under the various stress conditions by fluorescent in situ hybridization (FISH) in combination with 
immunofluorescence (IF) or through the use of fluorescent proteins to monitor mRNA localization. In 
the latter example, a system such as MS2 (from the bacteriophage MS2), would be used, which entails 
cloning stem loops into your gene of interest and then co-expressing a viral capsid protein fused to 
GFP that recognizes the cloned stem loops (Bertrand et al., 1998; Fig. 6.5). The FISH/IF method is 
optimal as a screening method to determine whether or not the candidate mRNAs are enriched in P-
bodies when 
 
Figure 6.5: The MS2 system is used for imaging mRNA in live cells              
MS2 loops can be added to your gene of interest. In this case, they have been placed in the 3’UTR of the 
mRNA. mRNA can be visualized by co-expressing the MS2 coat protein (MS2CP) fused to GFP, which binds 
the stem loops in the mRNA. 
 
exposed to a specific stress. After it has been established that an mRNA localizes to P-bodies, MS2 
loops can be cloned into the mRNA sequence and real time imaging can be preformed.  
By performing imaging pre-, during, and post-stress one can determine how the P-body acts 
during a particular stress. If a candidate mRNA is seen to localize to P-bodies upon stress and then 
leave once the stress is alleviated, this may indicate that these P-bodies are acting as storage granules, 
rather than being involved in decay. Techniques such as Northern blotting of qPCR would allow us to 
examine the stability of candidate mRNA under normal growth conditions as well as under different 
stresses. This data would provide us with information about the state of the P-body during different 
stresses and whether they are acting as sites of storage or degradation. Finally, since there are likely 
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several different mRNAs found in P-bodies per stress condition, we can examine the mRNA for signal 
sequences that may drive them into P-bodies. By examining the deep sequencing data, there may be 
portions of the candidate mRNAs, which are highly enriched in various genes. By comparing these 
sequences across many genes, we may find a common linear sequence. Alternatively, the sequences 
found may not be identical at the base pair level, but they may form a similar hairpin/loop type 
structure. These hairpin structures may act as a binding site for a specific RBP, which may localize the 
candidate mRNA into P-bodies. Subsequently, these sequences can be mutated or replaced and the 
localization of the candidate mRNA can be examined as described above. An additional experiment 
could then be performed to identify the RBP binding an mRNA with a particular hairpin sequence 
through the use of a transcript specific RNA aptamer (Iioka et al., 2011). This data will give insight into 
the mRNA-ome for P-bodies in yeast and how it differs based on the stress that the yeast encounters.
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Discussion  
 
There are several unanswered questions in the field of mRNA decay, but one of the major 
question is simply, which mRNAs localize to P-bodies and under what conditions? It is predicted that 
10-15% of the yeast genome is modulated by environmental stress (Gausch et al., 2002) and as 
previously mentioned, P-bodies form protein aggregates to cope with these stresses through the 
storage and decay of mRNA. P-bodies are known to contain mRNA in various states of decay and this 
mRNA component is essential to their formation (Sheth and Parker, 2003; Teixeira et al., 2005; Eulalio 
et al., 2007). Despite this requirement for mRNA, very few mRNAs are known to localize to P-bodies. 
Previous studies into the decay state of mRNAs contained within P-bodies have used a reporter mRNA 
construct that localizes to P-bodies via the non-sense mediated decay pathway. Although this 
construct was instrumental in determining the presence of mRNA in P-bodies (Sheth and Parker, 2003) 
and the alternative role of P-bodies as storage granules (Brengues et al., 2005), it does not reflect the 
mRNA composition of P-bodies under different stresses. UFO1, an mRNA that was found to localize to 
P-bodies in yeast, was differently altered in its stability upon induction of various stresses (Lavut and 
Raveh, 2012). For example, arsenite stress caused no effect in mRNA stability of UFO1, whereas H2O2 
slightly destabilized the mRNA. UFO1 mRNA under both arsenite and H2O2 stress was found to co-
localize with the P-body component Dcp1. Although this is a single example, it reflects that not every 
stress causes immediate decay of the mRNA when localized to P-bodies.  
To extend our knowledge of how specific mRNAs are affected by localization to P-bodies under 
various stress conditions in S. cerevisiae, we set out to develop a protocol suitable for the identification 
of these mRNAs. We utilized our HBH-tandem affinity protocol, which successfully identified P-body 
components as well as P-body interacting proteins (Chapter 5). Through various trials we modified a 
protocol based on published CLIP methods to isolate P-body contained mRNAs (Hafner et al., 2010; 
Granneman et al., 2009). 
Crosslinking is an integral step in published CLIP protocols as well as in our protocol to ensure 
that the mRNA-protein interactions are maintained (Granneman et al., 2009; Hafner et al., 2010; 
Mitchell, et al., 2012). UV crosslinking is a preferred method for identifying interactions between 
mRNA and proteins, as it is considered a zero distance crosslinking reaction, meaning all proteins and 
mRNAs are crosslinked regardless of how close they are to one another. We cannot apply UV 
crosslinking to study P-bodies because UV radiation poses a stress capable of inducing P-bodies and 
stress granules in yeast. (Teixeira et al., 2005; Mitchell et al., 2012). Furthermore, UV crosslinking of 
large yeast cell cultures is time consuming and the amount of time needed to filter and crosslink the 
cells was up to three times longer than the stress induction. A stress such as starvation is a non-
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adaptive stress and P-bodies remain as long at the cell is without glucose, so these P-bodies may fair 
well with UV crosslinking. With adaptable stresses such as osmotic stress or Ca2+ addition, we know 
that P-bodies assemble and disassemble within roughly 30 minutes (Kilchert et al., 2010). For cell 
subjected to adaptable stresses, it would be difficult to control whether P-bodies still remained intact 
at the time of crosslinking. In addition, the cells are likely subjected to stress during the filtering 
process due to starvation as well as from the high density of cells on the filter. Due to these factors, 
we instead chose to use chemical crosslinking by formaldehyde for our purifications. Formaldehyde is 
a small crosslinker, which is very fast acting and is easily quenchable, which allows for precise timing 
of the crosslinking reaction (Tagwerker et al., 2006). We took an approach in which we stressed the 
cells, added formaldehyde, and then quenched the reaction before proceeding with the purification. 
Indeed, we found that in only two minutes of crosslinking, we were able to identify the core 
components in P-bodies, giving us confidence that P-body mRNPs were captured during the 
crosslinking. One of the main advantages of formaldehyde over UV crosslinking was the shortened 
reaction time and therefore, the cell had much less time to adapt or be susceptible to the additional 
stresses compared to those that may occur by UV crosslinking.  
A recent study examined global RBP in the yeast S. cerevisiae to gain new insight into the basic 
principles of mRNA-protein interactions (Mitchell et al., 2012). The method identified RBPs through 
UV crosslinking followed by MS analysis. Enrichment of RBPs from starved cells was performed 
through the use of an oligo(dT) column, which allowed for binding of the poly(A) tail of mRNAs. Over 
120 different RBPs were identified, many of which were previously known and, thus, validated their 
screening method. Not surprisingly, the authors failed to find the majority of the decay machinery in 
their oligo(dT) based purifications because the decay machinery should bind to mRNAs lacking a 
poly(A) tail (Mitchell et al., 2012). Due to this reason we decided against the use of oligo(dT) or similar 
methods to identify mRNAs contained within P-bodies. mRNA should not be contained within P-bodies 
unless it is deadenylated by the Ccr4/Not complex (Tucker et al., 2001; Wiederhold and Passmore 
2010). Therefore, an affinity column to bind poly(A) tails of mRNAs would not be capable of enriching 
for P-body proteins. By using a modified CLIP protocol, we were able to purify P-bodies and extract 
the mRNA within the aggregates. This protocol is sequence and length independent because adapters 
are ligated to each end of the RNA molecule. These adapters are used for priming of the reverse 
transcription reaction and so there should be no sequence bias, such as with oligo(dT), and all of the 
mRNA should be taken into account.   
Despite using an oligo(dT) column, some P-body proteins (Pat1, Dhh1, Lsm1, and Sbp1) were 
identified during the RBP screening process (Mitchell et al., 2012). These decay factors are suspected 
to interact with translationally competent mRNA as well as mRNA in a state of decay, explaining their 
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identification in oligo(dT) screen (Tharun et al., 2001; Coller and Parker, 2004, Coller and Parker, 2005, 
Segal et al., 2006). These four candidates were subjected to CLIP using published protocols and the 
mRNAs associated with each candidate was examined (Ule et al., 2005; Wang et al., 2009). They were 
able to recover mRNA targets and binding sites with a high degree of reproducibility and found that 
all four proteins shared substantial overlap in the mRNAs identified. This was not especially surprising 
as all four proteins have been shown assemble together in P-bodies, seemingly on the same mRNA. 
Specific linear mRNA motifs bound by P-body proteins were not identified (Mitchell et al., 2012). One 
thing that was not examined in this study was the structure of the mRNA targets. To identify target 
sequences, DREME, a program that finds highly similar linear motifs, was used (Bailey et al., 2011). 
There are many reports of mRNAs harboring RBP binding sites as structural motifs (Jansen, 2001; Holt 
and Bullock, 2009;). Two examples of structural motifs include the bicoid mRNA in Drosophila and the 
ASH1 mRNA in budding yeast (MacDonald et al., 1988; Chartrand et al., 1999). In both cases, the stem 
loops in the 3’ UTR direct the transport of the mRNA to the proper location in the cell. Therefore, 
searching for linear motifs is likely not enough. There are programs available that are able to predict 
structural motifs in mRNA, but these programs are still in their infancy (Zhao et al., 2013). Future 
experimental work may prove that some of the mRNA targets identified harbor structural motifs able 
to somehow recruit mRNAs into P-bodies.  
With the series of mRNAs bound by P-body components now identified through our own CLIP 
purification as well as others (Mitchell et al., 2012), we can begin to group mRNAs by stress condition 
and examine them for potential protein binding sites. Searches will first be performed to look for 
conserved linear motifs. As mentioned, previous studies failed to find conserved linear motifs in their 
target mRNAs bound by P-body components (Mitchell et al., 2012). Due to this finding, we will also 
perform analysis to search for structural motifs. With the knowledge gained through the CLIP 
experiment it will certainly open the door to understanding the decay state of mRNAs in the cell and 
what the P-body requirements (i.e. storage versus decay) are based on the stress the cell encounters.  
A positional bias of Pat1, Lsm1, and Dhh1 on target mRNAs became apparent during the 
published CLIP study (Mitchell et al., 2012). For example, Pat1 and Lsm1 shows a preference for 
sequences in the 3’UTR of the target mRNA, which was consistent with biochemical experiments 
showing that these proteins prefer to bind oligoadenylated 3’ ends (Chowdhury et al., 2007). This 
finding may indicate that each P-body protein may have a specific location on an mRNA. For proteins 
such as Dcp1/Dcp2, one would expect them to prefer the 5’ ends of mRNA as they perform the 
decapping reaction. Dhh1 did not appear to have a strong site preference on the mRNA and was found 
it bind at different positions throughout its mRNA targets (Mitchell et al., 2012). Perhaps for certain 
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P-body proteins like Scd6 or Dhh1, their positioning depends on the assembly of the other P-body 
proteins. Additional studies would be needed to investigate this possibility.  
Further CLIP experiments could include a variety of different P-body mutants, other mRNA 
granules, P-body regulators, and perhaps even time courses following stress introduction. One P-body 
mutant that may be interesting to examine is dcp1-2, which is deficient in decapping (Dunckley and 
Parker, 1999).  Early studies showed that mRNA is able to move into P-bodies upon starvation and 
upon alleviation of the stress, mRNA can move back into translation (Brengues et al., 2005). In the 
dcp1-2, stress removal caused most of the mRNA to move back into the translational pool, but P-
bodies were not completely abolished. Indicating that a subset of mRNAs localized to P-bodies during 
starvation are destined for decay regardless if the conditions improve. By using a dcp1-2 in a CLIP 
experiment, one could recreate the study described above and identify the mRNAs that are destined 
for decay and not purely stored under starvation conditions.  
Stress granules are storage granules that contain proteins such as ribosomes and translation 
initiation factors and their composition varies greatly depending on the cellular stress (Kedersha et 
al., 1999; Stoecklin et al., 2004; Buchan et al., 2008; Buchan et al., 2011). One could perform a CLIP 
experiment under a condition where stress granules and P-bodies form, such as starvation, and 
observe the differences in mRNA composition. Under this condition, one might suspect that P-body 
associated mRNAs will be decayed, whereas stress granule mRNAs will be primed for translation as 
soon as the stress is alleviated. It is possible that there may be overlap in the lists of associated mRNAs 
as it was reported that stress granules and P-bodies have been seen docking with one another and 
stress granules often form in close proximity to P-bodies (Wilczynska et al., 2005; Kedersha et al., 
2005; Buchan et al., 2008; Buchan et al., 2011). This spatial relationship may allow for the two granules 
to pass mRNA between them depending on the stress condition. As a P-body is an aggregate of mRNPs, 
it may be that a P-body itself is somehow subdivided into storage mRNPs and decay mRNPs. Further 
analysis of candidates mRNA by live cell imagining and using stem loops and binding proteins such as 
the MS2, PP7, or U1A systems would allow us to visualize several mRNAs at once and see if their 
occupation of a P-body during stress changes over time.  
Learning which mRNAs are present in P-bodies and under what conditions they localize is 
critical to the understanding of cell adaptation. This knowledge would enable us to determine which 
mRNAs the cell deems as unessential during stress conditions and which mRNAs are important to store 
until the stress is alleviated. One avenue that we may uncover through our studies is whether or not 
P-bodies contain some sort of timing mechanism. Previous studies indicated that mRNAs that enter 
P-bodies can be recycled once the stress is alleviated and, furthermore, deadenylation is often 
inhibited during stress (Brengues et al., 2005; Hilgers et al., 2006). These findings indicate that the cell 
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often keeps a plethora of mRNAs upon initial stress, which may later be released again into translation. 
The question of when and how the cell decides that P-bodies should transform from a storage granule 
to a decay granule is not yet understood. CLIP time course experiments may provide the answer as to 
when this timer is activated and a P-body turns from a storage granule into a decay granule. 
If we find that there is a timer for P-body contained mRNAs we can begin to elucidate the 
signals that activate this change. It may be that after a certain duration of time during a particular 
stress that a signaling cascade is activated and phosphorylation, or another post-translational 
modification, occurs on the P-body component. Since two core P-body components were determined 
to be phosphorylated (Ramachandran et al., 2001; Yoon et al;2010), it is possible that other 
components are also subjected to post-translational modification. This modification may then allow 
for the poly(A) tail of mRNAs already stored in P-bodies to become exposed and accessible to the 
deadenylation machinery. This deadenylation would then be the signal for the P-body to begin to 
decay and lose its ability to store mRNA. 
Our CLIP technique is crucial to learning more about P-bodies and the mRNA contained within 
them. By purifying P-bodies and isolating the mRNA within them, regardless of the decay state, we 
will learn not only about the composition, but the mRNA-protein relationship. These experiments 
could provide the first indication that there are specific groups of mRNAs within P-bodies. In addition, 
there may also be different pools of mRNAs, those that generally localize to P-bodies regardless of the 
stress, and those that are stress specific. The localization of specific mRNAs to P-bodies would indicate 
that they are part of not just a general, but of a specific stress response. Furthermore, these specific 
mRNAs may contain localization signals, which are then bound by specific protein interactors. 
Together, these protein interactors may be part of a signaling cascade that signals to the P-body 
component that specific mRNAs need to be bound and stored or decayed and, thus, leading to P-body 
formation.  
Since P-bodies are highly conserved among eukaryotes, what we learn in yeast may well be 
applicable to other cell types. During stress, changes in translation, mRNA degradation and mRNA 
localization occur with mRNAs often being shuttled into cytoplasmic granules. P-bodies are only one 
in a family of RNA granules including stress granules, neuronal mRNP granules and maternal mRNP 
granules. Moreover, several mRNP granules are associated with neurodegenerative diseases (Dewey 
et al., 2012; Buchan et al., 2013). In a disease state, there may be a improper regulation of mRNAs 
within the cell leading to too much or too little decay. By applying our CLIP technique to other types 
of granules, including those associated with human disease, they could be similarly studied and better 
understood.  
6. A Method Toward the Identification of mRNAs Contained witihin P-bodies 
 113 
 
7. Appendix-Materials and Methods 
 114 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7. Appendix-Materials and Methods 
 115 
7. Materials and Methods 
 
Biochemical Methods 
  
Many of the methods used in the lab are standard and so a large part of this section has been taken 
from the dissertation of Cornelia Kilchert (Kilchert, 2010). Changes have only been made where 
necessary. 
 
 
Determination of yeast cell density 
 
1 OD600 corresponds to 1.5 x 107 yeast cells per ml on the spectrophotometer Ultrospec 3100 pro 
(Amersham Biosciences). For measurements, cells were diluted to yield an OD600 of no more than 0.7. 
Unless otherwise indicated, logarithmically growing cells were harvested at an OD600 between 0.3 and 
0.7. 
 
Preparation of yeast total cell extract 
 
15 ml of yeast culture were harvested and the cells were resuspended In 150 µl 6 x Laemmli buffer. 
Approximately 120 µl of glass beads were added. After vigorous vortexing for 5 min, samples were 
incubated for 5 min at 65˚C followed by an additional 1 min of vortexing. Cell debris and glass beads 
were sedimented (2 min at 10,000 x g), and the supernatant was transferred to a fresh reaction tube. 
For subsequent analysis by SDS-PAGE and immunoblotting, 5 µl of the lysate was loaded per lane. 
 For comparison of protein expression levels, Laemmli buffer was replaced by LowDTT lysis 
buffer. The lysates were normalized to equal total protein concentration using the Biorad DC protein 
assay used according to the manufacturer’s protocol. Routinely, 20 µg of total protein were loaded 
per lane. 
 
6 x Laemmli buffer       LowDTT lysis buffer 
62.5 mM Tris/HCl (pH 6.8)      20 mM Tris/HCl (pH 8.0) 
5% -mercaptoethanol       5 mM EDTA 
10% glycerol        1 mM DTT   
2% SDS         1 % SDS 
0.0025% bromophenol blue 
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Determination of protein concentration 
 
Protein concentrations of detergent-free solutions were determined using the Biorad protein assay, 
which is based on the Bradford method (Bradford, 1976). Bovine gamma-globulin served as a protein 
standard. For detergent-containing solutions, the detergent-compatible Biorad DC protein assay was 
used, which is based on the Lowry method (Lowry et al., 1951). In this case, bovine serum albumin 
served as a standard. All determinations were performed according to the manufacturer’s 
instructions. 
 
Trichloro acetic acid (TCA) precipitation 
 
TCA precipitations of proteins were conducted essentially as described (Bensadoun and Weinstein, 
1976). One-tenth volume of 100% (w/v) TCA (4˚C) was added to the ice-cold protein solution. After 
incubation on ice for 30 min, the sample was centrifuged for 15 min (20,000 x g, 4˚C). The pellet was 
washed in 1 ml acetone (-20˚C) and sedimented again. After aspiration of the acetone, the pellet was 
dried for approximately 5 min at 65˚C and dissolved in a smaller volume of 100 mM Tris/HCl pH 8.0 
 
 
SDS- PAGE 
 
For discontinuous, denaturing SDS polyacrylamide gel electrophoresis (Davis, 1964; Ornstein, 1964; 
Laemmli, 1970), minigels (8 cm x 6.5 cm x 0.075 cm) were used. In all instances, the percentage of the 
stacking gel was 4%. The percentage of the separation gel was chosen according to the analytical 
problem. The protein samples to be analyzed were complemented by 1/3 volume of 6x Laemmli 
buffer, incubated at 65˚C for 5-15 min, briefly vortexed, and spun shortly. Formaldehyde cross-linked 
samples were boiled for 30 min at 95˚C to revert the crosslinking. The separation was performed at 
constant current (25 mA per gel). Examples of standard gel compositions are given below. 
 
SDS Running Buffer 
25 mM Tris 
192 mM glycine 
0.1% SDS 
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      10% Separation gel  4% Stacking gel 
Acrylamide 29.9%/Bisacrylamide 0.8%  20 ml    5 ml 
1.5 M Tris/HCl pH 8.0    15 ml    --- 
0.5 M Tris/HCl pH 6.8    ---    7.5 ml 
10% SDS     300 µl    150 µl 
dH2O      19.5 ml    17.1 ml 
TEMED      40 µl    30 µl 
10% APS     400 µl    200 µl 
     
  12.5% Separation gel  4% Stacking gel 
Acrylamide 29.9%/Bisacrylamide 0.8%  25 ml    5 ml 
1.5 M Tris/HCl pH 8.0    15 ml    --- 
0.5 M Tris/HCl pH 6.8    ---    7.5 ml 
10% SDS     300 µl    150 µl 
dH2O      19.5 ml    17.1 ml 
TEMED      40 µl    30 µl 
10% APS     400 µl    200 µl 
     
 
Silver staining of polyacrylamide gels 
 
Silver staining was performed essentially as described (Rabilloud et al., 1988). In short, after gel 
electrophoresis, the gel was incubated in fixative for 10 min, then washed twice in water (5 min). The 
gel was briefly incubated in a 0.02% thiosulfate solution (1/100 from stock; 1 min). After two brief 
washes in water (20 sec), the gel was stained in 0.1% silver nitrate solution for 30 min, and rinsed 
three times with water. The staining was completed by addition of developer. Once the desired 
staining intensity was reached, the reaction was stopped by addition of 10% acetic acid. All washing 
steps were carried out with 50 ml of solution. All solutions were prepared freshly, with exception of 
those given in bold below.  
 
Fixative Thiosulfate Stock Solution 
70% v/v methanol 2% w/v Na2S2O3 
0.1 ml formaldehyde (37 %) / 100 ml  
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Developer Stop Solution 
3% w/v NaCO3 
0.0004% Na2S2O3 (20 µl of 2% stock / 100 ml) 
0.1 ml formaldehyde (37%) / 100 ml 
10% acetic acid 
 
 
 
Immunoblots 
 
Proteins were transferred onto membranes using the wet-blot method (Towbin, Staehelin, & Gordon, 
1979). A sandwich was assembled consisting of the gel, the membrane, and gel blotting paper on each 
side. The proteins were electrotransferred in transfer buffer (3 h at RT, 30 V/250 mA) onto 
nitrocellulose membranes with 0.45 µm pore size. 
 After the transfer, the nitrocellulose was stained in Ponceau S solution for 5 min. Background 
was removed by washes with water. Complete destaining was accomplished by incubation in TBS. 
Unused binding sites were blocked by incubation in 5% milk (non-fat milk powder in TBS; 0.025% 
NaN3). The membranes were decorated with primary antibodies that were generally diluted in 5% 
milk in TBS for 2 h at RT or overnight at 4˚C. The membrane was washed repeatedly with TBST. Signals 
were detected using either ECL (GE Healthcare) according to the manufacturer’s recommendations or 
directly with the LiCor Odyssey system. Chemoluminescence was reported on ECL Hyperfilm 
(GE Healthcare) after different exposure times. 
 
Transfer buffer:  20 x TBS 
25 mM Tris  60 g Tris/HCl  
192 mM glycine  160 g NaCl 
0.25% SDS  4 g KCl 
20% methanol pH adjusted to 7.4 with HCl 
up to 1 l with H2O 
  
Ponceau S TBST 
0.2% w/v Ponceau S 1 x TBS  
3% trichloro acetic acid 0.1% v/v Tween-20 
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Co-immunoprecipitations 
 
Immunoprecipitations were performed as described previously (Sezen et al., 2009) with minor 
modifications. Briefly, 20 OD600 units of logarithmically growing cells grown in YPD, subjected to the 
various stresses as indicated, were disrupted with glass beads in 300 µl IP buffer. Lysates were 
incubated with 1% Triton X-100 for 10 min at 4°C. Extracts were cleared by centrifugation (3,000 x g 
for 10 min at 4°C). An aliquot was removed that served as the input control and the remainder of the 
extract was incubated with monoclonal anti-FLAG M2 antibody (Invitrogen) and magnetic bead slurry 
(Dynal) for 2.5 h at 4˚C. Beads were washed 3x with IP buffer containing 0.1% Triton X-100. The beads 
were resuspended in sample buffer and analyzed by immunoblot. 
For the RNase A treated samples, after the extracts were cleared by centrifugation, they were 
treated with 40 U of RNase inhibitor (Promega) or 1 µg/µl RNase A and incubated for 1 h at 4˚C.  The 
extracts were then spun 3 min at 3,000 x g and the supernatant was used for  immunoprecipitation as 
described above. 
 
IP Buffer 
50 mM triethanolamine pH 6.0 
150 mM KCl 
5 mM EDTA 
5 mM EGTA 
1 Roche protease inhibitor tablet per 10 ml 
1 mM PMSF 
1 mM benzamindine 
 
 
Polysome profile analysis 
 
Polysome preparations were performed according to de la Cruz et al. (1997) on 7-47% sucrose 
gradients. Briefly, 200 ml of yeast cells were grown to an OD600 of 0.5-0.7. After temperature shift or 
application of the indicated stress, cycloheximide was added to a final concentration of 100 
and the culture immediately placed into ice water. The cells were harvested at 4°C, washed once with 
10 ml cold breaking buffer, and resuspended in 0.5 ml cold breaking buffer supplemented with 1 mM 
DTT and 0.1 mM PMSF. 500 µl glass beads were added to the tube, and the cells lysed by vortexing for 
15 min at 4°C. The lysate was cleared by a short centrifugation (2 min, 10,000 x g) and the supernatant 
transferred to a fresh tube. For storage, 10% v/v glycerol was added and the lysates were stored at -
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20°C. A260 was measured in a 1:100 dilution and 8 units layered on top of a 7-47% sucrose gradient 
containing 1x Gradient Buffer. Settings of the Gradient Master (Nycomed Pharma) were according to 
the manufacturer’s recommendations for short SW41 gradients: Time: 1:58 min; Angle: 81.5°; Speed: 
16. The samples were spun in a TST41.14 rotor for 3 h and 32,000 rpm at 4°C. Gradient analysis was 
performed using a gradient fractionator (Labconco) and the Äcta FPLC system (Amersham Pharmacia 
Biotech) and continuously monitored at A254.  
 
 
Breaking Buffer 10 x Gradient Buffer 
10 mM Tris/HCl (pH 7.4) 500 mM Tris/HCl (pH 7.0) 
100 mM NaCl 120 mM MgCl2 
30 mM MgCl2 10 mM DTT 
 500 mM NH4Cl 
  
 
 
HBH purification 
 
 
The HBH-purification was carried out according to (Tagwerker et al., 2006) with modifications. Cells 
expressing Dcp2–HBH or Scd6-HBH were grown to mid to late log phase at 23˚C then shifted for 1 h 
to 37˚C. Cells were fixed by adding 37% formaldehyde to a final concentration of 1% and incubated at 
RT for 2 min with gentle agitation. The formaldehyde was quenched for 5 min by the addition of 
glycine to a final concentration of 1.25 mM. Cells were harvested (4,700 x g for 3 min at 4˚C), washed 
in 50 ml ice-cold ddH2O, pooled, sedimented by centrifugation (5 min at 3,000 x g), flash frozen in 
liquid nitrogen and stored at -80˚C. Cells were thawed and resuspended in 2 ml RT buffer 1 per gram 
of yeast cell pellet. One ml of the cell suspension was added per 2 ml screw capped tube containing 
500 µl glass beads. Lysis was performed in a FastPrep (Thermo and MP Biomedical) for 4 x 45 sec at 
4˚C. Glass beads and cell debris was cleared with a slow spin  (1,300 x g for 10 min at 4˚C) and the 
supernatant was removed and pooled. The supernatants were spun at 20,000 x g for 15 min at 4˚C 
and the resulting pellets were resuspended in 500 µl buffer 1 with 1% additional Tween-20 added. 2.5 
ml of Ni-NTA slurry washed in buffer 1 was added to the pooled lysates and rotated overnight at RT. 
The tubes were spun at RT for 3 min at 2,500 x g and washed with 10 ml buffer 1. Tubes were spun as 
before and 3 washes with 10 ml of each buffer (buffer 2, buffer 3, buffer 4) were sequentially 
performed. After the final wash and spin, 4 ml of elution buffer was added and rotated with the beads 
for 45 min. The beads were spun down as before, the elution was collected, and the elution step was 
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repeated. 300 µl streptavidin agarose washed in buffer 1 was added to the 8 ml of elute and rotated 
for 2 h at RT. The slurry was then spun as before and washed with 10 ml buffer 6. This step was then 
repeated with 10 ml buffer 7. The final wash was performed in buffer 8 and the streptavidin agarose 
was resuspended in 1 ml buffer 8. The slurry was then washed with 3x 1 ml 50 mM Tris/HCl pH 8.0, 
0.1% SDS, and 50 µl solution was left in the tube after the final wash.  To each tube 0.25 µl of 1 mg/ml 
ELC  (Endoproteinase LysC) was added and the tubes were placed at 37˚C with shaking. After 2 h, 0.25 
µl of 1 mg/ml ELC was added and the tubes were placed at 37˚C overnight with shaking. The tubes 
were briefly spun down and the supernatant was collected. The beads were extracted 2x with 50 mM 
Tris/HCl pH 8.0, 0.1% SDS (1x 200 µl, 1x 100 µl). The 3 samples were pooled and dried in the Speed-
Vac. The peptides were resuspended in 400 µl BS and loaded twice on a HILIC TopTip PolyLC spin 
column (PolyLC Inc.) that had been equilibrated with 3x 50 µl ES and 3x 50 µl BS. The column was 
washed (3x 50 µl BS) and the peptides were eluted 4x with 25 µl ES. All elutions were pooled and dried 
in a Speed-Vac. The peptides were then resuspended in 50 µl 50 mM NH4HCO3 and subjected to trypsin 
digest with 0.5 µl 1 mg/ml trypsin (Promega) for 6 h at 37˚C. Mass spectrometric analysis was 
performed using LC-MS/MS (Orbitrap) by Suzette Moes and Paul Jenö. 
 
 
 
Buffer 1  Buffer D 
50 mM NaPi (pH 8.0) 50 mM NaPi (pH 8.0) 
8 M Urea 8 M Urea 
300 mM NaCl 300 mM NaCl 
0.5% Tween-20 1% digitonin 
20 mM imidazole  20 mM Imidazole 
  
Buffer 2 Buffer 3 
50 mM NaPi (pH 6.4) 50 mM NaPi (pH 6.4) 
8 M Urea 8 M Urea 
300 mM NaCl 300 mM NaCl 
0.5% Tween-20 0.5% Tween-20 
 
 
 
 
20 mM Imidazole 
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Buffer 4 Elution Buffer 
50 mM NaPi (pH 6.4) 50 mM NaAc (pH 4.3) 
8 M Urea 8 M Urea 
300 mM NaCl 300 mM NaCl 
0.5% Tween-20 0.5% Tween-20 
40 mM Imidazole  
  
Buffer 6 Buffer 7 
50 mM Tris/HCl (pH 8.0) 50 mM Tris/HCl (pH 8.0) 
8 M Urea 8 M Urea 
300 mM NaCl 300 mM NaCl 
2% SDS 0.2% SDS 
  
BS ES 
5% acetonitril 85% acetonitrile  
10 mM NH4Ac/formic acid (pH 3.5) 10 mM NH4Ac/ formic acid (pH 3.5) 
  
 
Total RNA isolation 
 
Total RNA was isolated from yeast essentially as described (Schmitt et al., 1990). Briefly, yeast cells 
were grown to logarithmic phase and 20 OD600 were harvested. Cells were resuspended in 0.8 ml AE 
buffer, 80 μl 20% SDS and 0.8 ml PCI were added, and the tube vortexed for 10 sec. After incubation 
for 4 min at 65°C, tubes were chilled at -70°C for 30 s and then centrifuged (2 min, 10,000 x g, RT). The 
upper aqueous phase was transferred to a fresh tube and extracted with 400 μl PCI and vortexed 10 
sec. After phase separation by centrifugation, the upper aqueous phase was again transferred to a 
fresh tube and one-tenth volume of 3 M NaAc (pH 5.2) was added. The RNA was precipitated with two 
volumes 100% EtOH at -20°C, washed with 70% EtOH, and the pellet resuspended in 200 μl RNase-
free water. 
 
AE buffer 
50mM NaAc pH 5.2 
10mM EDTA 
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Quantitative reverse-transcription-PCR (RT-PCR) 
 
For qPCR, total RNA was isolated as described above. DNase treatment was carried out according to 
the manufacturer’s protocol (Promega). In short, 2 µg RNA were treated with RQ DNase and used 
directly for reverse transcription using random hexamers (Promega) and oligo(dTs) (Promega) and the 
Transcriptor Reverse Transcriptase Kit (Roche) according to the manufacturer’s protocol. 1/10 of the 
resulting cDNA was used for a test PCR to check for gDNA contamination. For the qPCR reaction, 50 
ng of cDNA was used per well and incorporation of SyBR green (Roche) was monitored on an ABI Step 
One Plus qPCR machine. 
 
Flotation of P-bodies 
 
Flotation of ER membranes was performed essentially as described previously (Schmid et al., 2006). 
The equivalent of 50 OD600 units was converted into spheroplasts at 37°C and lysed by dounce 
homogenization in 3 ml of EP buffer supplemented with 1 mM DTT and PMSF. After removal of cellular 
debris (5 min, 300 x g), membranes were pelleted by centrifugation (10 min, 13,000 x g), resuspended 
in 2 ml of EP buffer containing 50% sucrose, and layered on top of 2 ml 65% sucrose in EP buffer. Two 
additional 5 ml and 2 ml cushions (40% and 0% sucrose) were layered on top. The step gradient was 
spun in a TST41.14 rotor for 16 h and 28,000 rpm at 4°C. After centrifugation, 1 ml fractions were 
collected from each of the cushions and all interphases and TCA precipitated. The samples were 
analyzed by SDS-PAGE and immunoblot using monoclonal mouse anti-myc antibodies (9E10, Sigma) 
and polyclonal rabbit anti-Sec61 antibodies (a gift from R. Schekman and M. Spiess). 
 
EP Buffer  
20 mM Hepes/KOH (pH 7.6)  
100 mM sorbitol  
100 mM KAc  
5 mM Mg(Ac)2  
1 mM EDTA 
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HBH-CLIP (Crosslinking Immunoprecipitation) 
 
The HBH-CLIP protocol was modified from the protocols in (Tagwerker et al., 2006; Hafner et al., 2010).  
This is an intermediate protocol that was not used for deep sequencing experiments. Congwei Wang 
developed the final working protocol in the lab.   
Modified HBH-purification 
The HBH purification was performed as described previously (HBH purification) with modifications. 
Cells expressing Dcp2–HBH were subjected to various stresses, fixed by adding a final concentration 
of 1% formaldehyde, and then glycine was added to a final concentration of 1.25 mM to quench the 
reaction. Cells were harvested, washed, pooled, sedimented by centrifugation, and flash frozen in 
liquid nitrogen and stored at -80˚C. Cells were thawed and resuspended in 2 ml Lysis buffer per gram 
of yeast cell pellet. Cells were lysed using a FastPrep (Thermo and MP Biomedical) and glass beads and 
cell debris were cleared with a slow spin. The supernatant was pooled and subjected to a 20,000 x g 
spin for 15 min at 4˚C. The resulting pellets were resuspended in 500 µl Lysis Buffer with 1% additional 
Tween-20. 250 µl of streptavidin agarose slurry washed in Lysis Buffer was added to the resuspended 
pellets and rotated overnight at RT. The slurry was then spun at 3,000 x g for 3 min and washed with 
10 ml buffer 6. This step was then repeated with 10 ml buffer 7. The final wash was performed in 
buffer 8 and the streptavidin agarose was resuspended in 1 ml buffer 8.  
 
RNase T1 treatment 
The streptavidin beads were washed 3x in 1 ml of PNK buffer. After the final wash, the beads were 
resuspended in 1 bed volume of buffer and 2500 U of RNase T1 (Fermentas) was added. The tube was 
incubated at 22˚C for 15 min with occasional gentle mixing before incubation on ice for 5 min. The 
beads were washed 3x in 1 ml of PNK buffer.  
 
Dephosphorylation, radiolabeling and phosphorylation 
After the final wash the beads were resuspended in 1 bed volume of 1x NEB buffer 3 containing CIP 
(New England Biolabs) at a final concentration of 0.5 U/µl. The reaction was incubated at 37˚C with 
vigorous shaking for 10 min. Following the incubation, the beads were washed 2x with 1 ml of PNK 
buffer and 2x with 1 ml PNK buffer +DTT. The beads were resuspended in 1 bed volume of PNK buffer 
+DTT. Gamma-32P-ATP was added to a final concentration of 0.5 µCi/µl and T4 PNK (New England 
Biolabs) to a final concentration of 1 U/µl. The samples were then incubated at 37˚C for 30 min with 
vigorous shaking before the addition of ATP to a final concentration of 100 µM. Samples were 
incubated an additional 5 min at 37˚C as before. Beads were then washed 5x with 1 ml PNK buffer 
(without DTT). 
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RNA extraction 
The beads were resuspended in 2x Proteinase K buffer plus Proteinase K to a final concentration of 
1.2 mg/ml and incubated for 30 min at 55˚C. 1 ml  PCI was then added and the tube was vortexed for 
30 sec and spun for 10 min at 20,000 x g. The aqueous phase was removed and placed into a new tube 
and 50 µl DEPC and 100 µl chloroform was added. The tube was vortexed as before and allowed to 
set at RT for 2-3 min. The tube was then spun as before for 10 min at  20,000 x g. The aqueous phase 
was again removed and placed into a new tube. 1/10 vol of 3 M NaCl, 1 µl Glycoblue (Fermentas) and 
3 vol 100% EtOH was added and the RNA was allowed to precipitate 30 min at -80˚C or 1 h at -20˚C. 
The tube was spun at 4˚C for 30 min at  20,000 x g. The pellet was washed 1x with 70% EtOH and spun 
at 4˚C for 10 min at  20,000 x g. The supernatant was removed and the RNA pellet was allowed to air 
dry. 
 
3’ adaptor ligation 
The air-dried pellets were resuspended in 19 µl 3’ ligation mix, denatured at 95˚C for 30 sec, and then 
put immediately on ice. 1 µl of T4 RNA ligase 2 (1-249, K227Q) was added per tube and the reaction 
was incubated on ice for 15-20 h. 20 µl of RNA loading buffer was added and samples were run on a 
15% Urea-Acrylamide gel for 40 min at 15 W. The gel was then wrapped and placed into a phosphor-
imager cassette (Fuji) and screens were scanned on a Typhoon FLA7000 Phosphorimager (GE 
Healthcare) after 20 min, longer exposures were performed if necessary. Gel pieces corresponding to 
radioactively labeled RNA were cut from the gel and placed in 1 ml 0.4 M NaCl in DEPC and rotated at 
4˚C. The wash was collected and stored at 4˚C and replaced by 1 ml 0.4 M NaCl in DEPC. The gel slice 
was rotated at 4˚C overnight and the wash was collected the following morning. 1 ml of 100% EtOH 
and 1 µl Glycoblue was added to each of the collected 0.4 M NaCl in DEPC washes and the samples 
were placed at -80˚C for 30 min or -20˚C for 1 h. The samples were spun at 4˚C for 30 min at 13,000 
rpm. The supernatant was removed and the pellet was air dried and resuspended in 9 µl RNase free 
water 
 
5’ adaptor ligation 
To the sample, 9 µl of 5’ ligation mix was added and the RNA was denatured at 95˚C for 30 sec and 
then placed immediately on ice. 2 µl of T4 RNA ligase was added and the reaction was incubated at 
37˚C for 1 h. 20 µl of RNA loading buffer was added per reaction and the samples were run as before 
on a 15% Urea-Acrylamide gel for 40 min at 15 W. The gel was then wrapped and placed into a 
phosphor-imager cassette (Fuji) and screens were scanned on a Typhoon FLA7000 Phosphorimager 
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(GE Healthcare) after 1 h. If the signal was weak longer scans were performed, usually overnight. Gel 
pieces corresponding to radioactively labeled RNA were cut from the gel and placed in 1 ml 0.4 M NaCl 
in DEPC as described for the 3’ adaptor ligation. RNA was precipitated as previously described, air 
dried, and resuspended in 6 µl RNase free water. 
 
Ribominus rRNA removal kit: 
The RNA after 5’ adapter ligation was subjected to rRNA removal using the Ribominus rRNA removal 
kit used according to the manufacturer’s instructions (Invitrogen). The sample was then concentrated 
using the RiboMinus Concentration Module according to the manufacturer’s instructions (Invitrogen). 
The clean, concentrated RNA was stored at -80˚C until needed. 
 
Reverse Transcription 
The RiboMinus cleaned RNA was subjected to reverse transcription using Invitrogen Reverse 
Transcriptase III according to the manufacturer’s instructions. Oligo(dT)s (Promega) and random 
Hexamers (Promega) were used for priming the cDNA. 
 
PCR 
PCR was performed using 20 µl of freshly made cDNA. The primers used were SH134 and SH135, which 
correspond to sequences in the 3’ and 5’ adaptors. The PCR reaction was set up as described in 
Polymerase Chain Reaction (see Molecular Biological Methods) and run as follows:  
 
Step 1: 94˚C 5 min 
Step 2: 94˚C 30 sec 
Step 3: 53˚C 30 sec 
Step 4: 72˚C 45 sec 
Repeat steps 2-4, 35x. 
Step 5: 72˚C 10 min 
Step 6: Hold at 4˚C 
 
The resulting products were run out on a 3% agarose gel. The region of the gel corresponding to 
between 75 and 200 bp was excised. This size corresponded to the two adaptor sequences plus insert. 
The excised gel pieces were purified using the Macherey-Nagel Gel and PCR Clean-up Kit according to 
the manufacturer’s instructions. 
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TOPO Cloning and Blue/White Screening 
Purified PCR products were transformed into TOPO (pCR2.1) (Invitrogen) according to the 
manufacturer’s instructions. 1, 2, and 3 µl of PCR product were used in a 6 µl total reaction. The entire 
reaction was transformed into 50 µl chemically competent E.coli. For Blue/White screening of 
colonies, 80 µl of Blue/White screening mixture was spread on top of an LB+Amp plates and allowed 
30 min to dry. The E.coli transformations were then plated onto these Blue/White screening plates 
and they were incubated overnight at 37˚C. White colonies were picked, re-struck onto a new LB+Amp 
plate and subjected to colony PCR, as described above, using primers SH134/SH135. The resulting PCR 
products were run out on a 3% agarose gel. Colonies containing inserts larger than 75 bp were chosen 
for plasmid preparation and sequencing. 
 
Adapters and Primer sequences: 
3’ Adaptor: 5’ TGGAATTCTCGGGTGCCAAGG 
5’ Adaptor: 5’ GUUCAGAGUUCUACAGUCCGACGAUC 
SH134: 5’ CAAGCAGAAGACGGCATACGA 
SH135: 5’ AATGATACGGCGACCACCGACAGGTTCAGAGTTCTACAGTCCGA 
 
 
Buffers: 
 
Lysis Buffer      Buffer 6 
50 mM NaPi pH 8.0    50 mM Tris/HCl pH 8.0  
6 M guanidine hydrochloride   6 M guanidine hydrochloride 
300 mM NaCl      300 mM NaCl  
20 mM imidazole    2% SDS  
0.5% Tween-20 
 
Buffer 7      Buffer 8 
50 mM Tris/HCl pH 8.0    50 mM Tris/HCl pH 8.0 
6 M guanidine hydrochloride       6 M guanidine hydrochloride 
300 mM NaCl     300 mM NaCl 
0.2% SDS       
 
PNK buffer      PNK buffer +DTT 
50 mM Trish HCl pH 7.5    50 mM Trish HCl pH 7.5 
50 mM NaCl     50 mM NaCl 
10 mM MgCl2     10 mM MgCl2 
      5 mM DTT 
 
 
2x Protease K Buffer    15% Urea-Acrylamide gel 
100 mM Tris HCl pH 7.5    For 2- 15 cm gels  (30 ml) 
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200 mM NaCl     22.5 ml 20% acrylamide  
2 mM EDTA     7.5 ml 8M Urea in TBE (prepared fresh) 
1% SDS      120 µl 10% APS 
      12 µl TEMED 
 
Blue/White Screening Mixture 
40 µl  20 mg/ml X-gal 
40 µl  0.1 M IPTG 
 
 Molecular biological methods 
 
Standard techniques for nucleic acid manipulations were used throughout this study (Sambrook, 
1989). 
 
Transformations of E.coli 
 
Routinely, E. coli cells were transformed chemically. Usually, 50 μl chemically competent cells (which 
were available in the laboratory) were thawed on ice and mixed with 0.3 μl plasmid DNA or with 5 μl 
of a ligation reaction. The cells were heat-shocked for 30 sec at 42°C and immediately placed on ice. 
SOC medium (240 μl) was added to the cells. The mixture was incubated on a shaker for 30 min at 
37°C before the cells were plated out on selection plates.  
 
Plasmid preparations from E.coli 
 
Plasmid preparations from E. coli were performed according to the alkaline lysis method described 
with minor modifications (Birnboim & Doly, 1979). Routinely, 1.5 ml of an overnight culture were 
harvested (5 min, 16,000 x g, RT). Cells were carefully resuspended in 300 μl of cold buffer P1 and 
300 μl buffer P2 was added. After incubation for 5 min at RT, 300 μl of buffer P3 were added to stop 
the lysis. The solution was cleared by centrifugation (10 min, 16,000 x g, RT) and the supernatant was 
pipetted into a new tube. The plasmid DNA in the supernatant was precipitated by addition of 600 μl 
isopropanol and subsequent centrifugation (10 min, 16,000 x g, RT). The resulting pellet was washed 
with 1 ml 70% ethanol and spun again (5 min, 16,000 x g, RT). The pellet was dried at 65°C for about 
5 min and then dissolved in 20 μl H20 and stored at –20°C.  
In cases when very pure DNA was required, the Qiagen or Macherey-Nagel plasmid mini kit was used 
according to the supplier’s recommendations. 
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Buffer P1  Buffer  P2 Buffer P3  
20 mM Tris/HCl pH 8.0  0.2 M NaOH  3 M KAc pH 5.5 
10 mM EDTA  1% SDS   
100 μg/ml RNase  
Keep at 4˚C 
  
 
 
Determination of nucleic acid concentration 
 
The concentration of nucleic acids was determined using a spectrophotometer (Ultrospec 3100 pro, 
Amersham Biosciences) or the NanoVue (GE Healthcare). The nucleic acids were diluted in dH2O, and 
the absorption at 260 nm was determined. It was assumed that a unit of absorption at 260 nm 
corresponds to 50 μg/ml double-stranded DNA or 40 μg/ml single-stranded RNA. 
 
Restriction digest of DNA 
 
Plasmid preparations were analyzed by restriction digest and agarose gel electrophoresis with 
subsequent ethidium bromide staining. The guidelines for enzymatic digests provided by the suppliers 
of restriction endonucleases (NEB or Roche) were followed. For cloning purposes, restriction digests 
were purified with the PCR purification kit (Macherery-Nagel), and DNA fragments were eluted from 
agarose gels using the Gel extraction kit (Macherery-Nagel) according to the manufacturer’s 
recommendations. 
 
Cloning 
 
DNA fragments for (sub-)cloning were obtained either by restriction digest of plasmid DNA or by PCR 
amplification from genomic yeast DNA. For protein expression in yeast, the p4XX vector series was 
used (Christianson et al., 1992; Mumberg et al., 1995). In case of PCR amplification, suitable restriction 
sites were included in the primers. Purified vector DNA and purified DNA insert were ligated using the 
rapid ligation kit (Roche) following the manufacturer’s recommendations. If a unique restriction site 
was used, the digested vector was dephosphorylated with rAPid alkaline phosphatase (Roche) to 
prevent re-ligation. Positive clones were identified by colony PCR or restriction digest and verified by 
DNA sequencing. 
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Polymerase Chain Reaction (PCR) 
 
To produce DNA fragments for DNA cloning or homologous recombination, polymerase-chain-
reaction was used (Mullis et al., 1986). The proof-reading Expand High Fidelity System (Roche) was 
used for preparative production of DNA. A typical reaction contained 37 μl H2O, 5 μl 10 x reaction 
buffer, 5 μl 2 mM dNTPs, 2 x 1 μl 10 mM oligonucleotide primer and 1 μl template DNA. Usually, 35 
cycles of amplification were performed. The annealing temperature was typically at 53°C, and 
1 min/kb was allowed for elongation. 
 
DNA sequencing 
 
DNA sequencing was performed by a company (Microsynth). 
 
Glycerol stocks 
 
For the preparation of E. coli glycerol stocks, 750 μl of an overnight culture were mixed with 500 μl 
50% glycerol and stored at –80°C. For the preparation of yeast glycerol stocks, yeast cells streaked out 
as a patch and grown on appropriate plates. The plates were incubated until a dense lawn of cells was 
obtained. The cells were transferred into 800 μl 15% glycerol with a sterile glass pipette and stored at 
–80°C. 
 
Chromosomal manipulations of yeast cells 
 
To delete or tag genes in yeast cells or to place them under an exogenous promoter, PCR-generated 
cassettes were integrated into the genome as has been described (Knop et al., 1999; Gueldener et al., 
2002; Janke et al., 2004; Gauss et al., 2005; Tagwerker et al., 2006). Briefly, preparative PCR was 
performed on template plasmids with primers having 45 bp 5’-overhangs homologous to the desired 
target site in the yeast genome. The PCR-product was transformed directly into yeast cells without 
further purification. Cells were selected for with the corresponding auxotrophy or resistance marker, 
and correct integration was confirmed by analytical colony PCR. Wherever possible, expression of the 
appended tag was checked by immunoblotting on total yeast lysates. If required, the chromosomal 
manipulation was sequenced. In this case, a fragment containing the desired manipulation was 
amplified from genomic yeast DNA using the proof-reading Expand PCR system (Roche) and used as a 
template for the sequencing reaction. 
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Alleles were transferred into our preferred strain background by PCR-based allele 
replacement (Erdeniz et al., 1997) or integrated into the genomic locus using the pRS vector series 
(Sikorski & Hieter, 1989).  
 
Preparation of genomic yeast DNA 
 
Crude yeast DNA was obtained by rapid phenol/chloroform extraction (Hoffman & Winston, 1987). 
For this, 5 ml of yeast culture were grown to greater than 2 OD600 units per ml.  The cells were 
harvested and resuspended in 200 μl buffer A. Two hundred μl glass beads and 200 μl PCI were added. 
After vigorous vortexing for 5 min, 200 μl H2O were added. Phase separation was accomplished by 
centrifugation (5 min, 10,000 x g). The aqueous phase was transferred to a fresh reaction tube and 
1 ml 100% EtOH (RT) added to precipitate the DNA, which was pelleted by centrifugation for 5 min 
(16,000 g). The resulting pellet was dried at 65°C for about 5 min and resuspended in 40 μl H2O. 
Routinely, 0.5 μl genomic DNA were used per PCR reaction. 
 
Buffer A   
10 mM Tris/HCl pH 8.0    
100 mM NaCl    
1 mM EDTA    
2% Triton X-100    
1% SDS   
 
Yeast transformations 
 
Yeast cells were transformed by a highly efficienct lithium acetate transformation method (Gietz et 
al., 1995). Cells were grown over night to early log phase. Five OD600
 
of cells were harvested and 
washed once in sterile water. The cells were incubated for 5 min at 30°C in 100 mM LiAc. 
Subsequently, they were resuspended in 360 μl transformation mix and vortexed for 1 min. A heat 
shock was employed for 15-40 min at 42°C, after which the cells were pelleted (5 sec, 16,000 x g). The 
cell pellet was resuspended in 300 µl sterile water and 150 μl aliquots were plated on appropriate 
selection plates. If kanamycin or nourseothricin resistance cassettes were transformed, cells were first 
incubated in YPD for at least 3 h at RT before plating on the corresponding plates. Fast growing 
colonies were chosen for a second round of selection. Sometimes, replica plating was necessary to 
allow for the selection of stable transformants. 
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Transformation mix  
240 μl 50% (w/v) PEG (AMW 3,350)  
36 μl 1 M LiAc  
50 μl 2 mg/ml single-stranded salmon sperm DNA  
5 μl of PCR product or 0.25 μl plasmid DNA, ad 360 μl with H20 
 
 
Analytical PCR of yeast colonies 
 
Analytical PCR of yeast colonies was performed to confirm chromosomal manipulations of yeast cells. 
Generally, a forward primer binding 100-300 bp upstream of the desired integration event was 
combined with a reverse primer located on the integrated cassette, so that a product of the correct 
size was only amplified if the integration had taken place. Single yeast colonies were picked with a 
pipette tip and incubated in 10 μl 20 mM NaOH at 95°C for 5 min. Two µl was then added to the PCR 
reaction mix. A typical reaction contained 18.4 μl H2O, 2.5 μl 10 x reaction buffer, 1 μl 10 mM dNTPs, 
2 x 0.5 μl 10 μM oligonucleotide-primer, 0.15 μl Taq DNA-polymerase (Roche). Usually, the annealing 
temperature was set at 53°C, and 1 min/kb was allowed for elongation. Generally, 35 cycles were used 
for amplification. Routinely, 20 μl of the reaction were analyzed by agarose gel electrophoresis.  
 
 
Cell biological methods 
 
Pre-treatment of microscopy slides 
 
To increase cell adherence, microscopy slides were routinely pre-treated with concanavalin A (ConA). 
For ConA coating, 10  mg/ml in water) were spread on a slide to cover an area 
of approx. 1 cm2 and allowed to dry. Long-term storage at RT generally improved the adherent 
properties of ConA-coated slides.  
 
Fluorescence microscopy of GFP-fusion proteins in living cells 
 
Cells were grown over night to logarithmic phase in YPD or in the appropriate selection medium. If 
yeast cells carried an ade2 marker that caused them to accumulate a fluorescent metabolite to 
accumulate in the vacuoles, the medium was supplemented with 50 mg/l adenine to suppress cellular 
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autofluorescence. Cells were shifted for 1 h to non-permissive temperature, if necessary. A 1 ml 
aliquot was taken from liquid culture, and subjected to a specific stress if required. Cells were then 
harvested (30 sec, 16,000 x g, RT), resuspended in 50 μl HC complete that was complemented with 
glucose unless stated otherwise; if stresses were applied, the HC medium was complemented 
accordingly. 10 μl of cell suspension were spread on slides that had been pre-treated with ConA, and 
directly visualized under an Axioplan 2 fluorescence microscope from Zeiss using the GFP and eqFP611 
filters. Pictures were taken by Axiocam MRm using Axiovision software. Image processing was 
performed with Adobe Photoshop CS5. For counting, pictures were taken randomly, exported to 
Photoshop, and the tonal range adjusted using the levels dialog box to facilitate counting; all pictures 
from the same experiment were treated equally. At least three independent experiments were used 
and a minimum of 200 total cells were counted. In the quantification graphs, the size of the box is 
determined by the 25th and 75th percentiles, the whiskers represent the 5th and 95th percentiles, 
the horizontal line and the triangle represent the median and the mean, respectively.  
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Materials 
Media 
 
 
 
LB medium:     10 g Bacto-tryptone (BD) 
5 g Bacto yeast extract (BD) 
10 g NaCl (Roth) 
dH2O up to 1 l  
autoclaved the same day 
 
 
LB agar:     5 g Bacto-tryptone (BD) 
2.5 g Bacto yeast extract (BD) 
5 g NaCl (Roth) 
10 g Bacto-agar (BD) 
dH2O up to 500 ml  
autoclaved the same day 
 
SOC medium:     5 g yeast extract (BD) 
      20 g Bacto-peptone (BD) 
      20 g dextrose (Roth) 
      10 mM NaCl 
      2.5 mM KCl     
      10 mM MgSO4 
dH2O up to 1 l  
autoclaved the same day 
 
 
YP-medium:     1% Bacto yeast extract (BD) 
      2% Bacto-peptone (BD) 
dH2O up to 1 l  
autoclaved the same day 
 
7. Appendix-Materials and Methods 
 135 
YP agar:     10 g Bacto-peptone (BD) 
      5 g Bacto yeast extract (BD) 
      10 g Bacto-agar (BD) 
dH2O up to 450 ml  
autoclaved the same day 
50 ml of 20% (w/v) glucose was added before plates 
were poured. 
 
 
 
5-FOA plates: 0.34 g Yeast Nitrogen Base without amino acids (BD) 
      0.05 g 5-Fluoroorotic acid (Biovectra 1555) 
1 g Dextrose (Glucose-monohydrate, Roth 6780.2) 
      5 ml 10x HC- complete selection mixture 
dH2O up to 20 ml and filter sterilized into 25 ml warm 
(55˚C) sterile agar (1 g in 25 ml H2O) 
 
10x HC-selection mixture:    0.2 mg/ml adenine hemi-sulfate 
      0.35 mg/ml uracil 
      0.8 mg/ml L-trytophan 
      0.2 mg/ml L-histidine-HCl 
      0.8 mg/ml L-leucine 
      1.2 mg/ml L-lysine-HCl 
      0.2 mg/ml L-methionine 
      0.6 mg/ml L-tyrosine 
      0.8 mg/ml L-isoleucine 
      0.5 mg/ml L-phenylalanine 
      1.0 mg/ml L-glutamic acid 
      2.0 mg/ml L-threonine 
      1.0 mg/ml L-aspartic acid 
      1.0 mg/ml L-valine 
      2.0 mg/ml L-serine 
      1.0 mg/ml L-arginine-HCl 
      autoclaved without the component to selected for 
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10x YNB:     33.5 g Yeast Nitrogen Base w/o amino acids (BD) 
      up to 500 ml with dH2O 
wrapped in aluminum foil and autoclaved the same 
day 
 
HC medium:     800 ml dH2O 
100 ml 10x HC-XX (without the component to select 
for) 
      100 ml 10x YNB 
 
 
HC plates: hot sterile agar (10 g Bacto-agar (BD) dissolved in 350 
ml) 
 50 ml 20% dextrose 
 50 ml 10x YNB 
 50 ml 10x HC selection mixture 
 
 
Commonly used solutions and buffers 
 
Antibiotics 
1000 x ampicillin    100 mg/ml in dH2O, filter sterilized 
250 x kanamycin    10 mg/ml in dH2O, filter sterilized 
100 x G418     20 mg/ml geneticin in dH2O, filter sterilized 
2000 x ClonNAT     200 mg/ml nourseotricin in dH2O, filter sterilized 
100 x hygromycin B    50 mg/ml in dH2O, filter sterilized 
 
Inhibitors 
 
1000 x tunicamycin    1 mg/ml tunicamycin in DMSO 
333 x benomyl     10 mg/ml benomyl in DMSO 
100 x PMSF     0.1 M in isopropanol 
1000 x benzamide    1 mg/ml benzamide in dH2O 
1000 x pepstatin A    1 mg/ml in DMSO    
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1000 x leupeptin    1 mg/ml in DMSO  
1000 x antipain     1 mg/ml in ddH2O 
 
 
Solutions 
 
1000 x DTT     1 M DTT in dH2O 
X-Gal      20 mg/ml X-gal in DMSO 
150 x IPTG     150 mM, filter sterilized    
 
 
Buffer P1:     50 mM Tris/HCl pH 8.0 
      10 mM EDTA 
      100 µg/ml RNase 
      Stored at 4˚C 
 
 
Buffer P2:     0.2 M NaOH 
      1% SDS 
 
 
Buffer P3:     3 M KAc, pH 5.5 
 
 
TE Buffer:     10 mM Tris/HCl pH 7.5 
      1 mM EDTA 
 
Carrier DNA for transformations: 200 mg Salmon Sperm DNA (Sigma D1626) up to 100 
ml with TE buffer sterilized 
 
 
6x DNA loading buffer:    0.25% bromophenol blue 
      0.25% xylene cyanol 
      30% glycerol 
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50 x TAE-buffer     2 M Tris/HAc pH 7.7  
      5 mM EDTA 
 
 
5 x Laemmli-buffer    62.5 mM Tris/HCl pH 6.8 
      5% b-mercaptoethanol  
      10% glycerol 
      2% SDS 
      0.0025% bromophenolblue 
 
20 x TBS:     60 g Tris/HCl pH 7.4 
      160 g NaCl 
      4 g KCl 
      up to 1 l with dH2O 
 
TBST:       TBS with 0.1% Tween-20 
 
 
20 x PBS:     46.6 g Na2HPO4 x 12 H2O 
      4.2 g KH2 PO4 
      175.2 g NaCl 
      44.8 g KCl 
      up to 1 l with dH2O 
 
 
 
50 x Denhardt’s reagent:   10 g Ficoll type 400 
      10 g BSA fraction V 
      10 g polyvinylpyrrolidone 
      up to 1 l with dH2O, filter sterilized and stored at 
 -20˚C 
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20 x SSC:     3 M NaCl 
      0.3 M Na-citrate/NaOH pH 7.0 
 
 
DEPC-H2O :     1 l H2O 
      1 ml DEPC 
      stirred for > 1 h, then autoclaved
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Yeast Strains, oligonucleotide primers, plasmids, antibodies, and web resources 
 
Yeast Strains 
 
The yeast strains used in this study can be found in Chapters 4 (table 1) and Chapter 5 (supplementary table 1). 
 
Oligonucleotide primers 
 
Table 7.1: Oligonucleotide primers used in this study 
 
Primer Designation Sequence Purpose 
JW01 Pub1-S3  CCG GTT ATG TCT GAG CAA CAA CAG CAA CAG CAG CAA CAG CAG CAA CAA CAA CGT 
ACG CTG CAG GTC GAC  
C-terminal tagging 
(pYM); forward 
JW02 Pub1-S2 GCC TCT CTT TCT TCT TTC TTT TTG TTT CAT TCC ACT TTT CTT CAT AAT ATT TAA TCG ATG 
AAT TCG AGC TCC 
C-terminal tagging 
(pYM); reverse 
JW03 Edc3-S3  TTC CAA AAC TGT GAT CTT TTC GTC ACT GAC GGG TCC CTG CTA TTA GAT TTG CGT ACG 
CTG CAG GTC GAC 
C-terminal tagging 
(pYM); forward 
JW04 Edc3-S2  ACC GTA TGC TTA TAC GTA TCT ATC CAG TTT AGG CTA AAG TAA TTC TTG GTT TAA TCG 
ATG AAT TCG AGC TCC 
C-terminal tagging 
(pYM); reverse 
JW07 Pub1 tag test for  TGT CCT TCA TTT TCC TCT CGT tagging control; forward 
JW08 Pub1 tag test rev  AGG CCC TTT TAT TTT TCH AGC tagging control; reverse 
JW09 Edc3 tag test for  ATT ACC CTG GAT TTG AAG CCC tagging control; forward 
JW10 Edc3 tag test rev  CAT TAC CCG GGA AAG AGA AA tagging control; reverse 
JW14 Edc3 tag test int for  CGT CGG AAG TTA TTG AAA GCA tagging control; forward 
JW15 Pub1 tag test int for  TGT CTG AGC AAC AAC AGC AA tagging control; forward 
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JW24 
 
TIF4632 C term tag 
  
GAA TTA AAA AGG AAA AAG ACT AGC TTA TCG TTT CTA AAA GAA AAT CTT TTA atc gat 
gaa ttc gag ctc g 
 
C-terminal tagging 
(pYM); forward 
JW25 TIF4632 C term tag  CCA AGA GCT AAT ATG TTC GAC GCA TTA ATG AAT AAC GAT GGG GAC AGT GAT cgt acg 
ctg cag gtc gac 
C-terminal tagging 
(pYM); reverse 
JW26 Prt1 C term tag  CT AGA TAT TGT TGT TAG TTT ACA TAC AAG CCC GTA AGT TCA TGA AAT TTA atc gat gaa 
ttc gag ctc g 
C-terminal tagging 
(pYM); forward 
JW27 Prt1 C term tag  CA TCG AAG AGA TAG TTG AAG AAG TTT TGG AAG A AA CAA AGG AAA AGG TCG AA cgt 
acg ctg cag gtc gac 
C-terminal tagging 
(pYM); reverse 
JW28 Prt1 internal   AACGCCGAAAGGAAAAAGGT tagging control; forward 
JW29 Prt Reverse   ATTTGCGCTTTTTAGTCCAA tagging control; reverse 
JW30 TIF 4632 Internal   CGTGAAGGAATTGAGGGAAA tagging control; forward 
JW31 TIF 4632 Reverse  AAGAGCCCACAAAATGTGCT tagging control; reverse 
JW34 Scd6 HBH Forward  AGC AGA CCA GCC AAC CAG TTT TCG CAA CCT CCT TCC AAC GTT GAA TTT 
CGGATCCCCGGGTTAATTAA 
C-terminal tagging 
(pYM); forward 
JW35 Scd6 HBH Reverse  TAT GTA CAT ACT GAA TGA TAT ACT TAA TTT ACA TAG AAA CAT CAT TTT A 
GAATTCGAGCTCGTTTAAAC  
C-terminal tagging 
(pYM); reverse 
JW36 internal forward GTTGAACGTTGACACCTTTGG tagging control; forward 
JW37 Reverse  CGGATGGAAGAAGCCATAAA tagging control; reverse 
JW110 cmd1 Forward 
deletion 
ATCGAACTAC AAAGAAAGAG CTTAGTTAAT ACAAATAAAA AAGTACA cagctgaagcttcgtacg deletion (pUG); forward 
JW111 cmd1 Reverse deletion GAATGGTAAG GGTAAGATAG CGGGAGCAAA AAATCACAAG GATGCAC 
gcataggccactagtggatctg 
deletion (pUG); reverse 
JW112 cmd1 Forward check TTCAAGCACCCTCTTTTCCA tagging control; forward 
JW113 cmd1 Reverse check  TGCGTGTGGTTGTCAAACTT tagging control; reverse 
JW114 gcn2 Forward deletion TTTTTTTTCA ATAATTTTCC GTTCCCCTTA ACACATACTA TGTATAA cagctgaagcttcgtacg deletion (pUG); forward 
JW115 gcn2 Reverse deletion TTTACCTTTA ACTGATGCGT TATAGCGCCG CACAGATCTT TAAAGGC 
gcataggccactagtggatctg 
deletion (pUG); reverse 
JW116 gcn2 Forward check CCCAACATCACTTTACACGAA tagging control; forward 
JW117 gcn2 Reverse check CGCACACATTTATATTCACCG tagging control; reverse 
JW118 ire1 Forward deletion TAAAAAAACA GCATATCTGA GGAATTAATA TTTTAGCACT TTGAAAA cagctgaagcttcgtacg deletion (pUG); forward 
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JW119 ire1 Reverse deletion CATTAATGCA ATAATCAACC AAGAAGAAGC AGAGGGGCAT GAACATG 
gcataggccactagtggatctg 
deletion (pUG); reverse 
JW120 ire1 Forward check GGAGATCAATGAGCCAACTT tagging control; forward 
JW121 ire1 Reverse check CACCAAAAAAGTCAGTGTTGA tagging control; reverse 
JW132 Bfr1 Forward deletion CCTTTTA TCAACGTAAT AGCATATTTT CTAACAACAC AGCCATTGCC 
CAGCTGAAGCTTCGTACGC 
deletion (pUG); forward 
JW133 Bfr1 Reverse deletion GTAA TGAAGAAAGA TCAGGAGAAA AATTTTTTTC TACTTCAGGT 
GCATAGGCCACTAGTGGATCTG 
deletion (pUG); reverse 
JW134 Bfr1 Forward check TGCTACTTTGGCCGAATTAGA tagging control; forward 
JW135 Bfr1 Reverse check CACAATTATCATCGTCACACC tagging control; reverse 
JW136 Scp160 Forward 
deletion 
ACGCTTAAAATATACTTCCCACACCCCCTCCTTCCATTATAACTGCAATGCAGCTGAAGCTTCGTA
CGC 
deletion (pUG); forward 
JW137 Scp160 Reverse 
deletion 
TAAAAGCCAAAATCTATATTGAAAAAAATTGGTTTCAAAGAGCTTGTCTAGCATAGGCCACTAGT
GGATCTG 
deletion (pUG); reverse 
JW138 Scp160 Forward check AGCATTCTCTCTGACGGTGAA tagging control; forward 
JW139 Scp160 Reverse check TGCCTAAAATCCTTGGTTTTC tagging control; reverse 
JW148 Bfr1 upstream of start 
Forward 
TTCATTTTGCCCCTCCATCT tagging control; forward 
JW149 scp160 upstream of 
start Forward 
TTTTCCTTTGAAATTGCTGTC tagging control; forward 
JW202 Bfr1-S1 CTCCTTTTATCAACGTAATAGCATATTTTCTAACAACACAGCCATTGCCATG 
CGTACGctgcaggtcgac 
N-termimal tagging 
(pYM); forward 
JW203 Bfr1-S4 CTTGTCTCTAACGGAGACATCTGGGCGCTTGAACTTGTGTTGTTGGGAGGA 
catcgatgaattctctgtcg  
N-termimal tagging 
(pYM); reverse 
JW204 Bfr1 Internal Reverse 
Check 
TGTCAGCATCAACAGACTTTCTG internal tagging control; 
reverse 
JW205 Scp160-S1 ACCACGCTTAAAATATACTTCCCACACCCCCTCCTTCCATTATAACTGCAATG 
CGTACGctgcaggtcgac 
N-termimal tagging 
(pYM); forward 
JW206 Scp160-S4 CAGATCCTTCGACAGTGGAAGGGGGAGAGTCAATAGCGGTTTGTTCTTCAGACatcgatgaattctct
gtcg 
N-termimal tagging 
(pYM); reverse 
JW207 Scp160 Internal 
Reverse Check 
GTTCGCGAAGGCAGCATTTGAAC internal tagging control; 
reverse 
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JW217 Bfr1 Forward check CTTACCCGCACTGTGGCGGTG tagging control; forward 
JW218 Bfr1 Reverse check GAATGTGTACGTTGGTAGATG tagging control; reverse 
JW219 Scp160 Forward check CTTCCTTCGAAACATTGGCTA tagging control; forward 
JW220 Scp160 Reverse check ACATAGTTATGCTTTTCACCG tagging control; reverse 
JW221 Bfr1 Reverse check GATTCTTTGCTTGGCTTCTG tagging control; reverse 
JW222 Scp160 Reverse check CAGGTCCAAAGTGAAAGCCTC tagging control; reverse 
JW231 Sequencing Bfr1 CTTGTACAAGAAGCGTGACG sequencing primer; 
reverse 
JW232 Sequencing Scp160 GTGCTTTGATTGGCCCTGGTG sequencing primer; 
reverse 
JW233 Sequencing Scp160 TCATGGTAGTCTGATTGGTC sequencing primer; 
reverse 
JW234 Sequencing Scp160 TCCACCTTCCGAAACCCTG sequencing primer; 
reverse 
JW235 Sequencing Scp160 GTGAAATTAGTGATGCCTAC sequencing primer; 
reverse 
JW236 Sequencing Bfr1 CAAGAAGAAGAACCAACAGAAG sequencing primer; 
reverse 
JW248 Dhh1 Forward 
upstream 
CTCAT CATTGGATTC AGTTTTGTTT CAT tagging control; forward 
JW249 Dhh1 Reverse 
Downstream 
GCTCTTGATATGGACGGTAGTATTG tagging control; reverse 
common Kan&HIS-Primer tgggcctccatgtcgctgg internal tagging control; 
reverse 
common TRP-Primer GCTATTCATCCAGCAGGCCTC internal tagging control; 
reverse 
BZ055 pUG73-LEU2-rev ctaacgtgcttgcctcttcc internal tagging control; 
reverse 
BZ056 pUG72-URA3-rev ggacagaaaattcgccgata internal tagging control; 
reverse 
CK320 pUG72-URA3-160rev cacggtgcaacactcacttc internal tagging control; 
reverse 
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GFP-3' GFP 3' rev AAAGGGCAGATTGTGTGGAC internal tagging control; 
reverse 
GFP-5' GFP 5' rev tttccgtatgttgcatcacc internal tagging control; 
reverse 
CK059 dcp2-S2 TTCATTTACAGTGTGTCTATAAAACGTATAACACTTATTCTTTCAATCGATGAATTCGAGCTCG C-terminal tagging 
(pYM); reverse 
CK060 dcp2-S3 GGAACTTCAGGGTCTAATGAATTATTAAGCATTTTGCATAGGAAGCGTACGCTGCAGGTCGAC C-terminal tagging 
(pYM); forward 
CK063 dcp2-tagtestfor CAGCACCAAAACAGCCCTAT tagging control; forward 
CK064 dcp2-tagtestrev CTTCGGCTGCCTTCATTTAC tagging control; reverse 
CK068 dhh1-S2 AAGCGTATCTCACCACAGTAGTTATTTTTTCTTAGATATTCTTTAATCGATGAATTCGAGCTCG C-terminal tagging 
(pYM); reverse 
CK070 dhh1-tagtestfor CAAGCGATACCTCAGCAACA tagging control; forward 
CK071 dhh1-tagtestrev AATAAAAACGGTGCGCAAAT tagging control; reverse 
CK086 dhh1-S3-2 GAACATTTCATGGCGATGCCACCTGGTCAGTCACAACCCCAGTATCGTACGCTGCAGGTCGAC C-terminal tagging 
(pYM); forward 
CK095 scp160-S2 GCCAAAATCTATATTGAAAAAAATTGGTTTCAAAGAGCTTGTCTA ATCGATGAATTCGAGCTCG C-terminal tagging 
(pYM); reverse 
CK096 scp160-s3 GGTGTCGAAAAGGCCGGTGAAATGGTTTTGAAATCCTTAAGAAGA CGTACGCTGCAGGTCGAC C-terminal tagging 
(pYM); forward 
CK097 scp160-tagtestfor TGTTGGTAGCGGTGGTCATA tagging control; forward 
CK098 scp160-tagtestrev GAGGAATTTCGATTGGAGCA tagging control; reverse 
CK470 scd6-S3 AGACCAGCCAACCAGTTTTCGCAACCTCCTTCCAACGTTGAATTT CGTACGCTGCAGGTCGAC C-terminal tagging 
(pYM); forward 
CK471 scd6-S2 TACATACTGAATGATATACTTAATTTACATAGAAACATCATTTTA ATCGATGAATTCGAGCTCG C-terminal tagging 
(pYM); reverse 
CK472 scd6-tagtestfor TGAACGTTGACACCTTTGGA tagging control; forward 
CK477 pat1-deltestfor2 ATGGCCATCGAATACAGAGC tagging control; forward 
CK478 pat1-1627seqfor TTGGATAAGCAGCAAAAATTGA internal tagging control; 
forward 
CK492 PAT1-S3 TGGGGTTGGTGTATCGCGATGGTGAAATATCAGAACTAAAGcgtACGCTGCAGGTCGAC C-terminal tagging 
(pYM); forward 
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CK493 PAT1-S2 AAAAAATACATGCGTAAGTACATTAAAATTACAGGAAAAATCTTAATCGATGAATTCGAGCTCG C-terminal tagging 
(pYM); reverse 
MT-A1 Bfr1-S3 GAAAAAAGATTGAAAGAACAGGAAGAGTCTGAAAAAGATAAAGAAAATCGTACGCTGCAGGTC
GAC 
C-terminal tagging 
(pYM); forward 
MT-A2 Bfr1-S2 AGTAATGAAGAAAGATCAGGAGAAAAATTTTTTTCTACTTCAGGTATCGATGAATTCGAGCTCG C-terminal tagging 
(pYM); reverse 
common M13 F GTAAAACGACGGCCAGT sequencing primer; 
forward 
common M13 R AACAGCTATGACCATG sequencing primer; 
reverse 
3' adapter 3' adapter for CLIP TGGAATTCTCGGGTGCCAAGG adapters for CLIP 
5' adapter 5' adapter for CLIP GUUCAGAGUUCUACAGUCCGACGAUC RNA adapter for CLIP 
SH134 CLIP primers CAAGCAGAAGACGGCATACGA Primers for cDNA library 
& PCR 
SH135 CLIP primers AATGATACGGCGACCACCGACAGGTTCAGAGTTCTACAGTCCGA Primers for cDNA library 
& PCR 
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Plasmids 
 
Table 7.2: Plasmids used in this study 
Plasmid Description Source 
pUG72 loxP-URA3 cassette J. Hegemann 
pUG73 loxP-LEU2 cassette J. Hegemann 
pSH63 Cre-recombinase, TRP1 J. Hegemann 
pYM6 9myc-TRP1-cassette E. Schiebel 
pYM12 yeGFP-kanMX4-cassette E. Schiebel 
pYM16 6HA-hphNT1-cassette M. Knop 
pYM21 9myc-natNT2-cassette M.Knop 
pYM26 yeGFP-kanMX4-cassette M. Knop 
pYM51 eqFP611-kanMX4-cassette M.Knop 
pYM-N19 natNT2-pTEF-cassette M.Knop 
pRP1661 Pub1-mCherry R.Parker 
pYM-3FLAG 3FLAG-TRP1-cassette U.Rockenbauch 
pFA6a-HBH-TRP1 HBH-TRP1-cassette P. Kaiser 
pSM1960 Sec63-RFP expression, URA3 S. Michaelis 
pMS449 Scp160 ∆C2, TRP1 M.Seedorf 
pMS450 Scp160 ∆C4, TRP1 M.Seedorf 
pMS451 Scp160 C1067R , TRP1 M.Seedorf 
pSM1959 Sec63-RFP expression, LEU2 S. Michaelis 
pHS47 cmd1-3 expression, URA3 E. Schiebel 
 
 
Antibodies 
 
Table 7.3: Antibodies used in this study 
Antibody Dilution Source 
Rabbit anti-Sec61, polyclonal 1:,10,000 WB M. Spiess 
Rabbit anti-GFP, polyclonal 1:1,000 WB Torrey Pines 
Mouse anti-Myc-epitope, 
9E10, monoclonal 
1:1,000 WB Sigma 
Mouse anti-FLAG M2, 
monoclonal 
1:1,000 WB Invitrogen 
Mouse anti-
hemagglutinin(HA11), 
monoclonal 
1:1,000 WB Covance 
Rabbit anti-Scp160, polyclonal 1:1,000 WB This Study 
Rabbit anti-Bfr1, polyclonal 1:1,000 WB This Study 
Goat anti-mouse-HRP 1:10,000 WB Pierce 
Goat anti-rabbit-HRP 1:30,000 WB Pierce 
ImmunoPure Streptavidin, 
HRP-conjugated 
1:7,500 WB Thermo Scientific 
Goat anti-rabbit IgG EM BBInternational 
Rabbit anti-Myc-epitope EM Abcam 
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Web Resources 
 
Resource URL Application 
Entrez Pubmed http://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed literature 
searches 
SGD http://www.yeastgenome.org/ genomic 
sequences; data 
mining 
Proteome https://portal.biobase-international.com/cgi-
bin/portal/login.cgi 
data mining 
Euroscarf http://web.uni-
frankfurt.de/fb15/mikro/euroscarf/index.html 
plasmid 
sequences 
NEB enzyme finder http://www.neb.com/nebecomm/EnzymeFinder.asp cloning 
Primer3Plus http:// http://bioinfo.ut.ee/primer3-
0.4.0/primer3/input.htm 
qPCR primer 
design 
Manipulate a DNA 
sequence 
http://www.vivo.colostate.edu/molkit/manip/ Sequencing; 
primer design 
NCBI Blast http://blast.ncbi.nlm.nih.gov/Blast.cgi Sequence Blast 
Yeast GFP 
database 
http://yeastgfp.yeastgenome.org/getOrf.php?orf=YOR23
9W 
yeast GFP 
fusion 
localization 
ImageJ http://rsb.info.nih.gov/ij/plugins/index.html image analysis 
Motif Scan http://myhits.isb-sib.ch/cgi-bin/motif_scan 
 
Protein Motif 
search  
Pubcrawler http://pubcrawler.gen.tcd.ie/ literature 
searches 
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Abbreviations: 
 
A260  absorbance at 260 nm 
aa  amino acid  
Ac  acetate 
AP  alkaline phosphatase 
APS  ammonium persulfate 
ARF1  ADP ribosylation factor 1 
ATP  adenosine-5’-triphosphate 
bp  base pair 
BFA  brefeldin A 
BSA  bovine serum albumin 
cDNA  complementary DNA, generated by reverse transcription of RNA 
C. elegans  Caenorhabditis elegans 
CHX  cycloheximide 
ConA  concanavalin A 
COPI  coat protein complex 1 
COPII  coat protein complex 2 
CV  column volume 
DAPI  4’,6-Diamindino-2-phenylindole dihydrochloride 
DEPC  diethyl pyrocarbonate 
dH2O  distilled water 
DMSO  dimethylsuloxide 
DNA  deoxyribonucleic acid 
DNase  DNA-hydrolyzing enzyme 
dNTPs  deoxynucleotide triphosphates 
DTT  dithiothreitol 
ECL  enhanced chemoluinescence 
E. coli  Escherichia coli 
EDTA  ethylenediaminetetraacetic acid 
eGFP  enhanced GFP 
eIF  eukaryotic translation initiation factors 
ELC  endoproetinase Lys-C 
EM  electron microscopy 
eqFP611  Entacmaea quadricolor fluorescent protein, emission maximum at 611nm 
ER  endoplasmic reticulum 
EtOH  ethanol 
FISH  fluorescent in situ hybridization 
FISH/IF  fluorescent in situ hybridization combined with immunofluorescence 
g   gravitational acceleration constant 
GAP  GTPase-activating protein 
GDP  guanosine-5’-diphosphate 
GEF  guanine nucleotide exchange factor 
GFP  green fluorescent protein 
GTP  guanosine-5’-triphosphate 
GTPase  GTP hydrolyzing enzyme 
HBH  6xHis-biotinylation sequence-6xHis 
HEPES  N-[2-Hydroxyethyl]piperazine-N’-[2-ethanesulfonic acid] 
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HRP  horseradish peroxidase 
IF  immunofluorescence 
IP  immunoprecipitation 
kb   kilo base 
K. lactis  Kluyveromyces lactis 
KPi  potassium phosphate buffer 
LB   lysogeny broth 
LC-MS  liquid chromatography coupled to mass spectrometry 
MeOH  methanol 
miRNA  micro RNA 
mRNA  messenger RNA 
mRNP  messenger ribonucleoparticle 
MS  mass spectrometry 
MT  microtubule 
MW  molecular weight 
NaPi  sodium phosphate buffer 
Ni-NTA  Nickel-Nitrilo tetra-acetic acid agarose 
NMD  nonsense-mediate decay 
OD600  optical density at 600 nm 
O/N  overnight 
PAGE  polyacrylamide gel electrophoresis 
P-bodies processing body 
PBS  phosphate buffered saline 
PCI  phenol:chloroform:isoamylalcohol 
PCR  polymerase chain reaction 
PEG  polyethylene glycol 
PSMF  phenylmethylsulfonylfloride 
qPCR  quantitative PCR 
RBD  RNA-binding domain 
RBP  RNA-binding protein 
RNA  ribonucleic acid 
RNAi  RNA interference 
RNase  RNA-hydrolyzing enzyme 
rpm  revolutions per minute 
RT  room temperature 
RT-PCR  reverse transcription followed by PCR 
S. cerevisiae Saccharomyces cerevisiae 
SDS  sodium dodecyl sulfate 
SRP   signal recognition particle 
TBS  tris-buffered saline solution 
TBST  tris-buffered saline solution + 0.1% tween-20 
TCA   trichloro acetic acid 
TEMED   N,N,N’,N’-Tetramethylethylenediamine 
TGN  trans Golgi network 
tRNA  transfer RNA 
ts  temperature sensitive 
UTR  untranslated region 
WB  western blot 
WT  wild type 
yeGFP  yeast codon-optimized GFP
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